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Abstract 
Cardiovascular disease (CVD) accounts for ~17.7 million deaths annually, worldwide. 
Although several key risk factors including smoking, diet and obesity have been 
identified, these account for only 40-50% of all cases. Historically, poor oral hygiene 
and the chronic oral condition, periodontitis, characterised by gum bleeding and tooth 
loss has been implicated in the aggravation of CVD. It has been postulated that in cases 
of periodontitis, oral bacterial pathogens including Porphyromonas gingivalis and 
Tannerella forsythia can access the vascular system during gum bleeding and 
inflammatory responses within the periodontal pocket and subsequently contribute to 
atherosclerosis though interactions with platelets. This study aims to determine how 
periodonto-pathogens interact with platelets and contribute to CVD, specifically 
atherosclerosis.  
Here it is demonstrated that the CHRF-288-11 megakaryocytic-like cells can be utilised 
through a series of methodologies to study the pathogenic effects of periodontal 
pathogens on platelets and megakaryocytic cells. In vitro P. gingivalis, but not T. 
forsythia, is able to interact with platelets by inducing both platelet activation and 
aggregation. P. gingivalis is able to initiate platelet activation though intracellular 
calcium mobilisation that leads to the release of both alpha and dense granules, 
independent of bacterial outer membrane protein OMPA. P. gingivalis NCTC 11834, 
but not ATCC W50, actively associates and interacts with integrin α2β1 inducing strain 
dependant platelet aggregation and could suggest a role for bacterial fimbriae within 
platelet interactions.  
Taken collectively, this data suggests that P. gingivalis could contribute to CVD and 
atherosclerosis through interactions with platelets following invasion of the 
vasculature. Interestingly, direct interactions between bacterial cells and platelets, as 
well as bacterial genetics and virulence, appear key to the extent of platelet response 
and could highlight novel risk factors for future patient treatments. 
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Chapter 1: Introduction  
2 
1.1 Introduction Part I: Periodontitis and the oral microbiome 
1.1.1 The oral microbiota 
During gestation, a human infant remains essentially sterile but during birth, 
immediately acquires microbial communities from the birth canal and surrounding 
environment (Perez-Muñoz et al., 2017). It is these pioneering bacterial colonies that 
form the human microbiome resulting in symbiotic relationships that inhabit various 
areas of the human body, including the skin, digestive tract and the mouth (Costello et 
al., 2012). The oral cavity, provides distinct microbial habitats including the tongue, 
cheek, lip and oesophagus, as well as specific localised areas such the gingiva and the 
enamel (Xu et al., 2015) (Figure 1.1). 
 
 
Figure 1.1 Tooth, a cross section of an adult human molar. A structural, anatomical depiction of the 
human tooth, showing some areas of biofilm inhabitation such as the enamel and gingiva. 
(Encyclopaedia Britannica, 2013)  
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In healthy individuals, the human oral cavity is heavily colonised by a magnitude of 
microorganisms including bacteria, fungi, viruses and archaea (Winkelhoff et al., 1986; 
Mager et al., 2003; Wade, 2013). To date, around 700 bacterial species are known to 
form the complex structure of the human oral microbiota, although it has been 
hypothesized that a large number are yet to be identified due to lack of successful in 
vitro cultivation (Avila, Ojcius and Yilmaz, 2009). These diverse, polymicrobial, 
communities that inhabit the oral cavity exist predominantly as biofilms and function 
as a co-ordinated, fully metabolic society on every surface of the mouth including the 
teeth, gums, tongue and saliva (Marsh, 2004). 
 
1.1.2 Oral biofilm formation 
Biofilms can be defined as dynamic, complex biological systems that house multiple 
microorganisms providing a protected mode of growth, allowing cells to both survive 
in hostile environments and diverge to inhabiting new niches (Hall-Stoodley, Costerton 
and Stoodley, 2004). The first observation of biofilms was made by van Leeuwenhoek, 
who over 300 years ago described the vast array of 'animalcules' within dental plaques 
using primitive microscopy (Donlan, 2002). A general theory however, was not 
developed until 1978, stating that the majority of bacteria grow in biofilms that are 
adherent to surfaces, enclosed in an extra-cellular polymeric substance matrix and that 
differ profoundly from their planktonic (floating) counterparts (Costerton, Geesey and 
Cheng, 1978). 
Contrary to initial thoughts, oral biofilm formation is not a simple, uniform process but 
rather a sequence of complex developmental phases consisting of five stages (Hall-
Stoodley, Costerton and Stoodley, 2004). Stages one and two are generally termed as 
4 
the association of transient bacteria which is followed by adhesion. Stages three and 
four are identified as the aggregation of cells into micro-colonies followed by their 
subsequent growth and maturation. The fifth stage describes a return to the mobile, 
transient phase following significant bacterial disturbance (Hall-Stoodley, Costerton 
and Stoodley, 2004). Within the mouth the initial stage which consists of transient 
bacteria, termed 'early colonisers', pioneer the colonisation process, in hopes of 
altering the habitat so that it is suitable for other species to populate (Socransky and 
Haffajee, 2005). These specific early colonisers have the unique ability to adhere to 
oral surfaces such as the host epithelial cells of the cheeks and gums, other established 
bacterium or bacterial fragments as well as the salivary pellicle; the latter being a 
selective, protective barrier between the tooth surface and the oral environment, 
consisting of host proteins, peptides and other organic molecules (Kolenbrander et al., 
1993; Li et al., 2003; Black et al., 2004). A selection of early colonising bacteria (Figure 
1.2), depicts the interactions between bacteria and specific adhesion receptors within 
the salivary pellicle including agglutinins, mucins, phospho-proteins, proline-rich 
proteins and specific enzymes such as alpha-amylase, known bacterial interactions 
within the biofilm are also highlighted (Kolenbrander, Andersen, David, et al., 2002). Of 
the early colonisers, between 47-90% of the cultivatable species consist of Streptococci 
with the remainder population constituting of other genera including Actinomyces, 
Veillonella and Neisseria (Palmer et al., 2003; Li et al., 2004).  
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Figure 1.2 Model of biofilm formation on the tooth surface. Early colonisers are shown to interact with 
receptors on the salivary pellicle. Co-aggregation between the early colonisers, Fusobacterium 
nucleatum as well as later colonisers such as Porphyromonas gingivalis and Treponema denticola are 
also illustrated. (Kolenbrander, Andersen, David, et al., 2002) 
 
After initial colonisation, further bacterial species can become established within the 
biofilm through coaggregation; a process which allows cell-to-cell recognition and 
adhesion between genetically different bacteria, through facilitating mediators called 
adhesins (Figure 1.2) (Kolenbrander et al., 2006). One such example is the late 
coloniser Fusobacterium nucleatum which is able to coaggregate intergenetically with 
all known types of oral bacterial species(Gibbons and Nygaard, 1970; Kolenbrander et 
al., 2010). 
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1.1.3 Subgingival biofilm and periodontal disease 
In healthy individuals, the oral microbiota generally consists predominantly of 
commensals or non-pathogenic bacteria such as Streptococci , Actinomyces and 
Veilonella (Jenkinson and Lamont, 2005). However, within a diseased state, the 
formation of a dysbiotic biofilm together with an increase in the pathogenic bacterial 
load leads to periodontal diseases, which encompasses any disorder of the tissues 
surrounding and supporting the teeth (the periodontium) and can affect up to 90% of 
the global population (Pihlstrom, Michalowicz and Johnson, 2005). Currently, whilst it 
is well-established that pathogenic bacteria are prevalent within periodontal diseases, 
the initial trigger or underlying cause which initiates this increase in pathogenic load 
and results in a diseased state remains to be elucidated. It is currently unclear whether 
this is a consequence of changes in one or more bacterial species, or whether it is 
initiated by the host, locally or systemically (Socransky and Haffajee, 2005). 
Periodontal disease usually refers to the common inflammatory conditions of gingivitis 
and periodontitis. Gingivitis, the mildest form, is highly prevalent, effecting between 
50-90% of the global population and is easily reversible through routine oral care 
(Albandar and Rams, 2002). Periodontitis, the chronic inflammatory form of the 
disease, is characterised by the destruction of the periodontium and surrounding 
connective tissues, with severe cases resulting in alveolar bone loss and loss of teeth 
(Lamont et al., 1995; Pihlstrom, Michalowicz and Johnson, 2005). The progression of 
gingivitis to advanced periodontitis is shown in Figure 1.3. 
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Figure 1.3 Periodontal disease progression. Progression of periodontal disease is measured by the level 
of inflammation, gum recedence and the progressive loss of both connective and bone tissue. The 
disease has two main classifications: the acute condition, gingivitis and the chronic condition, 
periodontitis (Hajishengallis, 2015). 
 
Studies conducted by Socransky and collagues (1998) have shown that several 
bacterial complexes are associated with either periodontal health or disease. With 
regard to periodontitis, three bacterial species have been termed the 'red-complex' of 
perio-pathogens due to their involvement with the disease (Figure 1.4). These gram 
negative, anaerobic, red complex pathogens; Porphyromonas gingivalis, Tannerella 
forsythia and Treponema denticola have been associated with periodontal disease with 
P. gingivalis being reported as the keystone pathogen in periodontitis (Lamont et al., 
1995; Socransky et al., 1998; Darveau, 2010).  
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Figure 1.4 Bacterial complexes of the oral microbiome. Microbial complexes of the subgingivial biofilm 
including P. gingivalis, T. forsythia and T. denticola termed as the 'red complex'. Bacterial species are 
colour coded into groups that represent the microbial complexes that exist in clusters within the 
subgingivial plaque. Adapted from Socransky et al., (1998). 
 
Regardless of the initial trigger, 'red complex' pathogens such as P. gingivalis are able 
to integrate within developing biofilms by utilizing certain levels of metabolic 
cooperation and compatible adhesins provided by early colonizing bacteria (Holt and 
Ebersole, 2005). It is the growing availability of these factors provided by localised 
tissue degradation and further bacterial colonisation that drives the increasing 
population and complexity of the gram-negative, anaerobic bacterial populations 
resulting in the bacterial community moving from a commensal environment and 
producing a phenotypical shift to a diseased state (Ruby and Barbeau, 2002; Jenkinson 
and Lamont, 2005). The progression of periodontal disease from a mild gingivitis state 
to the chronic, inflammatory state of periodontitis is the consequence of several cycles 
of tissue destruction caused by the combined impact of the now substantial 
pathogenic bacterial challenge and subsequent localised inflammatory response by the 
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host; with the bacterial challenge being supressed by the host immune response 
before the cycle repeating itself  (Wilson and Henderson, 1995). 
1.1.4 Pathogenic bacterial species 
It is clear that the development of periodontal disease is reliant on a series of complex 
host/bacterial interactions with specific keystone pathogens implicated throughout the 
progression of the disease (Socransky et al., 1998; Holt and Ebersole, 2005). Of these 
fundamental pathogens, both P. gingivalis and T. forsythia have been reproducibly 
found in elevated numbers in patients with periodontitis (Byrne et al., 2009; Zhu et al., 
2013) and although the pathological mechanisms of these bacteria are still under 
scrutiny, it is their unique virulence qualities that allows them to evade the host 
immune system and produce the destructive characteristics of the disease (Hernandez 
et al., 2011). 
1.1.4.1 Porphyromonas gingivalis  
Porphyromonas gingivalis is a rod shaped, Gram-negative, non-motile, asaccharolytic, 
black pigmented, anaerobic bacteria that can exist with or without fimbriae (Mayrand 
and Holt, 1988). Within the healthy oral flora, P. gingivalis can be found in low 
abundance contributing <5% of the total bacterial population (Forng et al., 2000), with 
this number increasing during the conversion from a symbiotic to a dysbiotic 
microbiota, through accumulation and proliferation of the bacterium within the dental 
plaque (Haffajee et al., 1998). Despite the aetiology of periodontitis remaining 
inconclusive, the underlying presence of P. gingivalis within periodontitis, coupled with 
the pathogen's ability to manipulate the oral bacterial community, has led to the 
classification of P. gingivalis as a 'keystone' pathogen within periodontal disease 
(Hajishengallis, Darveau and Curtis, 2012). As a survival strategy, P. gingivalis is known 
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to adhere to and invade host cells as well as produce a variety of virulence factors in 
order to acquire nutrients, proliferate and evade the active surveillance of the immune 
system (Papapanou et al., 1994; Holt et al., 1999). An overview of these bacterial 
virulence factors are detailed below. 
1.1.4.1.1 Lipopolysaccharide 
Lipopolysaccharide (LPS) is a major component of Gram-negative bacterial cell walls 
which provides membrane stability and structural integrity to the bacteria (Ulevitch 
and Tobias, 1999). LPS is also able to stimulate host immune response through 
interactions with various receptors on the host's cells, initiating host cell activation and 
the production of innate host defence mediators such as proinflammatory cytokines, 
adhesion molecules and apoptosis (Caroff and Karibian, 2003; Dauphinee and Karsan, 
2006). Bacterial LPS consists of three domains; a hydrophobic domain known as lipid A 
(or endotoxin), a non-repeating 'core' oligosaccharide and a distal polysaccharide O-
antigen that interacts with the external environment (Ogawa and Yagi, 2010). The 
structural composition of LPS can however vary between bacterial species, for example 
changes within the fatty acid chain composition and charge, which can significantly 
vary the stimulation of host response. In the case of P. gingivalis, LPS released within 
outer membrane vesicles (Grenier and Mayrand, 1987) can penetrate periodontal 
tissues and stimulate innate immunity, thus contributing to the progression of 
periodontal disease (Moore, Wilson and Kieser, 1986; McCoy et al., 1987). Specifically 
P. gingivalis derived LPS has been shown to interact with various mammalian receptors 
including; toll-like receptor 2 and 4 within endothelial cells (Darveau et al., 2004), 
activation of monocytes through interactions with CD14 (Shapira et al., 1994) as well 
as acting as an antagonist for E-selectin supressing endothelial cell adhesiveness and 
promoting bacterial colonisation (Darveau et al., 1995). In addition, LPS derived from 
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P. gingivalis have been shown to vary in profile according to clinical isolates and can 
affect antibiotic resistance to polymyxin B and colony morphology (Díaz et al., 2015). 
However, despite the plethora of research focussing on P. gingivalis LPS, the 
underlying roles of LPS as well as the basis of inter-stain LPS variation are yet to be 
fully established. 
1.1.4.1.2 Gingipains 
One of the most studied aspects of P. gingivalis virulence are a group of cysteine 
proteases belonging to the peptidase C25 family, termed gingipains (Eichinger et al., 
1999). P. gingivalis actively expresses three types of gingipain; the arginine specific 
gingipain A (RgpA), arginine specific gingipain B (RgpB) and a lysine specific gingipain 
(Kgp) (Curtis et al., 1999). These 'trypsin like' enzymes are known to cleave 
polypeptides at the C-terminal of the respective arginine and lysine residues (Li and 
Collyer, 2011) and accounts for ~85% of the proteolytic activity of P. gingivalis 
(Potempa, Pike and Travis, 1997). 
Functionally, the gingipains expressed by P. gingivalis have been implicated in a 
number of bacterial and eukaryotic cell interactions. For example, gingipain activity has 
been shown to facilitate binding of P. gingivalis to extracellular matrix proteins such as 
fibronectin and collagen (O’Brien-Simpson et al., 2005) as well as bacterial adherence 
to both epithelial and endothelial cells (Pathirana et al., 2007). All three gingipains 
have also been shown to be involved in nutrient acquisition through haemolysis 
(Smalley et al., 2008; N. Li et al., 2010), in haem uptake (Simpson, Olczak and Genco, 
2004) and in the disruption of the coagulation system via the degradation of fibrinogen 
(McAlister et al., 2009) and activation of thrombin and factor IX (Imamura et al., 2001). 
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Previous work by several groups have also linked gingipain protease activity to the 
disruption of innate immune response through the degradation of multiple signalling 
peptides including complement proteins (Popadiak et al., 2007), cell surface receptors 
CD4 (Kitamura et al., 2002) and CD8 (Kitamura et al., 2002), intracellular adhesion 
molecule 1 (ICAM-1; Tada et al., 2003), as well as several cytokines including IL-1β 
(Stathopoulou et al., 2009), IL-6 (Banbula et al., 1999), IL-8 (Uehara et al., 2008) and 
TNF-α (Calkins et al., 1998). 
1.1.4.1.3 Hemagglutinins 
Hemagglutinins are a large class of virulence factors that are highly implicated with 
bacterial adhesion and nutrient acquisition (Han, Whitlock and Progulske-Fox, 1996; 
Lee, Hillman and Progulske-Fox, 1996; Shi et al., 1999). P. gingivalis is known to 
express at least eight hemagglutinins, of which a subset has been characterised and 
are known to be encoded by the group of hag genes, hagA-hagE (Connolly et al., 
2017). Hemagglutinins are known to play key role in the absorption of heme, through 
erythrocyte binding, the facilitation of gingipain activity and agglutination (Lewis et al., 
2006; Olczak et al., 2008), as well as been shown to mediate the adherence to both 
epithelial (Connolly et al., 2017) and endothelial (Song et al., 2005) cells. Further to 
this, work by Ito and colleagues (2010) identified that the hagA gene mediates co-
aggregation between P. gingivalis and Treponema denticola, suggesting a role for 
hemagglutinin domains within biofilm formation as well as mammalian cell adhesion. 
1.1.4.1.4 Fimbriae 
Fimbriae are  thin, proteinaceous filaments that protrude from the outer membrane of 
bacterial cells (Jonson, Normark and Rhen, 2004) and were first identified on P. 
gingivalis by Yoshimura and colleagues (1984). P. gingivalis is known to express two 
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distinct types of fimbriae encoded by the fimA gene, termed long/major fimbriae and 
the mfa1 gene, termed short/minor fimbriae (Enersen, Nakano and Amano, 2013). 
Major fimbriae of P. gingivalis can be classified into six types; types I-V and Ib which 
are dependent on amino terminals and DNA sequences (Nakagawa et al., 2000, 2002). 
Interestingly the presentation of major fimbriae varies between strains of P. gingivalis. 
Strains such as ATCC 381 and NCTC 11834 are highly fimbriated type I strains whereas 
strains such as ATCC W50 and W83 have much shorter, sparsely populated, type IV 
fimbriae (Sojar, Hamada and Genco, 1997).Despite the limited characterisation of 
mfa1 expression, both major and minor fimbriae are thought to contribute to both 
bacterial virulence and the progression of periodontal disease (Nakagawa et al., 2002). 
The primary role of fimA is to promote bacterial adherence to oral surfaces with fimA 
deficient strains presenting a reduced capacity for both adherence (Hamada et al., 
1994) and invasion (Njoroge et al., 1997; Weinberg et al., 1997) of oral epithelial cells. 
It is also thought that minor fimbriae contribute to the adhesive properties of P. 
gingivalis through the coaggregation of bacterial species, the formation of micro-
colonies and resistance to sheer forces (Lamont et al., 2002; Lin, Wu and Xie, 2006). 
Further to this, both the major (Ogawa, Uchida and Hamada, 1994) and minor (Amano 
et al., 2004) fimbriae have been shown to initiate immune response through the 
stimulation of inflammatory cytokine production by both monocytes and macrophages 
including interleukin 1β, interleukin 6, interleukin 8 and tumour necrosis factor α 
(Ogawa, Uchida and Hamada, 1994; Amano et al., 2004).  
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1.1.4.1.5 Outer membrane A-like proteins 
Within Escherichia coli and other Enterobacter species, the outer membrane protein, 
OmpA, is a highly abundant protein responsible for several functions including acting 
as an adhesin, an invasin, an evasin as well as forming an immune target and 
contributing to biofilm formation (Smith et al., 2007). The two major outer membrane 
subunits which form the OmpA-like protein within P. gingivalis have been shown to 
share a high degree of similarity to that of the OmpA of E. coli and have been proposed 
to hold similar cellular functions (Nagano et al., 2005). Previous research by Iwami and 
colleagues (2007) identified that OmpA is crucial for l membrane stability of P. 
gingivalis with further work by Murakami and colleagues (2014) suggesting that the 
individual subunits of OmpA could be responsible for glycoprotein interaction. 
Recently, the OmpA protein, specifically the A2 subunit, has been shown to contribute 
to both biofilm formation and host-cell interactions with epithelial cells (Naylor et al., 
2016), with the ompA genes being upregulated in highly invasive populations of P. 
gingivalis (Suwannakul et al., 2010). 
1.1.4.1.6 Adherence and invasion 
As well as virulence factors, P. gingivalis, like any bacterial species, possess the ability 
to interact with cellular surfaces of the host cells to acquire necessary growth factors 
and ultimately to survive the harsh counter measures produced by the host (Stafford 
et al., 2012). As part of this survival strategy, P. gingivalis can adhere to and invade a 
variety of host cells and tissues by exploiting cellular pathways to evade the active 
surveillance of the immune system (Papapanou et al., 1994; Lamont et al., 1995; 
Deshpande, Khan and Genco, 1998; Dorn et al., 2000). After invasion, both pathogens 
and host cells remain viable for an extended period of time during which several 
cytological changes take place (Belton et al., 1999; Simin F Nakhjiri et al., 2001; Tribble 
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et al., 2006). These cytological changes include; remodelling of the tubulin and actin 
cytoskeleton (Yilmaz et al., 2003), prevention and manipulation of the apoptosis 
pathway through transcriptome alterations (Simin F Nakhjiri et al., 2001), secretion of 
an ATP hydrolysing enzyme (Yilmaz et al., 2008), dysregulation of cellular calcium 
signalling in the host cells (Izutsu et al., 1996), selective targeting of the MAP kinase 
pathway (Watanabe et al., 2001) and a down regulation of interleukin 8 expression at 
both the transcriptional and post-transcriptional level (Darveau et al., 1998).  
 
1.1.4.2 Tannerella forsythia 
Tannerella forsythia, an anaerobic, gram negative bacterium of the Cytophaga-
Bacteroides family, was originally isolated from the oral cavity and described as 
Bacteroides forsythus by Tanner and colleagues (1986). 
To date, whilst the presence of T. forsythia in periodontitis is well documented through 
clinical studies,  the virulence factors of the bacterium are not fully characterised 
(Sharma, 2010). Studies have shown that T. forsythia adheres to and invades epithelial 
cells both in vivo (Rudney, Chen and Sedgewick, 2005; Colombo et al., 2007) and in 
vitro (Sabet et al., 2003; Inagaki et al., 2006; Sakakibara et al., 2007). In addition, T. 
forsythia is known to induce enzymatic activity that both protect the bacterium from 
the innate immune system, whilst also digesting host proteins as a molecular resource 
(Sharma, 2010). Specifically T. forsythia is able to trigger an up-regulation of host 
metalloproteinases (including MMP- 2, 3, 8, 7, 13 14 (Tervahartiala et al., 2000; Kiili et 
al., 2002), induce neutrophil recruitment, increase inflammatory response (Jusko et al., 
2012; Garred et al., 2016) and degrade host proteins such as collagen, elastin, gelatin 
and casein (Ksiazek, Mizgalska, Eick, et al., 2015). The pathogen also expresses 
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endolases which can digest fibronectin and induce pro-inflammatory cytokine 
production (IL-1β, 6, 8 and TNF-α) (Lee et al., 2015). Furthermore, T. forsythia 
expresses sialidase enzymes, which cleave the sialic acids contained within host's 
surface glycoproteins (Sharma, 2010). As well as acting as a sources of macronutrients, 
this process also aides bacterial adhesion to mammalian cells and promotes biofilm 
development (Godoy et al., 1993; Thompson et al., 2009; Honma, Mishima and 
Sharma, 2011). T. forsythia has also been shown to directly affect host cell 
transcription by upregulating the  expression of an array of host genes (Bakthavatchalu 
et al., 2011). Taken together, all of these factors ultimately result in cytopathogenic 
consequences (Nakajima et al., 2006). 
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1.2 Introduction Part II: Platelets 
1.2.1 Megakaryocytes and platelet production 
Megakaryocytes constitute a highly specialized subset of the haematopoietic stem cell 
lineage, that through proliferation and terminal differentiation give rise to circulatory 
platelets (Deutsch and Tomer, 2006). Usually residing within red bone marrow, 
immature megakaryocytes undertake a series of maturation stages (Figure 1.5) which 
result in the expansion of cytoplasmic mass, measuring >50-100 nm and 
polyploidization up to 128N (Tomer, Harker and Burstein, 1988; Patel, Hartwig and 
Italiano, 2005).  
 
 
Figure 1.5 The cell lineage of megakaryocytes. Diploid megakaryocyte progenitor cells, blast forming 
units (BFU) and colony forming units (CFU), undertake several genetic replications, through endomitosis 
before reaching maturity. Adapted from Italiano and Hartwig (2007). 
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Until recently  the bone marrow was thought to be the only location for platelet 
maturation (Levine et al., 1993). Studies have since demonstrated  that 
megakaryocytes have the ability to migrate out of the red marrow and enter the 
circulatory system before translocating to the extravascular space of the lung tissue 
where they undertake platelet biogenesis (Lefrançais et al., 2017). However despite 
these novel findings, the precise understanding of mass platelet production remains to 
be elucidated.  
It was initially hypothesized that platelets stem from long cytoplasmic protrusions, 
which extend from megakaryocytes, to form what is termed 'pro platelets' (Radley and 
Scurfield, 1980) and although other mechanisms were proposed, a modified version of 
the proplatelet hypothesis provides the most reliable model both in vivo and in vitro 
(Italiano et al., 1999; Johnson, Fletcher and Morgan, 2016; Ru et al., 2016).This 
modified model proposes that during the formation of pro platelet, cytoplasmic 
extensions act as a cellular highway on which megakaryocytes transfer a plethora of 
cellular structures and proteins to form the anucleate platelets (Deutsch and Tomer, 
2006). For example, platelet proteins such as fibrinogen receptors and von Willebrand 
factor are synthesised by the megakaryocytes before being conveyed to either the 
newly formed platelet outer-membrane or are packaged into specialised secretory 
granules (Richardson et al., 2005). Individual organelles such as alpha/dense granules, 
lysosomes and mitochondria also migrate from the main cellular body of the 
megakaryocyte, with ~30% of organelles being in motion at any one time (Richardson 
et al., 2005). During this process, the pro-platelets extend into the sinusoidal space, 
where they fragment and detach into individual platelets (Machlus and Italiano, 2013). 
However the underlying mechanism of how platelets are packaged with the necessary 
organelles and granules remains to be fully understood. 
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1.2.2 Platelet morphology and ultrastructure 
Platelets are small, discoid, anucleate cells, measuring 2-3 µm that hold a fundamental 
function within haemostasis (Thon and Italiano, 2012). An adult human maintains 
approximately one trillion platelets, of which two-thirds are in circulation, with the 
remaining third reversibly sequestered in the spleen (Thon and Italiano, 2010). 
Circulatory platelets are maintained for 7-10 days, and as well as being anucleate, 
platelets contain several distinguishing organelles including the open canalicular 
system, the dense tubular system, as well as alpha and dense granules (Heijnen and 
Korporaal, 2017). 
1.2.2.1 The open canalicular system 
The surface connected open canalicular system (OCS) comprises of a complex series of 
intracellular membrane channels that form an interconnected membrane store with 
specific function (Heijnen and Korporaal, 2017). As platelets are anucleate and have a 
limited RNA stores, platelets have restricted capacity for protein synthesis and rely on 
protein uptake from the surrounding plasma (Zucker-Franklin, 1981). Proteins such as 
fibrinogen (Harrison et al., 1989) and tissue factor (Escolar et al., 2008) are 
endocytosed via the OCS and distributed to the relevant organelles, here the alpha 
granules within the platelet. 
The OCS also functions as a cellular delivery system. During platelet activation both 
alpha and dense granule stores fuse with the OCS and plasma membrane, allowing 
their content to be trafficked to the cellular surface which does not only facilitate 
granule release but is also thought to potentiate the activation process (White and 
Krumwiede, 1987; Fogelson and Wang, 1996). 
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As well as acting as a cellular transportation network, the OCS is crucial in maintaining 
the concentration of adhesion receptor levels on the outer membrane (Sixma, 1986; 
Escolar, Leistikow and White, 1989), by acting as a storage site for glycoprotein 
adhesion receptors. For example the glycoproteins GPIIbIIIa (Cramer et al., 1990) and 
GPIb (Cramer et al., 1990), are found to be evenly expressed between the outer 
membrane and the OCS. It is hypothesised that the reserves of adhesion molecules 
contained within the OCS are trafficked to the membrane during activation to 
upregulate adhesion receptors available during thrombus formation (Escolar, Leistikow 
and White, 1989). Despite the OCS not being classified as a completely separate 
cellular component, it is thought that this intracellular plasma membrane (Escolar, 
Leistikow and White, 1989) as well as secretory alpha granules (Peters, Michelson and 
Flaumenhaft, 2012) facilitate the membrane remodelling process during platelet 
spreading and filapodia formation. Whether the OCS and plasma membrane are able 
to fuse remains to be fully understood but it has been suggested that the OCS is crucial 
for platelet activation acting as both cellular storage and enabling trafficking of both 
granule stores and glycoproteins, regulating platelet adhesion and aggregation 
(Selvadurai and Hamilton, 2018). 
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1.2.2.2 The dense tubular system 
Circulatory platelets do not contain ribosomal endoplasmic reticulum. To compensate 
for this, platelets contain the dense tubular system (DTS) which is derived from the 
parent endoplasmic reticulum of megakaryocytes (White, 1972). The DTS is primarily 
thought to regulate and store intracellular calcium in a similar way to that of the 
sarcoplasmic reticulum of striated muscle cells (White, 1972). During platelet 
stimulation the DTS has been shown to rapidly discharge stored calcium ions and raise 
cytoplasmic calcium concentrations (Dean, 1984; Ware et al., 1986) thereby facilitating 
multiple aspects of platelet activation including granule centralisation (Kroll and 
Schafer, 1989) and regulation of aggregation (Nesbitt et al., 2003). 
1.2.2.3 Alpha granules, dense granules and lysosomes 
One of the defining characteristics of platelet haemostatic activity is their large 
granular storage; namely the alpha granules, dense granules and lysosomes which 
contain a number of biologically active molecules (Rendu and Brohard-Bohn, 2001). 
Alpha granules, the most abundant of the granules within platelets (40-80 per 
platelet), contain both soluble proteins which are released extracellularly, and 
membrane bound proteins that become expressed on the plasma membrane (Blair 
and Flaumenhaft, 2009). This proteinous payload is highly involved in platelet adhesion 
as well as wound healing, vascular remodelling, immune response and inflammation 
(Heijnen and van der Sluijs, 2015). Dense granules are the second most abundant of 
the platelet granules and house a variety of haemostatically active molecules that are 
predominantly responsible for recruiting further platelets to the site of vascular insult 
(Flaumenhaft, 2013). Further to this, platelets are also known to contain few primary 
and secondary lysosomes. Although their function is not well studied, it has been 
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suggested that their enzymatic content is involved in endosomal digestion as observed 
in nucleated cells (Flaumenhaft, 2013). Key alpha granules, dense granules and 
lysosomes are detailed in Table 1.1. 
 
Granule Compound  Function 
α granule 
Platelet factor 4 Neutralises heparin effect/cytokine 
β thromboglobulin Promotes fibroblast chemotaxis 
Platelet derived growth factor 
Mitogen for fibroblast and smooth 
muscle cells. Chemotaxin for 
neutrophils 
von Willebrand factor Adhesion molecule 
Thrombospondin 
Promotes platelet-platelet 
interaction 
Fibronectin Adhesion of platelets and fibroblasts 
Fibrinogen Promotes adhesion and coagulation 
Factor V Promotes coagulation 
vascular endothelial growth 
factor 
Vascular remodelling 
Dense 
granules 
ADP Activation of platelets 
ATP Source of ADP 
Serotonin Vasoconstriction 
Calcium Coagulation 
Lysosomes 
β-galactosidase Glycoside hydrolase 
Acid phosphatase Hydrolyses acid phosphatases 
hexosaminidase Hydrolyses hexosamines 
 
Table 1.1 Platelet granules and their primary functions. Adapted from Pallister and Watson (2011).  
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1.2.3 Platelet receptors 
Platelets, like many cells types express a multitude of surface receptors in order to 
sense and interact with their environment. The major platelet receptors as well as 
their agonist or ligands are summarised in Table 1.2. Platelet integrins/membrane 
glycoproteins specific to this thesis are reviewed in more detail within Section 1.2.4. 
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Receptor Classification Platelet Receptor Ligand/Agonist Physiological Role 
Integrins 
α2β1 (GPIaIIa, CD49b/61) Collagen Platelet adhesion and thrombus stabilisation  
α5β1 (CD49e/61) Fibronectin Platelet adhesion 
α6β1 (CD49f/61) Laminin Platelet adhesion 
αLβ2 (CD102, ICAM-2)) Leukocyte function-associated antigen 
1 (LFA-1) 
Leukocyte adhesion 
αIIbβ3 (GPIIbIIIa, 
CD41/61) 
Fibrinogen, fibrin, von Willebrand 
factor, fibronectin, vitronectin and 
thrombospondin 
Promotion of platelet aggregation and 
platelet-platelet binding 
αVβ3 (CD51/61) Vitronectin, fibrinogen, von 
Willebrand factor, prothrombin and 
thrombospondin 
Platelet adhesion 
Selectins 
P-selectin (CD62P, GMP-
140) 
P-selectin glycoprotein ligand-1 (PSGL-
1), GPIb-IX-V 
Expressed during platelet activation through 
alpha granule release. Binds to neutrophils 
and monocytes. 
C-type lectin-like receptor-
2 (CLEC-2) 
Podoplanins and rhodocytin Platelet aggregation 
Leucine-rich repeat 
receptors 
GPIb-IX-V von Willebrand factor, thrombin, P-
selectin, factor XI, factor XII 
Platelet adhesion and aggregation 
Toll-like receptor 2 (TLR2) Identify various products of bacteria, 
viruses, protozoa and fungi 
Innate immune response and platelet 
activation 
Toll-like receptor 4 (TLR4) Identify various products of bacteria, 
viruses, protozoa and fungi 
Innate immune response and platelet 
activation 
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Receptor Classification Platelet Receptor Ligand/Agonist Physiological Role 
Transmembrane 
receptors 
P2X1 Adenosine triphosphate (ATP) Extracellular calcium influx, platelet activation 
and aggregation 
P2Y12 Adenosine diphosphate (ADP), P2Y1 Calcium mobilisation, platelet spreading, 
granule release, thromboxane production, 
αIIbβ3 activation and platelet aggregation 
P2Y1 Adenosine diphosphate (ADP), P2Y12 Calcium mobilisation, platelet spreading, 
granule release, thromboxane production, 
αIIbβ3 activation and platelet aggregation 
Immunoglobulin 
receptors 
GPVI Collagen Intracellular calcium mobilisation, cytoskeletal 
rearrangement, granule release, GPIIbIIIa 
activation 
FcγRIIA (CD32) Binding of GPVI Intracellular calcium mobilisation, cytoskeletal 
rearrangement, granule release, GPIIbIIIa 
activation 
Prostaglandin receptors Thromboxane 
A2/prostaglandin H2 
Thromboxane A2 Calcium mobilisation and platelet activation 
Prostacyclin receptor 
(PGI2) 
Prostacyclin Platelet inhibitor, retains platelet resting state 
Prostaglandin receptors Thromboxane 
A2/prostaglandin H2 
Thromboxane A2 Calcium mobilisation and platelet activation 
Prostacyclin receptor 
(PGI2) 
Prostacyclin Platelet inhibitor, retains platelet resting state 
 
Table 1.2 Major platelet receptors and their ligands/agonists. Adapted from Saboor and colleagues (2013) and Watson, Morgan and Harrison (2015). 
  
 26 
1.2.4 Platelet integrins/glycoproteins 
Glycoproteins are a family of transmembrane adhesion and signalling proteins, which 
within platelets are fundamental to haemostasis and thrombus formation (Clemetson 
and Polgár, 1997). Many of the glycoproteins expressed by platelets belong to the 
supergene family of integrins (Saboor et al., 2013). Mammalian integrins are expressed 
as heterodimers of non-covalently associated α and β subunits (Hynes, 2002). There 
are 18 α subunits and eight β subunits that construct the 24 separate heterodimers 
shown in Figure 1.6. 
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Figure 1.6 Representation of the 24 prototypical mammalian integrins. The integrin family of proteins 
are constructed of 24 heterodimers, each containing an α and β subunit. (Barczyk, Carracedo and 
Gullberg, 2010). 
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Platelets are known to express six integrins; namely three β1 associated integrins 
(α2β1, α5β1 and α6β1), a further two β3 associated integrins (αIIbβ3 and αVβ3) as well 
as integrin αLβ2 which are summarised in Section 1.2.3 (Table 1.2). In addition to 
integrins, platelets are also known to express other glycoproteins such as the von 
Willebrand factor receptor complex, GPIb-IX-V and the collagen receptors GPIV and 
GPVI (Saboor et al., 2013). Glycoproteins relevant to the work described in this thesis 
are reviewed in detail, below. 
1.2.4.1 Integrin αIIbβ3/GPIIbIIIa 
Expressing 80,000-100,000 copies, integrin αIIbβ3 (GPIIbIIIa, CD41/61) is the major 
integral plasma membrane protein of platelets, accounting for ~17% of the total 
membrane mass (Wagner et al., 1996a). Like all integrins, αIIbβ3 is a heterodimer and 
consists of a 1008 amino acid αIIb subunit and a 762 amino acid β3 subunit. Each of 
the subunits consist of a large extracellular region, a single transmembrane spanning 
region and a short cytoplasmic tail (Bennett, 2005). The extracellular domain of the 
alpha subunit consists of the N-terminal β-propeller domain, the thigh domain and two 
calf domains (Xia et al., 2004). The extracellular domain of the β3 subunit is composed 
of an A domain, PSI domain (plexin/semaphorin/integrin), hybrid domain, four EGF 
domains and a membrane-proximal βTD domain (Xiong et al., 2001; Xia et al., 2004). 
These 12 domains assemble as two cytoplasmic 'tails' and a globular 'head' that is 
formed by the interaction of the seven-bladed β-propeller of the α-subunit and the βA 
domain (Figure 1.7; Takagi et al., 2002; Xia et al., 2004). 
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Figure 1.7 The structure of integrin αIIbβ3. The αIIb (blue) and β3 (red) subunits depicted in the 
extended formation. (Bledzka et al., 2013).  
 
Located between the thigh and calf domains is a bending point, referred to as a 'genu' 
or 'knee'. This genu allows both subunits of the αIIbβ3 integrin to exist in two extreme 
conformations; a bent resting state or an activated extended state (Takagi et al., 2002). 
In the bent conformation, the ligand binding site of αIIbβ3 is partially sequestered 
resulting in a low affinity phenotype, but during platelet activation, this inactive bent 
integrin extends upwards in a 'switch blade' like motion, opening the head piece into a 
high affinity state for the ligand (Shimaoka, Takagi and Springer, 2002; Takagi et al., 
2002). 
αIIbβ3 is known to recognise and bind to the amino acid sequence Arg-Gly-Asp (RGD) 
present on many extracellular matrix proteins including fibrinogen, fibronectin, 
vitronectin and von Willebrand factor (Bennett, 2005). Although αIIbβ3 is known to 
contribute to platelet adhesion through interactions with extracellular matrix proteins 
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such as von Willebrand factor, this integrin holds a predominant role in facilitating 
platelet aggregation (George, 2000). Following activation and conformational changes 
in the αIIbβ3 integrin structure, the receptor is able to bind to soluble circulatory 
fibrinogen, which then acts as bridging molecules between two αIIbβ3 receptors on 
adjacent platelets (Refaai and Laposata, 2002).  
The conformational change undertaken by integrins following platelet activation are 
often attributed to the process of inside-out' signalling. Despite this process not being 
fully understood, it is known that integrin ligand binding by an external stimulus such 
as collagen or ADP, induces a series of cellular signalling pathways including activating 
the protein kinase C pathway and calcium mobilisation (Takagi et al., 2002). This in 
turn then stimulates integrin activation through 'inside-out' signalling, increasing 
ligand affinity thus driving platelet aggregation and thrombus formation (Bennett, 
2005; Bledzka et al., 2013). 
1.2.4.2 Integrin α2β1/GPIaIIa 
The α2β1 integrin (GPIaIIa, CD49b/61), expressed at 2000-4000 copies per platelet, is 
often hailed as the second most important platelet receptor after integrin αIIbβ3 
(Clemetson and Clemetson, 2007). The importance of α2β1 within coagulation was 
first identified in patients lacking in α2β1 expression, who present with a mild bleeding 
disorder and a defective aggregatory response following collagen stimulation 
(Nieuwenhuis et al., 1985).  
The activity of α2β1 is often discussed with the other major platelet collagen receptor 
GPVI. Historically it was believed that α2β1 was solely responsible for collagen 
adhesion, with GPVI acting as a regulatory mediator of the subsequent platelet 
aggregation (Jung and Moroi, 1998). However recent advancements have found that 
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binding of GPVI to collagen generates further inside-out signalling, activating integrin 
α2β1 allowing it to also bind to the collagen ligand (Jung and Moroi, 1998, 2000). 
Interestingly agonists specific to αIIbβ3-induced platelet aggregation have also been 
shown to activate integrin α2β1 increasing its affinity and initiating collagen binding 
(Jung and Moroi, 2000). Further to this, under sheer flow the α2β1 collagen receptor is 
not able to initiate platelet adhesion independently (Sarratt et al., 2005). In vitro, 
platelets depend on the initial tethering of GPIb of the GPIb-IX-V complex, to initiate 
adhesion before secondary binding activity is undertaken by further collagen binding 
proteins such as α2β1 and GPVI, further emphasising the complexity of platelet 
thrombus formation (Clemetson and Clemetson, 2007). 
1.2.4.3 GPIb-IX-V 
The GPIb-IX-V complex is a platelet surface receptor with unique properties regarding 
structure, function and signalling pathways (López, 1994). The history of GPIb-IX-V 
begins with the discovery of the congenital bleeding disorder, Bernard-Soulier 
syndrome (Bernard and Soulier, 1948), in which patients present with an increased 
bleeding time, thrombocytopenia and extremely large platelets, which was later 
attributed to a deficiency of GPIb-IX-V expression (López et al., 1998). GPIb-IX-V 
consists of the following subunits; GPIbα (CD42bα) disulphide-linked to GPIbβ 
(CD42bβ/CD42c), noncovalently complexed with GPIX (CD42a) and GPV (CD42d) all of 
which contain leucine-rich repeat regions and are expressed in a ratio of 2:2:2:1 
respectively (Figure 1.8) (Andrews, Lopez and Berndt, 1997; López et al., 1998; Berndt 
et al., 2001). 
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Figure 1.8 The GPIb-IX-V complex. GPIb-IX-V is constructed of the following subunits; GPIbα disulphide-
linked to two GPIbβ subunits which are noncovalently associated with GPIX and GPV. The N-terminal 
houses the ligand binding site and leucine-rich repeat regions. (Hadjkacem, Gargouri and Gargouri, 
2011). 
 
The 282 amino acid residues within the N-terminal of GPIbα house the binding site for 
the ligands von Willebrand factor, macrophage-1 antigen (Mac-1), P-selectin, α-
thrombin, clotting factors XI and XIIa, as well as circulatory high-molecular weight 
kininogen (HMWK; Berndt et al., 2001). 
During haemostasis, the predominant function of GPIb-IX-V is adhesion to von 
Willebrand factor under high sheer flow, after which, several signalling pathways are 
initiated with platelets, resulting in intracellular calcium mobilisation, cytoskeletal 
rearrangement, degranulation, inside-out activation of αIIbβ3 and ultimately in 
platelet aggregation (Andrews, Lopez and Berndt, 1997; López et al., 1998; Bodnar et 
al., 1999; Gu et al., 1999; Berndt et al., 2001). GPIbα is also known to bind α-thrombin, 
thereby inducing thrombin dependant platelet aggregation and can bind to factor XI 
and XIIa which regulates the coagulation cascade (Berndt et al., 2001). 
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In addition, GPIb-IX-V is also thought to contribute to innate immune response. 
Interactions between GPIb-IX-V and neutrophil Mac-1 or P-selectin are suggested to 
facilitate the formation of platelet-leukocyte-endothelial multi-cellular complexes, 
localising immune response to the site of vascular insult (Cerletti, Evangelista and de 
Gaetano, 1999; Cerletti, de Gaetano and Lorenzet, 2010). 
1.2.5 Platelets in haemostasis 
Haemostasis is the process in which, following vessel injury, platelets form a clot which 
serves to limit the resulting haemorrhage (Rasche, 2001). This process is defined in two 
stages; primary haemostasis consists of the initial adhesion of platelets to the injured 
vessel and secondary haemostasis which is often referred to as the coagulation 
cascade. The original coagulation cascade proposed by Macfarlane (1964) suggested 
that coagulation was initiated by contact of the blood with foreign substances or 
damaged tissues. This contact then initiates a series of enzymatic steps in which 
coagulation factors, generally indicated by roman numerals, act firstly as a substrate 
and then as an activator or catalyst for the subsequent stages (Macfarlane, 1964). 
Since then, the majority of these 13 coagulation factors have been shown to circulate 
within the blood stream as zymogens, before being activated into serine proteases 
(Davie, Fujikawa and Kisiel, 1991) The exceptions are factors V and VIII which are 
glycoprotein cofactors as well as factor XIII which is a transglutaminase (Chaudhry and 
Babiker, 2018). Combined, these factors result in the coagulation cascade which 
concludes in the conversion of fibrinogen to fibrin and thrombus formation (Chaudhry 
and Babiker, 2018). The coagulation cascade can be separated into the three distinct 
extrinsic, intrinsic, and common activation pathways which are detailed in Figure 1.9 
and summarised below. 
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Figure 1.9 The intrinsic, extrinsic and common pathways of the coagulation cascade. The intrinsic 
pathway is activated through contact with a negatively charged surface or through exposure to collagen. 
The extrinsic pathway is activated through exposure to tissue factor released by damage vessel. Both 
the intrinsic and extrinsic pathway result in the activation of the common pathway, which through 
activation of factor X result in the formation of fibrin and a stabilised thrombus. Adapted from Pallister 
and Watson, 2011. 
 
 
1.2.5.1 The intrinsic pathway 
The intrinsic pathway is the longer of the two pathways of secondary haemostasis. In 
vitro this pathway is initiated through platelet interaction with the exposed collagen 
within the damaged extracellular matrix of the vascular endothelium. This interaction 
initiates the activation of the serine kinase factor XII which becomes XIIa, which in turn 
acts as a catalyst activating factor XI to factor XIa. This activated XIa then results in the 
activation of factor X to Xa, giving rose to the subsequent stages of the coagulation 
cascade (Gailani and Renné, 2007). 
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1.2.5.2 The extrinsic pathway 
The extrinsic pathway is the shorter of the two haemostatic pathways and was named 
so because of its dependence on the exogenous stimulation by tissue factor (TF) 
(Davie, Fujikawa and Kisiel, 1991). Following damage to the vessel wall, endothelial 
cells release tissue factor forming the activated TF-VIIa complex (Nemerson, 1988). 
This TF-VIIa complex is the key initiator of the protease coagulation cascade, resulting 
in the activation of both factor IX to IXa and X to Xa (MacKman, 2009). The extrinsic 
pathway also results in the production of low amounts of thrombin, which further 
amplifies to coagulation cascade by activating the glycoprotein cofactors V and VIII 
(Edgington et al., 1991). 
1.2.5.3 The common pathway 
The common pathway begins with the activation of factor X to Xa, which unifies both 
the intrinsic and extrinsic pathways. Activated factor X, factor V, tissue phospholipids, 
platelet phospholipids as well as calcium ions form the thrombinase complex which 
cleaves prothrombin (factor II) to thrombin (factor IIa) (Coughlin, 2000). Thrombin 
then cleaves fibrinogen into insoluble fibrin and activates factor XIII, which covalently 
crosslinks the fibrin polymers, forming the dense fibrin mesh and a definitive 
secondary haemostatic plug (Palta, Saroa and Palta, 2014). 
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1.2.6 Platelet adhesion, aggregation and plug formation 
The complex series of events that result in normal haemostatic response not only 
require the enzymatic stages of the coagulation cascade but also rely on fundamental 
changes in platelet phenotype and cellular activity (Gailani and Renné, 2007). In 
platelets, primary adhesion or primary haemostasis refers to the attachment of 
platelets to the sub endothelium, while platelet to platelet 'adhesion' is termed 
aggregation to differentiate the two processes entirely (Clemetson and Polgár, 1997). 
Upon the initial insult to the vessel wall, platelets are recruited to the injury site via 
interactions with the exposed subendothelial extracellular matrix (ECM), resulting in 
primary adhesion (Ruggeri, 2009). Following contact with the ECM, the platelet 
glycoprotein (GP) complex Ib-IX-V binds to von Willebrand factor associated with the 
exposed collagen fibres of the subendothelium. This initial tethering with GPIb-IX-V 
then leads platelets to undertake subsequent activation signalling and phenotypic 
cytoskeletal spreading/flattening(Ruggeri and Mendolicchio, 2007).  
Once activated, platelets then initiate a further barrage of cellar events, resulting in 
secondary haemostasis and platelet plug stabilisation. Platelet aggregation is initiated 
through conformational changes within GPIIbIIIa, which increases the receptors' 
binding affinity for fibrinogen, resulting in platelet-platelet aggregation (Clemetson and 
Polgár, 1997). The growing platelet aggregate is stabilised through a multitude of 
platelet to platelet interactions contained within the thrombus and remains adhered 
to the vessel wall through further interaction with the secondary collagen receptors 
GPIaIIa, GPIV and GPVI (Holinstat, 2017).  
In addition to this, thrombin, as well as acting as a platelet agonist, converts fibrinogen 
to fibrin, forming a dense, insoluble, fibrin mesh that intertwines adhered platelets and 
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passing red blood cells, resulting in a definitive platelet plug (Tomaiuolo, Brass and 
Stalker, 2017). Once formed the haemostatic plugs become firmly adhered to the site 
of vascular injury, preventing further haemorrhage whilst also resisting the sheer force 
of circulatory blood flow (Minors, 2007). 
1.2.7 The roles of platelet within innate and adaptive immunity 
As well as having a substantial involvement within the haemostasis, platelets also hold 
a primary role within the immune system, which at the very principle level rapidly 
accumulate to the epicentre of any vascular injury and provide an immediate barrier 
against infection (Gardiner and Andrews, 2013). Platelets have been shown to 
accumulate and attract other immune cells to sites of infection through active 
chemotaxis and the release of antimicrobial chemokines, such as platelet factor 4 and 
interleukin 8 (Lowenhaupt et al., 1982; Juselius and MacDonald, 2004; Skoglund et al., 
2008; Ali, Wuescher and Worth, 2015). Further studies have demonstrated that 
platelets have both the ability to internalize pathogens (Yeaman, 1997, 2010a, 2010b) 
and to exhibit antimicrobial activity which is triggered by bacterial LPS stimulation 
(Zielinski et al., 2001; Lopes-Pires et al., 2012). Bacterial LPS has also been shown to 
upregulate the production of IL-6, cyclooxygenase-2 and prostaglandin E2 through 
stimulation of toll-like receptor 4, the MAP-kinase pathway and Nf-kB signalling (Scott 
and Owens, 2008). Periodontitis has also been implicated in bacterial-platelet 
interactions, with periodontal pathogens, specifically Porphyromonas gingivalis 
increasing the levels of P-selectin excretion, triggering platelet activation (Laky et al., 
2011; Ganji et al., 2014), as well as causing an up regulation of CD40L expression 
through TLR-2 and 4 interactions (Assinger et al., 2012). 
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1.3 Introduction Part III: Periodontitis and cardiovascular 
disease 
1.3.1 The systemic impact of periodontitis  
Periodontitis and the associated chronic periodontal inflammation have historically 
been linked to other systemic diseases (Kerr, 1951, 1962). Both periodontal diseases 
and systemic diseases share a number of the similar risk factors such as smoking, age 
and obesity and often have inflammation as an underlying principle basis (Beck et al., 
1998; Paquette, Brodala and Nichols, 2007). A highly studied example of the systemic 
impact of periodontitis is the development of endocarditis. Although the specific 
factors that lead to endocarditis are unknown, it is believed that the increased 
bacterial load of predominantly Staphylococcus, Streptococcus and Enterococcus 
species found within the bloodstream that leads to infected cardiac tissue could 
originate from the dysbiotic biofilm found within periodontitis (Carinci et al., 2018). 
Further to this, recent research has shown that periodontal bacteria are found within 
post-mortem human brains (Poole et al., 2013), have been implicated in nerve cell 
damage (Watts, Crimmins and Gatz, 2008) and shown to exacerbate pathogenesis 
(Miklossy, 2011) within Alzheimer's disease. In addition, there have been further links 
between periodontal pathogens and rheumatoid arthritis (RA) with genomic material 
derived from P. gingivalis been discovered within samples of patient synovial fluid 
(Martinez-Martinez et al., 2009; Reichert et al., 2013), encouraging suggestions that 
these bacteria may provide a novel mechanism for the progression of RA (Wegner et 
al., 2010). Further relationships between periodontal pathogens and diabetes have 
also been suggested by groups such as Demmer et al., 2008, with further groups 
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suggesting that periodontitis could produce adverse effects for patients with diabetes 
(Borgnakke et al., 2013) but also that diabetes may increase the progression of 
periodontitis (Chávarry et al., 2009). Furthermore, several mechanisms linking 
periodontitis  to the atherosclerotic process and atherosclerotic disease such as stroke 
and myocardial infarction have been put forward (Joshipura et al., 2003; Reyes et al., 
2013; Scannapieco and Cantos, 2016). 
Although clear evidence links oral infection and systemic disease, the bacterial 
interactions that take place are likely to be complex and involve more than a singular 
mechanism. Due to this fact several theorised mechanisms that have been proposed 
by which periodontal disease may impact further than the immediate oral 
environment and have a distal effect (Table 1.3). 
 
 
Table 1.3 Theoretical mechanisms proposed to how explain periodontal disease may have a systemic 
impact. Adapted from Reyes et al (2013).  
Oral bacterial invasion of epithelial and endothelial cells; 
• Protects bacteria from host defence to extend bacterial survival 
• Stimulates innate immune response and exacerbates systemic inflammation  
Oral bacteria penetrate and enter the vascular system; 
• Able to migrate and establish infection within other organs and tissues (e.g. 
brain abscess) 
• Exacerbate or stimulate inflammation in non-localised tissues 
• Directly impact other organs or tissues (e.g. arteries, liver.). 
Biologically active molecules from chronic oral inflammation enter the vascular system 
and impact both ongoing inflammation or organ/tissue systems (e.g. LPS, cytokines) 
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1.3.2 Periodontal infection and atherosclerotic vascular disease 
Cardiovascular disease (CVD) and atherosclerosis are globally a leading cause of death 
accounting for ~30% of all deaths worldwide (WHO, 2018). Various cross-sectional 
studies have suggested that periodontitis is directly associated with atherosclerotic 
cardiovascular disease independently of traditional risk factors such as smoking and 
obesity (Bahekar et al., 2007; Friedewald et al., 2009; Kebschull, Demmer and 
Papapanou, 2010). 
When considered broadly, periodontal disease and atherosclerotic vascular disease 
(AVD) have a multitude of common etiological and epidemiological factors including 
sharing several risk factor groups (smoking, diabetes, diet) and producing correlative 
biological markers (C-reactive protein, interleukin 1, endothelial growth factor, 
interleukin 8 etc.) (Aarabi et al., 2015). Periodontal infection has also been shown to 
cause an increase in AVD associated markers (Eberhard et al., 2013). Studies have 
found bacterial DNA through PCR analysis of endarterectomy samples (Nakano et al., 
2006, 2007, 2008; Pucar et al., 2007; Gaetti-Jardim et al., 2009), with both genetic 
material and viable cells of both P. gingivalis and T. forsythia found in atherosclerotic 
legions (Marcelino et al., 2010). Further studies have shown that periodontal 
pathogens can directly influence endothelial cells in vitro, causing the up-regulation of 
inflammatory cytokines, such as IL-1β, IL-6 and IL-8, as well as causing up-regulation of 
adhesion molecules, monocyte chemotactic protein (MCP-1), intracellular adhesion 
molecule (ICAM-1), vascular adhesion molecule (VCAM-1), and endothelial-leukocyte 
adhesion molecule (E-selectin) (Takahashi et al., 2006; Ho et al., 2009). Interestingly, P. 
gingivalis and its fimbriae are able to induce cell adhesion molecule cleavage and 
endothelial apoptosis (Sheets et al., 2005, 2006). In vitro studies have demonstrated 
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that monocytes suffer very similar consequences to endothelial cells when exposed to 
periodontal pathogens (Hajishengallis et al., 2006). Further reports also highlight an 
increased adhesion of monocytes to P. gingivalis infected endothelial cells (Roth, 
Moser, et al., 2007), with both P. gingivalis and T. forsythia causing an increase in 
monocytic cytokine and adhesion molecule production (Pollreisz et al., 2010; Sahingur 
et al., 2010). P. gingivalis has been described to increase the low density lipoprotein 
(LDL) uptake of monocytes, promoting the formation of foam cells (Giacona et al., 
2004). Although conclusive evidence is yet to be presented, three specific and distinct 
pathways have been proposed as to how periodontal pathogens may migrate into the 
vascular system; Firstly, bacteria conduct trans-cellular migration, moving through 
multiple epithelial cells until reaching vascular endothelial cells (Kebschull, Demmer 
and Papapanou, 2010). Secondly, the pathogen either invade or exploit phagocytosis 
of host immune cells, evading the intracellular digestion processes and elicit a 'Trojan 
horse' method of transportation and thirdly, external influence, such as dental work, 
chewing or brushing of the teeth and gums, directly ruptures the vascular system , 
bridging the gap to the periodontal infection (Reyes et al., 2013). It is therefore 
essential to understand the key stages of AVD progression and how periodontal 
pathogens may influence this process. The following three figures describe; (A) the 
potential role of periodontal pathogens in the initiation and development of 
endothelial dysfunction (Figure 1.10a), (B) how these pathogens may contribute to the 
formation of fatty streaks and atherosclerotic plaques (Figure 1.10b) and (C) the 
proposed pathways that model the maturation and rupture of atherosclerotic plaques 
(Figure 1.10c) (Kebschull, Demmer and Papapanou, 2010).  
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Figure 1.10 Schematic representation of the potential role of periodontal pathogens in atherosclerotic 
vascular disease progression. (A.) Vascular endothelial cells are exposed to and invaded by periodontal 
pathogens e.g. P. gingivalis, which proceed to multiply intracellularly, triggering activation of toll-like 
receptor 2 (TLR2) and an up regulation of pro-inflammatory cytokines, cell adhesion molecules and 
apoptosis. (B). Further potential progression of atherosclerotic plaque formation, through foam cell 
formation due to exposure to periodontal pathogens. Apoptosis of low-density laden (LDL) macrophages 
cause accumulation of lipids. Periodontal pathogens also influence the induction of smooth muscle cell 
proliferation, extracellular matrix (ECM) build-up and the attraction of T-cells within the plaque. (C) 
Exposure to periodontal pathogens causes the up regulation of endothelial apoptosis or anti-endothelial 
auto antibodies. Pathogen assisted breakdown of the ECM matrix also occurs by plaque macrophages, T-
cells and plasma cells leading to mature plaque formation and subsequent vessel rupture. (Kebschull, 
Demmer and Papapanou, 2010) 
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Another mechanism that resides at the heart of atherosclerotic biology is the 
substantial role of platelets. Platelets can be activated either indirectly, through the 
vascular endothelium and exposed surface markers or through direct interaction with 
bacterium or their biological products such as LPS (Jennings, 2009). Oral pathogenic 
bacteria have been described to interact with platelets through toll-like receptors 
(TLR's), causing activation and the release of activation markers such as P-selectin and 
ADP (Shiraki et al., 2004; Blair et al., 2009; Zhang et al., 2009). Both T. forsythia and P. 
gingivalis have been described to increase the activation of platelets, inducing the up 
regulation of P-selectin and platelet-monocyte complexes (Nicu et al., 2009; 
Papapanagiotou et al., 2009; Laky et al., 2011), with P. gingivalis also inducing the pro-
thrombotic pathway (Roth et al., 2009). However, the mechanisms underlying these 
interactions and the resulting consequences remain to be elucidated. 
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1.4 Research rationale and Thesis aims 
The periodontopathogens Porphyromonas gingivalis and Tannerella forsythia found 
within the chronic oral disease of periodontitis have been suggested to contribute to 
and exacerbate the progression of atherosclerotic vascular disease. It is hypothesised 
that through the destructive phenotypes of chronic periodontitis and the subsequent 
localised bleeding within the periodontium, opportunistic pathogens P. gingivalis and 
T. forsythia are able to gain access to the vasculature. During this process, these 
periodonto-pathogens are able to directly or indirectly interact with circulatory 
platelets, resulting in an activated platelet state and the formation of platelet 
aggregates. It is then this altered platelet state which exacerbates or contributes to the 
progression of atherosclerotic vascular disease. 
In order to investigate the potentiated interactions between periodonto-pathogens 
and mammalian platelets: 
• The use of the megakaryocytic-like cells, CHRF-288-11 was investigated as a 
putative in vitro platelet-like cell model.  
• A multicolour flow cytometry panel was developed to study the effect of 
periodontal pathogen interactions on platelet marker expression. 
• The direct interactions of pathogens with platelets were characterised 
• The possible induction of platelet aggregation by a range of P. gingivalis and T. 
forsythia strains at varying multiplicities of infection was investigated. 
• The mechanisms by which periodonto-pathogen might induce platelet 
activation were determined. 
  
 45 
Chapter 2: Materials and methods 
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2.1 Materials 
All chemical reagents unless otherwise stated were purchased from Sigma-Aldrich or 
ThermoFisher Scientific.  All manufacturers and suppliers are shown in Table 2.1. 
Supplier Location 
ABBIOTEC California, USA 
Abcam Cambridgeshire, UK 
Biolegend London, UK 
BMG Labtech Buckinghamshire, UK 
G E Healthcare Buckinghamshire, UK 
Gibco, ThermoFisher Scientific Leicestershire, UK 
Hawksley Sussex, UK 
Invivogen Toulouse, Fr 
Oxoid, ThermoFisher Scientific Hampshire, UK 
Pierce, ThermoFisher Scientific Illinois, USA 
Roche Hertfordshire, UK 
Sigma-Aldrich Poole, UK 
Sysmex Buckinghamshire, UK 
ThermoFisher Scientific Leicestershire, UK 
TOCRIS Gloucestershire, UK 
Table 2.1 Manufacturers and suppliers.  
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2.2 Antibodies 
All antibodies against P. gingivalis and T. forsythia were kindly donated by Dr Graham 
Stafford, School of Clinical Dentistry, University of Sheffield, Sheffield, UK. Details of 
antibodies used in this study are provided in the Table 2.2 below: 
Antibody Name Host 
Animal 
Raised Against 
mAb 1B5 Mouse Porphyromonas gingivalis LPS 
TF S-Layer 
Rabbit 
Tannerella forsythia S-layer 
TF Whole Cell 1 Tannerella forsythia ATCC 43037 
PG Whole Cell 1 Porphyromonas gingivalis NCTC 11834 
PG Whole Cell 2 Porphyromonas gingivalis, NCTC 11834 
α nanH Sialidase 
Rat 
Tannerella forsythia ATCC 43037, sialidase 
mutant (ΔnanH) 
α nanS Sialate-exterase 
Porphyromonas gingivalis ATCC 381, sialate-O-
acetylesterase mutant (ΔnanS) 
Table 2.2 Bacterial specific antibodies used within this study. 
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Table 2.3 shows mammalian antibodies used throughout this body of work, with Table 
2.4 detailing secondary antibodies used within this study. 
Specificity Alternate Name Host Species Supplier and 
Catalogue Number 
Integrin β1 CD29 Mouse Abcam #ab30394 
Integrin β3 CD61 Mouse Abcam #ab34409 
mToR N/A Rabbit Cell Signalling #7C10 
Phalloidin-X Texas 
Red 
N/A N/A ThermoFisher #T7471 
Zombie Green N/A N/A Biolegend #423111 
CD42b-PE GP1b Mouse Biolegend #303906 
CD61-PE/Cy7 Integrin β3, GPIIIa Mouse Biolegend #336416 
CD41-Pacific Blue Integrin αIIb, GPIIb Mouse Biolegend #303714 
CD62P-PE/Cy7 GMP-140, PADGEM Mouse Biolegend #304922 
CD41/61-APC Integrin αIIbβ3, GPIIbIIIa Mouse Biolegend #359808 
PE-IgG Control N/A Mouse Biolegend #400112 
Pacific Blue-IgG 
Control 
N/A Mouse Biolegend #400151 
PE/Cy7-IgG Control N/A Mouse Biolegend #400126 
APC-IgG Control N/A Mouse Biolegend #4000222 
Table 2.3 Primary antibodies used throughout this study. Antibodies were optimised and used at assay 
dependant concentrations detailed within each relevant section of Chapter 2. 
 
Specificity Host Species Catalogue Number and 
Supplier 
Anti-Rabbit Alexa Fluor 488 Goat Invitrogen #A11008 
Anti-Mouse Alexa Fluor 488 Goat Abcam #ab150117 
Table 2.4 Secondary antibodies used throughout this study.  
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2.3 Bacterial Strains and Mutants 
All bacterial strains used were kindly donated by Dr G. Stafford and details of the 
strains are shown in Table 2.5. 
Species Genotype Relevant characteristic(s) 
Tannerella 
forsythia 
43037 ATCC Strain 
43037 ΔNanH 
NanH sialidase deficient mutant of ATCC 
43037 (eryR) (Honma, Mishima and Sharma, 
2011) 
43037 ΔWecC 
WecC isogenic mutant of ATCC 43037 (eryR) 
(Honma et al., 2007) 
Porphyromonas 
gingivalis 
NCTC 11834 NCTC Strain 
NCTC 11834 ΔOmpA1 
OmpA1 (PGN_0729) deletion mutant of ATCC 
33277 (eryR) (Naylor et al., 2016) 
NCTC 11834 ΔOmpA2 
OmpA2 (PGN_0728) deletion mutant of ATCC 
33277 (eryR) (Naylor et al., 2016) 
ATCC 381 ATCC Strain 
ATCC 381 ΔSia0352 
Sialidase 0352 deficient mutant of ATCC 381 
(eryR) 
 ATCC W50 ATCC Strain 
Table 2.5 Bacterial strains and mutants used within this study. EryR - erythromycin resistance.  
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2.4 Bacterial Growth 
P. gingivalis strains were maintained on fastidious anaerobic agar (FA) supplemented 
with 5% horse blood (Oxoid, ThermoFisher) while T. forsythia strains were maintained 
on FA agar supplemented with 5% horse blood, 0.17 mM N-acetylmuramic acid (NAM) 
and 25 μg/mL gentamycin. 
For growth in liquid cultures, P. gingivalis was grown in brain heart infusion (BHI) 
(Oxoid, ThermoFisher) broth supplemented with 0.4 % yeast extract, 1 mg/mL vitamin 
K1, 1 mg/mL hemin and 250 μg/mL cysteine.  
T. forsythia was grown as liquid cultures in tryptic soy broth (TSB) supplemented with 
0.5% yeast extract, 5 μg/mL hemin, 0.5 μg/mL vitamin K, 0.17 mM NAM and 0.1% 
cysteine.  
Erythromycin (10 μg/mL) was included as a selective antibiotic in the media after 
autoclaving where appropriate (see table 2.5) and bacteria grown on solid surface or 
as liquid cultures were incubated at 37 °C under anaerobic conditions (10% H2, 80% N2, 
10% CO2). Bacterial counts were determined using a bacterial counting chamber 
(Hawksley). 
2.4.1 Long Term Bacterial Storage 
For long term storage, bacterial cultures were kept at -80 °C. Routine bacterial cultures 
were maintained as in section 2.4 before being removed from supplemented FA plates, 
resuspended in ice-cold fresh growth medium containing 17% glycerol and 
immediately stored. 
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2.5 Megakaryocytic Cell Culture and Differentiation 
2.5.1 Megakaryocyte Cell Line CHRF-288-11 
The CHRF-288-11 cell line was kindly provided by Prof. Willem Ouwehand & Dr Cederic 
Ghevaert (Division of Transfusion Medicine, Department of Haematology, University of 
Cambridge, Cambridge, UK). The CHRF-288-11 cells were routinely cultured in RMPI-
1640 medium containing L-glutamine (Gibco, ThermoFisher Scientific) supplemented 
with 1% non-essential amino acids and 10% foetal bovine serum (FBS) at 37 °C in a 
humidified incubator with 5% CO2. 
2.5.2 Cell Passaging 
CHRF-288-11 cells were grown until confluent (~1x106 cells/mL) before passaging. Cells 
suspensions were transferred to a fresh tube before centrifugation (200 g, 5 min, room 
temperature (RT)). The supernatant was discarded and the cell pellet was resuspended 
in phosphate-buffered saline (PBS). Following further centrifugation (200 g, 5 min, RT), 
cells were resuspended in fresh RPMI at a density of 1x105 cells/mL. 
2.5.3 Cryopreservation of Cells 
Cells were cryopreserved for long term storage. Cells at confluency (1x106 cells/mL) 
were pelleted at 200 g for 5 min at RT before being resuspended and washed in PBS. 
Cells were then further centrifuged for 5 min (200 g, RT) and re-suspended in freezing 
media (complete RPMI-1640 containing 10% dimethyl sulfoxide (DMSO). Cells at a 
density of ~5x105 cells/mL were then transferred into cryopreservation tubes before 
being placed into a Mr Frosty™ for 24 hours at -80 °C, after which the vials were 
transferred to liquid nitrogen for long term storage. When needed, cells were revived 
by quickly thawing in a water bath at 37 °C. Cells were then immediately transferred 
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into fresh culture media and cultured for 6h. After this time period, the cell media was 
replaced to remove the DMSO and normal cell culture protocol was then followed. 
2.5.4 CHRF-288-11 Differentiation 
For differentiation, CHRF-288-11 cells were seeded in routine culture medium (RPMI-
1640 with L-glutamine (Gibco, ThermoFisher Scientific), 1% non-essential amino acids, 
10% FBS) containing 50 ng/mL of Phorbol 12-myristate 13-acetate (PMA). Cells were 
then cultured for five days without a media change at 37 °C in a humidified incubator 
with 5% CO2. For experiments requiring cells in suspension, differentiated CHRF-288-
11 cells were washed twice with PBS and incubated in 1x trypsin-EDTA for two min at 
37°C in a humidified incubator with 5% CO2. Cell detachment was confirmed using light 
microscopy and an equal volume of complete RPMI-1640 was added to neutralise 
trypsin activity. After detachment cells were then processed in an assay dependant 
manner.  
2.5.5 Cell Counting 
Cells were counted using the Countess II FL automated cell counter (Invitrogen). Cell 
suspensions were removed and mixed with an equal volume of trypan blue before 
being transferred into a countess chamber slide. Cell counts were then generated 
automatically, with none viable cells being discounted by trypan blue exclusion. 
2.6 Platelet Isolation 
Blood was obtained from healthy volunteers within the Biomolecular Sciences 
Research Centre, Sheffield Hallam University, UK, with informed consent. The use of 
platelets in this study was approved by the Sheffield Hallam University Research Ethics 
Committee (Ethics application No. HWB-BIO-03), Sheffield Hallam University, Sheffield, 
UK. 
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2.6.1 Blood collection 
After a tourniquet had been applied, the first sample was drawn into an EDTA-
containing Vacutainer. The tourniquet was then removed and any subsequent samples 
were drawn into sodium citrate Vacutainers, allowing blood to flow by gravity. All 
tubes were inverted to ensure full distribution of the anticoagulant and then processed 
accordingly. Full blood count (FBC) was determined using the EDTA blood sample by a 
haematology analyser (XP-300, Sysmex). 
2.6.2 Platelet rich plasma preparation 
Each sample was centrifuged at 200 g for 20 min at room temperature with no brake 
applied. After centrifugation, the straw-coloured platelet rich plasma (PRP) layer was 
removed using a sterile Pasteur pipette and transferred to a fresh tube. The isolated 
PRP was analysed by the Sysmex XP-300 to determine platelet concentration and 
confirm that the sample is free of other blood contaminants. 
2.6.3 Platelet poor plasma preparation 
Previously isolated PRP was further centrifuged at 800 g for 20 min at room 
temperature with no brake in order to pellet platelets. After centrifugation, the 
supernatant was carefully removed and transferred to a fresh tube before being 
utilised to set '0% aggregation' in an experiment dependant manner. 
2.6.4 Modified Tyrode's Buffer 
Modified Tyrode's Buffer was made by adding; 134 mM NaCl, 12 mM NaHCO3, 2.9 mM 
KCl, 0.34 mM Na2HPO4, 1 mM MgCl2, 10 mM HEPES, to dH2O and adjusting the pH to 
7.4. Prior to use, the buffer was supplemented with 5 mM glucose, 25 mM CaCl2 and 3 
mg/mL BSA. 
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2.7 Phenotypic Analysis Methods 
2.7.1 Antibiotic Protection Assays 
Antibiotic protection assays were carried out in a Class II safety cabinet that had 
previously been sterilised by UV light. CHRF-288-11 cells were seeded at a density of 
1x106 cells/mL into 24 well plates in complete RPMI media and allowed to differentiate 
for five days (Section 2.5.4). Before starting the antibiotic protection assay, all buffers 
and cell culture media were pre-warmed to 37 °C. Three 'sacrificial' wells were washed 
three times with PBS, before 1x trypsin-EDTA was added to the plate and incubated for 
two min at 37 °C in a humidified incubator with 5% CO2. The trypsin-EDTA was then 
neutralised with an equal volume of complete media, the cell suspensions were 
removed, counted and averaged to determine the relevant bacterial count for an MOI 
of 1:100. The remaining wells were washed twice with PBS to remove any 
undifferentiated cells before incubating with complete RPMI supplemented with 2% 
BSA for one hour at 37 °C in a humidified incubator with 5% CO2. During this 
incubation, P. gingivalis strains (wild-type or mutants) were removed from 72 hour 
blood agar plates, resuspended in complete RPMI before being counted and adjusted 
to equal an MOI of 1:100. Following blocking of non-specific sites, wells were washed 
three times with PBS before the addition of the bacterial suspension. In parallel, the 
bacterial suspension was added to three wells not seeded with mammalian cells to 
assess bacterial viability throughout the assay. Well seeded with CHRF-288-11 cells but 
not infected were also included as controls. Samples were incubated for 90 min at 
37°C in a humidified incubator with 5% CO2. Following bacterial incubation, to 
determine percentage invasion, cells were washed three times with PBS, before being 
incubated for a further 60 min with complete RPMI media supplemented with 200 µM 
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of metronidazole in order to asses in the invaded population. All wells containing 
mammalian cells were then washed a further three times with PBS before the addition 
of sterile water and each well was scraped for one minute for ensure complete cell 
lysis. Cell lysates were then serially diluted and spotted onto blood agar plates using 
the Miles-Misra method. Well containing only bacterial cells were only serially diluted 
before being plated the same way. Blood agar plates with then incubated 
anaerobically at 37 °C for up to five days before colony forming units (CFU's) were 
counted and recorded. 
2.7.2 Immunofluorescent Microscopy 
2.7.2.1 Phenotypic characterisation of CHRF-288-11 differentiation 
Sterile 13mm coverslips were added to each well of a 24-well plate. The wells were 
then washed twice with PBS before being seeded at a density of 1x106 cells and 
allowed to differentiate for up to seven days (Section 2.5.4). Cells were also seeded at 
a density of 5x105 cells as an undifferentiated control. After the appropriate 
differentiation period, cell media was removed, each well was washed three times 
with PBS before cells were fixed for 10 min in 4% paraformaldehyde (PFA). After 
fixation, cells were washed three times in PBS, permeabilised with 0.5% Triton-X in PBS 
for 8 min and washed a further three times with PBS. Cells were then blocked with 3% 
BSA for one hour at room temperature, washed three times with PBS before being 
incubated with the high affinity F-actin probe Texas Red-X phalloidin at a 
concentration of 1:3500 in PBS with 3% BSA for a further hour at room temperature, 
protected from light. Each well was washed a further three times with PBS before the 
coverslips were removed and mounted with ProLong Gold anti-fade mountant with 
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DAPI (Invitrogen). Each slide was then left in the dark for 24 hours at room 
temperature before imaging with a fluorescent microscope (Olympus BX60). 
2.7.2.2 Phenotypic evaluation of bacterial challenge on differentiated CHRF-
288-11 cells 
Sterile 13 mm coverslips were added to each well of a 24-well plate. The wells were 
then washed twice with PBS before being seeded at a density of 1x106 cells and 
allowed to differentiate for five days (Section 2.5.4) at 37°C in a humidified incubator 
with 5% CO2. Cells were also seeded at a density of 5x105 cells as an undifferentiated 
control. P. gingivalis (wild-type or mutants) or T. forsythia strains were removed from 
72 hour blood agar plates, resuspened in RPMI before being counted and adjusted to 
equal an MOI of 1:100. Cells were then challenged with bacterial suspensions for 90 
min at 37°C in a humidified incubator with 5% CO2 before fixation in 4% PFA for 10 min 
at room temperature. As above, cells were washed three times in PBS, permeabilised 
with 0.5% Triton-X in PBS for 8 min and washed a further three times with PBS. Cells 
were then blocked with 3% BSA for one hour at room temperature, washed three 
times with PBS before being incubated with primary antibodies (see Table 2.3) at a 
relevant concentration in 3% BSA. Cells were washed three times with PBS and before 
further incubation with the corresponding secondary antibodies (see Table 2.4) at the 
desired concentration in 3% BSA. Where applicable the high affinity F-actin probe 
Texas Red-X phalloidin (diluted 1:3500) was also included with the secondary 
antibodies. Each well was washed a further three times with PBS before the coverslips 
were removed and mounted with ProLong Gold anti-fade mountant with DAPI. Each 
slide was then left in the dark for 24 hours at room temperature to allow the mountant 
to cure before imaging with a fluorescent microscope (Olympus BX60). 
 57 
2.7.2.3 Visualisation of platelets challenged with perio-pathogens 
Isolated platelets (PRP) in sodium citrate Vaccutainers were counted using the Sysmex 
XP-300 and resuspended at 1x106 platelets/mL of modified Tyrode's buffer. Where 
applicable, this modified Tyrode's suspension also included either 20µM ADP or P. 
gingivalis strains that had been removed from 72 hour blood agar plates, counted and 
resuspended at an MOI of 1:10. Each platelet suspension was incubated at room 
temperature for 20 min before fixation in 0.5% PFA for 30 min again at room 
temperature. Each sample was then cytospun onto separate slide at 800 g for 20 min 
at room temperature before being washed three times with PBS, permeabilsed for 8 
min with 0.5% Triton-X, washed a further three times with PBS and blocked with 3% 
BSA for an hour at room temperature. Each slide was then incubated with primary 
antibodies (anti-integrin β1, anti-integrin β3, anti-mToR; see Table 2.3) for 1 hour at 
room temperature at a relevant concentration in 3% BSA, before being washed three 
times with PBS and further incubation with the corresponding secondary antibodies 
(see Table 2.4) at the desired concentration in 3% BSA for an hour at room 
temperature. Where applicable the high affinity F-actin probe Texas Red-X phalloidin 
was also included with the secondary antibodies at a concentration of 1:3500. Each 
slide was then washed three times with PBS before mounting with ProLong Gold 
antifade mountant containing DAPI. Each slide was left in the dark for 24 hours at 
room temperature before imaging with a fluorescent microscope (Olympus BX60). 
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2.7.3 Electron microscopy  
2.7.3.1 White's Saline  
White's saline A was made by adding; 2.4 M of sodium chloride (NaCl), 0.1 M of 
potassium chloride (KCL), 0.046 M of magnesium sulphate (MgSO4), 0.064 M of 
calcium nitrate tetrahydrate (Ca(NO3)2 4H2O) to 100 mL of distilled water. 
White's saline B was made by adding; 0.131 M of sodium carbonate (NaHCO3), 0.008 M 
of sodium phosphate dibasic heptahydrate (Na2HPO4 7H2O), 0.004 M of potassium 
phosphate monobasic (KH2PO4 anhydrous), 0.0003 M of phenol red to distilled water. 
The solution was adjusted to pH 7.4 before being further distilled water was added to 
a total volume of 100 mL. 
2.7.3.2 Electron microscopy of platelet/perio-pathogen interactions 
Isolated platelets (PRP) were counted using the Sysmex XP-300 and transferred into 
fresh Eppendorph tubes ( 4x108 platelets/test). Platelets were then infected with P. 
gingivalis (at an MOI of 1:10 ) that had been removed from 72 hour blood agar plates, 
resuspended in modified Tyrode's buffer and counted. As a positive control platelets 
exposed to 20 µM of ADP were also included. Samples were incubated for 20 min at 
room temperature before the addition of glutaraldehyde in equal volumes of both 
White's saline A and B to give a final concentration of 0.1% glutaraldehyde. Samples 
were fixed for 30 min before centrifugation at 800 g for 20 min and resuspended in 3% 
glutaraldehyde in an equal volume of White's saline A and B for a further 60 min.  
For SEM analysis, samples were post fixed using 2% aqueous osmium tetroxide for two 
hour at room temperature before being dehydrated in a graded series of ethanol 
solutions and partially dried in a 50/50 mixture of 100% ethanol and 
hexamethyldisilazane (HEX). Samples were fully dried in 100% HEX before being 
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mounted onto a pin-stub using Leit-C sticky tabs, gold coated using an Edwards S150B 
sputter coater and examined using a Tescan Vega3 LMU scanning electron microscope. 
Scanning electron microscope was operated at a voltage of 12 kV. 
For TEM analysis, samples were post fixed in 2% aqueous osmium textroxide, 
dehydrated using a graded series of ethanol solutions, cleared in epoxypropane (EPP) 
and infiltrated in 50/50 araldite resin:EPP mixture overnight on a rotor at room 
temperature. This mixture was replaced with two changes, over 8 hours with fresh 
araldite resin mixture before being embedded and cured at 60 °C for 72 hours. 
Ultrathin sections, approximately 85 nm thick, were cut on a Leica UC 6 
ultramicrotome onto 200 mesh copper grids, stained for 30 min with saturated 
aqueous Uranyl Acetate followed by Reynold’s Lead Citrate for 5 min. Sections were 
examined using a FEI Tecnai Transmission Electron Microscope at an accelerating 
voltage of 80 Kv. Electron micrographs were recorded using a Gatan Orius 1000 digital 
camera and Gatan Digital Micrograph software. 
Sample processing and acquisition was conducted by Chris Hill at the department of 
Electron Microscopy Services, University of Sheffield. 
2.7.4 Flow cytometry 
2.7.4.1 Relative expression of platelet markers by CHRF-288-11 cells 
Cell suspension of either differentiated or undifferentiated cells were counted using 
the Countess II cell counter and adjusted to 1x106 cells/mL in complete RPMI. Where 
required cells were exposed to either ADP (20µM) or P. gingivalis (MOI 1:100, wild 
type or mutant strains) as previously described. Platelet/bacteria samples were then 
incubated for 90 min at 37 °C in a humidified incubator with 5% CO2. Cells were 
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pelleted by centrifugation at 200 g for 5 min at room temperature before 
resuspending in PBS. The cells were then centrifuged again for 5 min at 200 g, room 
temperature before the supernatants were discarded and the pellet gently 
resuspended in the residual volume. The expression of each cell marker was 
determined by incubating with the relevant antibodies or IgG controls (see Table 2.3) 
at room temperature for 20 min before each sample was washed with PBS, centrifuged 
at 200 g for 5 min at room temperature and supernatants then discarded. Each sample 
was re-suspended in PBS and analysed on a Beckman Coulter Gallios flow cytometer.  
2.7.4.2 Phenotypic analysis of platelet/perio-pathogen interactions 
Isolated platelets (PRP) were counted using the Sysmex XP-300 and resuspended in 
modified Tyrode's buffer at a density of 1x106/100 µL. P. gingivalis strains (wild-type or 
mutants) were removed from 72 hour blood agar plates and resuspended in modified 
Tyrode's buffer at an MOI of 1:10. Platelets were exposed to the bacteria or ADP 
(20µM) for 20 min at room temperature before fixation with 0.5% PFA for 30 min. 
After fixation, each sample was resuspended in PBS before being centrifuged at 800 g 
for 20 min at room temperature. The supernatants were then discarded and the pellet 
gently resuspended in the residual volume. The expression of each cell marker was 
determined by incubating with the relevant antibodies or IgG controls (see Table 2.3) 
at room temperature for 20 min. Each sample was then diluted in PBS and analysed on 
a Beckman Coulter Gallios flow cytometer.  
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2.7.5  Enzyme linked immunosorbent assays (ELISAs) 
2.7.5.1 Development of a cell-based ELISA 
To investigate whether oral pathogens interacted with integrins β1 and β3, an in-house 
ELISA was developed. Cells were seeded at a density of 3x104 cells/well and allowed to 
differentiate for five days in a tissue culture grade 96-well plate (37 °C, 5% CO2). 
Following differentiation, media containing non-differentiated and non-viable cells 
were removed and discarded and cells were washed twice with PBS. Three of the wells 
were trypsinised to recover attached cells and the average number of differentiated 
cells per well was determined. The differentiated cells were subsequently challenged 
with bacteria (MOI 1:100 in complete media) and incubated for 90 min in a humidified 
incubator (37 °C, 5% CO2) after which supernatants were removed and discarded. The 
cells were washed twice with PBS containing 0.1% Tween20 (PBST) and blocked for 
one hour with PBS containing 3% BSA. Following blocking, cells were washed as 
described above and fixed using 4% paraformaldehyde. Wells were then incubated 
with anti-integrin β1 (2 µg/mL; Abcam), anti-integrin β3 (2 μg/mL, Abcam), a polyclonal 
rabbit IgG anti-P. gingivalis (1:5000) or a polyclonal rabbit IgG anti-T. forsythia (1:5000) 
for a further hour, after which cells were washed before incubation with secondary 
antibodies; either the peroxidase anti mouse IgG (1:40,000) or peroxidase goat anti-
rabbit IgG (1:20,000) for one hour. Wells were then washed three times with PBST and 
3,3',5,5'-tetramethylbenzidine peroxidase substrate (Fisher Scientific) was added. The 
reaction was allowed to develop before stopping with 2 M H2SO4. Plates were read 
spectrophotometrically at 450 nm with a Clariostar microplate reader (BMG Labtech). 
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2.7.5.2 Recombinant protein-based ELISA 
2.7.5.2.1  Coating Buffer 
Sodium bicarbonate coating buffer was made by adding 0.019 M NaCO3 and 0.035 M 
NaHCO3 to 1 L of dH2O, pH 9.6. The pH of this buffer was not adjusted and if not 
correct was remade. 
2.7.5.2.2 Detection of P. gingivalis binding to recombinant integrins 
Wells of 96-well MaxisorpTM microplates were coated with either recombinant integrin 
β1 or β3 at 5 μg/mL in coating buffer, overnight at 4 °C. After washing once with wash 
buffer (PBS with 0.05% Tween-20, 0.5 μM CaCl2), non-specific binding sites were 
blocked with blocking buffer (PBS with 3% BSA and 0.5 μM CaCl2) for one hour under 
agitation before washing a further two times. Bacterial cells were removed from FA 
agar, resuspended in blocking buffer before being added to the pre-coated plates and 
incubated at room temperature for one hour under agitation. Untreated wells were 
also included as a control. Wells were then washed three times with wash buffer 
before incubating with a polyclonal rabbit IgG anti-P. gingivalis (1:3500) or a polyclonal 
rabbit IgG anti-T. forsythia (1:3500) antibodies for one hour at room temperature 
under agitation. After washing three times with wash buffer, wells were incubated 
with peroxidase goat anti-rabbit IgG (1:20,000) for one hour under agitation, washed 
three times with PBST and 3,3',5,5'-tetramethylbenzidine peroxidase substrate (Fisher 
Scientific) was added. The reaction was allowed to develop before stopping with 2 M 
H2SO4. Plates were read spectrophotometrically at 450 nm with a Clariostar microplate 
reader (BMG Labtech). 
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2.8 Platelet Function Methodology 
2.8.1 Platelet Aggregation 
2.8.1.1 Agonist preparation 
2.8.1.1.1  Live perio-pathogens 
Initially bacterial strains (wild-type or mutants) of both P. gingivalis and T. forsythia 
were removed from 72 hour blood agar plates and resuspended in modified Tyrode's 
buffer. These suspensions were then counted and calculated to give a MOI of either 
1:10 or 1:1 
2.8.1.1.2 Heat killed perio-pathogens 
Strains of P. gingivalis or T. forsythia were prepared as above (Section 2.9.1.1.1) before 
being boiled for 5 min at 100 °C. In order to confirm bacterial viability, each bacterial 
suspension was transferred to a fresh blood agar plate and cultured at 37 °C in an 
anaerobic environment for five days. 
2.8.1.1.3 2.9.1.1.3 Bacterial supernatants 
Wild-type strains of P. gingivalis were grown in liquid cultures until they reached an 
optical density (O.D.) of 0.8 at 600 nm. Each culture was centrifuged at 13,000 g for 5 
min at room temperature before the supernatants were removed and passed through 
a 0.2 µm filter. 20 µL of this suspension was then added to platelet suspensions during 
aggregation determination. 
2.8.1.1.4 P. gingivalis lipopolysaccharide 
Commercial lipopolysaccharide (LPS; Invivogen) purified from P. gingivalis NCTC 
11834was used in aggregation investigations at concentrations of 10, 20 and 40 µg/mL. 
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2.8.1.2  Platelet inhibitors 
Before measuring aggregation, 250 µL of PRP was transferred into individual cuvettes 
and platelets were incubated with selective platelet inhibitors (shown in Table 2.6) for 
15 min at room temperature. Each cuvette was then analysed routinely as described in 
2.9.1.3. 
Inhibitor Supplier Final Concentration 
TRL-2 Invivogen 5 μg/mL 
TLR-4  Invivogen 5 μg/mL 
Integrin α2β1 TOCRIS 20 μM 
Integrin β3 ABBIOTEC 11.2 μg/mL 
Table 2.6 Platelet inhibitors. 
 
2.8.1.3 Light transmission aggregometry 
Prior to the measurement of aggregatory responses, each channel of the AggRAM light 
transmission aggregometer (Helena Biosciences), was blanked with PPP of the same 
donor. To measure aggregation, PRP was transferred into individual cuvettes 
containing a siliconised magnetic stirrer and incubated for one minute at 37 °C. Where 
applicable each agonist was then added to each cuvette and the aggregatory response 
was recorded for 10 min at 37 °C with continuous stirring at 650 nm. As a positive 
control measure and to determine 100% aggregation, PRP treated with 20 µM ADP 
was also included. The raw data files were exported and further processed using 
Microsoft Excel to determine initiation of aggregation (AG0) and time taken to reach 
50% aggregation (AG50). 
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2.8.2 Platelet Calcium Mobilisation 
Isolated PRP was initially counted using the Sysmex XP-300 before incubating with 
5µM FURA-2/AM for 45 min at room temperature. Platelets were then pelleted at 800 
g for 20 min at room temperature before being resuspended in modified Tyrode's 
buffer at a concentration of 4x108 platelets/mL. Wild-type or mutant strains of P. 
gingivalis were removed from 72 hour blood agar plates, resuspended in modified 
Tyrode's buffer and counted to determine an MOI of 1:10. The preloaded platelet 
suspension was transferred to each well of a 96-well plate, before recording the 
excitation of fluorescent intensities at both 340 and 380 nm simultaneously using a 
Clariostar microplate reader (BMG Labtech). The fluorescent emission of each test was 
recorded at 510 nm for 210 seconds with the initial 20 seconds being used as a 
baseline before automatically injecting platelet agonists or a buffer control.  
Intracellular calcium levels are then determined using the following equation; 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑜𝑓 𝑖𝑛𝑡𝑟𝑎𝑐𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝑐𝑎𝑙𝑐𝑖𝑢𝑚 =
𝐸𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑎𝑡 340𝑛𝑚
𝐸𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑎𝑡 380𝑛𝑚
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2.8.3 Platelet Granule Release Quantitation by Enzyme-linked 
Immunosorbent Assay (ELISA) 
PRP was initially counted using the Sysmex XP-300 before platelets were pelleted at 
800 g for 20 min at room temperature before resuspending at a density of 2x108/mL in 
modified Tyrode's buffer. Strains of P. gingivalis (wild-type or mutants) were removed 
from 72 hour blood agar plates, resuspended in modified Tyrode's buffer, counted and 
adjust to an MOI of 1:10. 2x108 platelets were then incubated with bacteria or ADP (20 
µM) for 20 min at room temperature before fixing in 0.5% PFA for 30 min, again at 
room temperature. Samples were centrifuged at 13,000 g for 5 min at 4 °C before the 
supernatants were removed and processed following the manufacturer's instructions 
of one of the following ELISA kits; human platelet factor 4 (PF4) (Abcam), interleukin 
1β (IL-1β) (Bio-Techne LTD) or Serotonin (Abcam). ELISA plates were read using and the 
data recorded using a Clariostar microplate reader (BMG Labtech). 
2.9 Statistical Analysis  
Statistical analysis was conducted using the StatsDirect3 software (StatsDirect Ltd, 
Cheshire, UK). Data normality was determined by a D'Agostino & Pearson normality 
test before subsequent statistical analysis. 
Parametric data was analysed using paired t-test. Non-parametric paired data was 
analysed using the Friedman test whereas non-paired non-parametric data was 
evaluated using the Kruskal-Wallis Test (Conover-Iman). The threshold for statistical 
significance was set at p<0.05; * = P≤ 0.05, ** = P≤ 0.01 and *** = P≤ 0.001. All 
experiments consisted of at least three biological replicates.  
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Chapter 3: Characterisation of an in vitro cellular 
model to study platelet-periodontal pathogen 
interactions 
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3.1 Introduction 
The development and application of megakaryocytic cell lines, derived from patients 
with leukaemia, allow a unique opportunity to study the maturation and 
differentiation of megakaryocytes and their associated platelet-like phenotypes (Saito, 
1997). The overall aim of this thesis is to investigate the effect of periodontal 
pathogens on platelet aggregation, activation and function. However, as experimental 
work on platelets requires fresh blood which needs to be immediately used due to an 
inability to effectively store samples (Bausset et al., 2012), the megakaryocytic cell line, 
CHRF-288-11 was recruited as a cellular model to study platelet-pathogen interactions. 
The CHRF-288-11 cell line is a megakaryocytic cell line, which was initially isolated from 
a biopsy of a metastatic tumour in a 17 month old infant with acute megakaryoblastic 
leukaemia (Fugman et al., 1990). Further characterisation of this cell line indicated that 
CHRF-288-11 cells can be used as an effective megakaryocyte/platelet model (Lev-
Lehman et al., 1997), which can be matured towards platelet production (Deutsch et 
al., 2008) as the cells express platelet derived growth factors (Yang et al., 1997) as well 
as expressing platelet markers including integrins which are involved in platelet 
adhesion, aggregation and activation (Fugman et al., 1990; Conran and Hemming, 
1998; Nurhayati, Ojima and Taya, 2015). 
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3.2 Aims 
The overall aim of this chapter is to validate a differentiated megakaryocytic cell line 
for the study of platelet-periodonto-pathogen interactions. This will be achieved by: 
• Investigating the use of the CHRF-288-11 cells as an in vitro platelet-like cell line 
by determining expression of platelet specific markers 
• Investigating CHRF-288-11 cells as an in vitro platelet-like model to study 
platelet pathogen interactions  
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3.3 Results 
3.3.1 Optimisation of CHRF-228-11 differentiation  
Differentiation and maturation of CHRF-288-11 (CHRF) cells following exposure to 
phorbol 12-myristate 13-acetate (PMA) was investigated by immunofluorescence 
microscopy. PMA at both concentrations (10 and 50 ng/ml) successfully induced CHRF 
differentiation over the period investigated. 
Successful differentiation was determined through cellular adherence, DAPI staining 
for nucleic morphology and an F-actin probe for cytoskeletal phenotyping. 
Representative micrographs are shown for both 10 ng/ml (Figure 3.1) and 50 ng/ml 
(Figure 3.2) PMA treatments. Both 10 and 50 ng/ml of PMA treatment induced 
differentiation from the day one time point as characterised by development of large 
multi-lobed nuclei and the formation of pseudopodial structures that protrude from 
the main cellular body when compared to the control cells. No changes were observed 
with cells treated with DMSO vehicle control, with consistent low cell numbers 
observed across all investigated time points. The observed phenotypic cellular 
differentiation was maintained throughout the day three, five and seven time points 
within both PMA treatments, with both treatments resulting in highly heterogeneous 
cellular populations with varying pseudopodia and no distinctive cytoskeletal 
structure. Cellular viability was also confirmed by trypan blue exclusion and remained 
at ~98% throughout all PMA treatments (data not shown). It was determined that 
50ng/ml for a period of five days yielded the most consistent differentiated cell 
densities and was therefore selected for future investigations utilising this cellular 
model.  
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Figure 3.1 CHRF-288-11 differentiation with 10 ng/ml of PMA. CHRF-288-11 cells were differentiated 
onto glass coverslips before being stained with a high affinity F-actin probe and DAPI. DAPI staining 
revealed the formation of large multi-lobed nuclei within 24 hours of PMA treatment. F-actin positivity 
showed the development of large pseudopodia that protruded from the cell body and became more 
defined over a seven day time course. DMSO was included as a vehicle control and is shown at the 7 day 
time point. Images are representative of at least three independent observations. Scale bars= 50 μm. 
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Figure 3.2 CHRF-288-11 differentiation using 50 ng/ml of PMA. CHRF cells were differentiated onto 
glass coverslips before being treated with an F-actin probe and the nucleic stain DAPI. Staining revealed 
the formation of large multi-lobed nuclei and large pseudopodial structures over the seven days of 
treatment. DMSO is included as a vehicle control and is shown at the 7 day time point. Images are 
representative of at least three independent observations. Scale bars= 50 μm. 
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To further characterise the differentiated CHRF cells, expression of 
megakaryocytic/platelet surface protein and activation markers was determined by 
flow cytometry. A general increase in expression of CD41 and CD41/61 was observed 
up to five days of culture after which a decrease was observed with both PMA 
treatments (10 and 50 ng/ml). Over the seven day time course CHRF-288-11 cells were 
found not to express CD42b, throughout both the 10 and 50 ng/ml treatments, whilst 
the expression of CD62P increased almost two-fold compared to the DMSO controls 
(Figure 3.3). No significant differences were observed between 10 and 50 ng/ml PMA 
treatments at any of the time points investigated. The decrease in overall expression at 
day seven was attributed to cell detachment. 
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Figure 3.3 Analysis of megakaryocytic protein expression following CHRF-288-11 differentiation. CHRF-
288-11 cells were treated with either 10 or 50 ng/ml of PMA and differentiation was monitored over a 
period of seven days. Cells were analysed by flow cytometry to determine the relative expression of cell 
surface proteins and platelet activation markers: CD41 (A), CD41/61 (B), CD62P (C) and CD42b (D). 
Expression of CD41, CD41/61 and CD62P increased within both PMA treatments when compared to the 
DMSO vehicle control up to day five before decreasing. CHRF cells did not express CD42b across all 
treatments and time points. No changes were observed in the DMSO vehicle control across all time 
points, with the day seven time point being included as a representative control. Data is expressed as 
the mean fluorescent index (MFI) ±SEM, n=3. 
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3.3.2 Periodontal pathogen invasion and adhesion of CHRF-288-11 
cells 
Following optimisation of CHRF differentiation, the ability of periodontal pathogens to 
adhere to and invade the differentiated CHRF-288-11 cells were investigated. Initially, 
undifferentiated and differentiated cells were treated with either P. gingivalis NCTC 
11834 or T. forsythia ATCC 43037 (MOI of 1:10 or 1:100) and probed with pathogen 
specific antibodies, a high affinity actin probe and DAPI as a nucleic stain. 
It was observed that, P. gingivalis associated with and invaded the undifferentiated 
CHRF-288-11 cells (Figure 3.4), with association and invasion increasing following 
CHRF-288-11 differentiation independent of MOI (Figure 3.5). Similarly T. forsythia was 
shown to interact with undifferentiated CHRF-288-11 cells (Figure 3.6) with cellular 
association and invasion increasing following CHRF differentiation (Figure 3.7) at both 
MOIs investigated. Within both undifferentiated and differentiated cells, P. gingivalis 
and T. forsythia were shown to localise within the cell membrane and the perinucleic 
space. 
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Figure 3.4 Invasion of CHRF-288-11 cells by P. gingivalis NCTC 11834. Undifferentiated CHRF-288-11 cells were challenged with P. gingivalis NCTC 11834 (MOI of 1:10 and 
1:100) for 90 minutes at 37 °C, before being fixed and mounted onto glass microscope slides. Cells were then permeabilised and probed with a pathogen specific antibody, 
PGWC1 (green), an F-Actin probe (red) and the nucleic stain DAPI (blue). P. gingivalis NCTC 11834 localised with and invade CHRF-288-11 cells (white arrows). Images are 
representative of at least three independent observations. Scale bars= 50 μm.  
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Figure 3.5 P. gingivalis invades differentiated CHRF-288-11 cells. CHRF cells were differentiated for five days before being challenged with P. gingivalis NCTC 11834 (MOI 1:10 
or 1:100) and fixed. Cells were then permeabilsed and stained with a P. gingivalis specific antibody (PGWC1; green), an F-actin probe (red) and mounted with DAPI (blue). A 
high level of invasion was observed with differentiated CHRF cells, with P. gingivalis localising within the membrane and nucleic regions of the cells. Images are representative 
of at least three independent observations. Scale bars= 50 μm. 
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Figure 3.6 CHRF-288-11 cellular invasion by T. forsythia ATCC 43037. Undifferentiated CHRF-288-11 cells were exposed at an MOI of 1:10 or 1:100 to T. forsythia ATCC 43037 
before being fixed and permeabilised. Cells were then stained with a pathogen specific antibody, TFWC (green), an F-actin probe (red) and DAPI (blue). These images 
demonstrate that T. forsythia invades and adheres to undifferentiated CHRF-288-11 cells (white arrows). Images are representative of at least three independent observations. 
Scale bars= 50 μm. 
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Figure 3.7 Invasion of differentiated CHRF-288-11 cells by T. forsythia. Cells were challenged with T. forsythia at an MOI of either 1:10 or 1:100 before fixation. Cells were then 
permeabilised and probed with a pathogen specific antibody, TFWC (green), a high affinity F-actin probe (red) and DAPI (blue). A high level of cellular invasion was observed 
with bacterial cells localising within the cellular membrane and around the nuclei (white arrows). Images are representative of at least three independent observations. Scale 
bars= 50 μm. 
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To quantitate cellular invasion, an antibiotic protection assays were performed on 
differentiated CHRF-288-11 cells (Figure 3.8). Differentiated CHRF-288-11 cells were 
challenged with wild-type strains of P. gingivalis (NCTC 11834, ATCC W50) or T. 
forsythia (ATCC 43037). To determine the role of the P. gingivalis outer-membrane 
protein (OMPA), cells were also challenged with deficient mutants lacking the two 
major subunits of the OMPA protein (NCTC 11834 ΔompA1, NCTC 11834 ΔompA2). 
All of the wild-type strains and mutants tested successfully adhered to and invaded the 
megakaryocytic-like cells. Although some variation in both cellular adhesion and 
invasion were observed, no significant differences were calculated between any of the 
variables tested. 
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Figure 3.8 Bacterial adhesion and invasion of CHRF-288-11 cell by periodontal pathogens. 
Differentiated CHRF-288-11 cells were challenged with P. gingivalis (NCTC 11834, NCTC 11834 ΔompA1, 
NCTC 11834 ΔompA2, ATCC W50) or T. forsythia (ATCC 43037) for 90 minutes (37 °C, 5% CO2). Invasion 
was defined as the percentage of bacterial inoculum protected from metronidazole, whereas total 
associated is the total percentage of bacterial cells recovered. The adhered population is then 
determined by subtracting the 'invaded' from 'total associated'. All P. gingivalis and T. forsythia strains 
tested were shown to adhere to and invade differentiated CHRF-288-11 cells. Data is presented as a 
percentage recovery relative to the total inoculum. ±SEM, n=3. 
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3.3.3 Analysis of CHRF-288-11 interactions with periodontal 
pathogens by immunofluorescent microscopy 
Following the initial immunofluorescent characterisation of periodontal-pathogen 
invasion of CHRF cells, further investigation focussed on exploring the impact of 
pathogen invasion on CHRF protein expression. The effects of P. gingivalis NCTC 11834 
and T. forsythia ATCC 43037 were determined in relation to the expression of two 
proteins of interest; the Mammalian Target of Rapamycin (mToR) and integrin β3. 
3.3.3.1 Analysis of CHRF-288-11 mToR expression following incubation with 
periodontal pathogens 
Undifferentiated CHRF-288-11 cells expressed mToR and the rate of bacterial 
association increased with increasing MOI with both P. gingivalis NCTC 11834 (Figure 
3.9) and T. forsythia 43037 (Figure 3.10). However, no variances in protein expression 
were observed in either bacterial treatment when compared to the untreated control. 
In contrast, while differentiated CHRF-288-11 cells also showed/demonstrated 
increased bacterial association with increasing MOI, the overall expression of mToR 
decreased following exposure to both P. gingivalis NCTC 11834 (Figure 3.11) but not 
with T. forsythia 43037 (Figure 3.12).  
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Figure 3.9 The effect of P. gingivalis invasion on mToR expression in CHRF-288-11 cells. CHRF cells were challenged with P. gingivalis NCTC 11834 for 90 minutes before being 
fixed and permeabilised. Cells were then probed for mToR expression (red), a pathogen specific antibody (PGWC1, green) and DAPI. Images highlight the CHRF-288-11 cells 
express mToR but its relative expression is not effected through bacterial association at an increasing MOI. Images are representative of at least three independent 
observations. Scale bars= 50μm.  
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Figure 3.10 Determination of mToR expression following exposure to T. forsythia in CHRF-288-11 cells. Cells were challenged with T. forsythia ATCC 43037 for 90 minutes 
before fixation. Cells were then permeabilised and stained for mToR (red), DAPI (blue) and T. forsythia (green). Despite bacterial association increasing with an increasing MOI, 
no changes in mToR expression were observed across any treatments. Images are representative of at least three independent observations. Scale bars= 50 μm.  
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Figure 3.11 P. gingivalis decreases mToR expression in differentiated CHRF-288-11 cells. CHRF-288-11 cells were differentiated for five days before being challenged with P. 
gingivalis at an MOI of either 1:10 or 1:100. Cells were then fixed, permeabilised and probed for DAPI (blue), mToR (red) and P. gingivalis (PGWC1, green). Large lobed nuclei 
confirm cellular differentiation, with bacterial association also increasing with an increasing MOI. Bacterial treatment resulted in no change within expression of mToR at both 
an MOI of 1:10 and 1:100. Images are representative of at least three independent observations. Scale bars= 50 μm.  
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Figure 3.12 Effect of T. forsythia invasion on mToR expression in differentiated CHRF-288-11 cells. Cells were differentiated for five days before being exposed to T. forsythia 
ATCC 43037 for 90 minutes and fixed. Cells were then permeabilised before being stained for mToR expression (red), nucleic phenotyping (DAPI, blue) and bacterial cells 
(TFWC, green). Bacterial treatment with T. forsythia resulted in no change within mToR staining despite an increased bacterial association at both an MOI of 1:10 and 1:100. 
Images are representative of at least three independent observations. Scale bars= 50 μm. 
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3.3.3.2 Analysis of CHRF-288-11 integrin β3 expression following incubation 
with periodontal pathogens 
Undifferentiated and differentiated CHRF-288-11 cells expressed integrin β3, uniformly 
diffused across the cell membrane (Figure 3.13-3.16). Exposure to bacterial cells at an 
increasing MOI resulted in an increased bacterial association and invasion by both P. 
gingivalis NCTC 11834 and T. forsythia 43037. Within both undifferentiated (Figure 
3.13 and 3.14) and differentiated (Figure 3.15 and 3.16) cells, exposure to either 
pathogen resulted in an increased expression of integrin β3 although no localisation 
between either pathogen or integrin β3 could be determined. 
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Figure 3.13 The effect of P. gingivalis invasion on integrin β3 expression in CHRF-288-11 cells. CHRF cells were challenged with P. gingivalis for 90 minutes before cells were 
fixed and permeabilised. Cells were then treated with anti-β3 (red) and pathogen specific (PGWC1, green) antibodies before being mounted with DAPI (blue). Incubation with 
P. gingivalis increases staining of integrin β3 most notably at an MOI of 1:100. Images are representative of at least three independent observations. Scale bars= 50 μm.  
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Figure 3.14 Relative integrin β3 expression following exposure to T. forsythia ATCC 43037. CHRF cells were treated with T. forsythia ATCC 43037 for 90 minutes before 
associated bacterial cells were removed. Cells were then fixed, permeabilised and probed for integrin β3 (red), T. forsythia ATCC 43037 (TFWC, green) and mounted with DAPI 
(blue). Bacterial challenge with T. forsythia ATCC 43037 increases integrin beta 3 expression at an MOI of 1:10 and 1:100. Images are representative of at least three 
independent observations. Scale bars= 50 μm.  
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Figure 3.15 The effect of P. gingivalis invasion on integrin β3 expression by differentiated CHRF-288-11 cells. CHRF-288-11 cells were differentiated for five days before being 
challenged with P. gingivalis NCTC 11834 at an MOI of with 1:10 or 1:100 for 90 minutes at 37 °C. Cells were then fixed, permeabilised and probed for P. gingivalis NCTC 11834 
(PGWC1, green), integrin β3 expression (red) and DAPI (blue). Incubation with P. gingivalis NCTC 11834 increased β3 expression at both an MOI of 1:10.and 1:100 when 
compared with the untreated controls. Images are representative of at least three independent observations. Scale bars= 50 μm. 
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Figure 3.16 T. forsythia increases β3 expression in differentiated CHRF-288-11 cells. CHRF-288-11 cells were differentiated before being exposed to T. forsythia ATCC 43037 at 
an MOI of either 1:10 or 1:100. Cells were then fixed and permeabilised before being stained for β1 (red), T. forsythia ATCC 43037 (TFWC, green) and DAPI (blue). Following 
exposure to T. forsythia ATCC 43037, integrin β1 staining increased at both an MOI of 1:10 and 1:100. Images are representative of at least three independent observations 
Scale bars= 50 μm. 
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3.3.4 Flow cytometric analysis of megakaryocytic/platelet markers 
following P. gingivalis challenge 
Having demonstrated that P. gingivalis invade differentiated megakaryocytic-like cells, 
impacting on integrin β1 and mToR expression, further investigations were undertaken 
to determine the effect of periopathogens on surface megakaryocyte/platelet 
markers. Using flow cytometry, P. gingivalis association with differentiated CHRF cells 
and the relative expression of CD41, CD61, CD41/61 and CD62P were quantified 
(Figure 3.17). 
Using this approach, sub-populations of cells associated with P. gingivalis (wild-type or 
OMPA deficient mutants) could not be identified as no significant increase in PGWC1 
fluorescence was detected when bacterial treated samples were compared to 
untreated controls (Figure 3.17a). Similarly, no significant change in integrin expression 
was detected with either CD41 (Figure 3.17b), CD61 (Figure 3.17c), CD41/61 (Figure 
3.17d) or CD62P (Figure 3.17e) following bacterial treatment with wildtype of mutant 
P. gingivalis. 
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Figure 3.17 Quantitation of megakaryocytic surface marker expression following challenge with P. 
gingivalis using flow cytometry. Differentiated CHRF-288-11 cells were challenged with either wild-type 
P. gingivalis (NCTC 11834, ATCC W50) or the OMPA deficient mutants NCTC 11834 ΔompA1 and NCTC 
11834 ΔompA2 before being treated with antibodies to detect the expression of platelet surface 
antigens and pathogen presence (PGWC1). No significant changes in detection of bacterial association 
(A) or the expression of CD41 (B), CD61 (C), CD41/61 (D) and CD62P (E) following bacterial challenge. 
Data is expressed as ±SEM, n=3.  
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3.3.5 Development of a cell-based ELISA for immunophenotyping of 
CHRF-288-11 cells following periodontal pathogen challenge  
To further quantify periodontal pathogen invasion of CHRF-288-11 cell and the effect 
of pathogen invasion on surface protein expression, a cell-based ELISA was developed. 
Cells were differentiated onto a solid surface and probed for bacterial binding using 
pathogen specific antibodies (PGWC1, TFWC) or the relative expression of CHRF 
integrins β1 and β3.  
Following bacterial challenge at an MOI of 1:100, significant binding of P. gingivalis 
NCTC 11834 and ATCC W50 was observed (p<0.001; Figure 3.18a), as well as a 
significant increase in expression of integrin β1 (p<0.001, Figure 3.18b). P. gingivalis 
NCTC 11834 was also found to induce a significant increase of β3 expression (p<0.001; 
Figure 3.18c). A slight increase in integrin β3 expression was also observed following 
exposure to ATCC W50, although this was determined as not statistically significant 
(Figure 3.18c). T. forsythia ATCC 43037 did not associate with differentiated CHRF-288-
11 cells (Figure 3.18a) or induce any change in either integrin β1 (Figure 3.18b) or β3 
(Figure 3.18c) expression. 
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Figure 3.18 Analysis of bacterial association and integrin expression by a cell-based ELISA. CHRF-288-11 were differentiated into well-plates before being challenged with 
periodontal pathogens (MOI 1:100), fixed and probed with pathogen specific antibodies (PGWC1 or TFWC) (A) or for expression of integrin β1 (B) and integrin β3 (C). Significant 
binding of P. gingivalis NCTC 11834 and ATCC W50 was detected at an MOI of 1:100 (A). A significant increase in expression of integrin β1 was detected following treatment 
with P. gingivalis NCTC 11834 and ATCC W50 (B), with P. gingivalis NCTC 11834 also stimulating a significant increase in β3 expression (C). Data is expressed as ±SEM, p=*** 
<0.001, n=3. 
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3.3.5.1 Is P. gingivalis association and interaction with CHRF-288-11 
dependent on the multiplicity of infection? 
Investigations to determine whether the observed association to CHRF-288-11 cells by 
P. gingivalis was MOI dependant. Differentiated CHRF-288-11 cells were challenged 
with P. gingivalis at an increasing MOI before cells were fixed and probed with 
pathogen specific antibodies (PGWC1). P. gingivalis NCTC 11834 (Figure 3.19a) and 
ATCC W50 (Figure 3.19b) were both shown to increase in bacterial association relative 
to an increasing MOI. 
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Figure 3.19 Specific periodontal pathogen interaction with differentiated CHRF-288-11 cells. 
Differentiated CHRF-288-11 cells were challenged with bacterial cells at an increasing MOI before 
fixation and detection with pathogen specific antibodies. The data demonstrates specific, pathogen 
binding in a direct relationship with increasing MOI following treatment with P. gingivalis NCTC 11834 
(A), P. gingivalis ATCC W50 (B). Data is expressed as ±SEM, n=3. 
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After confirming that periodontal pathogen interaction was specific and MOI 
dependant, the relationship between integrin expression and bacterial invasion was 
investigated. As above, differentiated CHRF-288-11 cells were challenged with a 
titrated MOI of periodontal pathogens before fixation and the relative expression of 
integrin β1 and β3 was detected (Figure 3.20). These results show that P. gingivalis 
NCTC 11834 stimulates an increase in expression of integrin β1 (Figure 3.20a) and 
integrin β3 (Figure 3.20b) at all the MOI's tested with the observed increase in 
expression appearing to be independent of MOI and of direct consequence, solely to 
bacterial treatment. Similar findings were also observed when cells were treated with 
P. gingivalis ATCC W50 (Figure 3.20c-d). 
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Figure 3.20 The effect of MOI on periodontal pathogen induced integrin expression in differentiated 
CHRF-288-11 cells. Differentiated CHRF cells were challenged with periodontal pathogens at an 
increasing MOI, before being fixed and probed for expression of integrin β1 and β3. Both P. gingivalis 
NCTC 11834 and ATCC W50 induced an increase in expression of integrin β1 (A and C) and β3 (B and D). 
Data presented is a representative figure of three independent observations.   
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3.4 Discussion 
The overall aim of this study is to determine whether an in vitro megakaryocytic cell 
line can be used to study platelet-pathogen interactions. Due to the ability of platelets 
to become readily activated and the lack of reliable storage options, platelet studies 
require fresh platelets and as such, also rely on regular blood donations (Bausset et al., 
2012).The availability of a platelet-like cell line will therefore help minimise the 
reliance on blood donations, an invasive procedure, whilst enabling studies to be 
conducted in vitro, prior to validation using fresh platelets isolated from donors. 
Earlier studies have proposed the use of megakaryocytic-like cell lines such as DAMI 
(Greenberg et al., 1988) and UT-7 (Komatsu et al., 1991) within platelet research. 
However, as with many cells lines, megakaryocytic-like cells carry many caveats 
including misidentification, contamination as well as genomic and phenotypic 
instability (Geraghty et al., 2014). As an example, UT-7 cells have since been shown to 
express markers of different cell lineages including those associated with erythroid and 
myeloid phenotypes (Saito, 1997). Further to this, although the DAMI cell line seemed 
promising as an in vitro platelet model, since its initial characterisation it is reported to 
either be contaminated with or share genetic markers with the HEL erythroleukemia 
cell line (MacLeod et al., 1997). For these reasons, initial investigations focussed on 
characterising the CHRF-288-11 cell line and exploring its suitability as a platelet-like 
model. 
Optimisations of the CHRF-288-11 cells confirmed that treatment with PMA (50 ng/ml) 
over a five day period yielded consistent CHRF differentiation. This was assessed by the 
characteristic changes in phenotype and illustrated by cell enlargement and the 
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formation of polyploidal, multi-lobed nuclei in line with previous reports by Fugman 
and colleagues (1990). 
Further analysis of differentiated CHRF cells via flow cytometry confirmed the 
expression of several markers attributed to the megakaryocytic cell lineage and 
platelet production. In agreement with findings by Conran and Hemming (1998), CHRF 
cells were found to express both CD41 (αIIb, GPIIb) and CD61 (β3, GPIIIa), which form 
the heterodimer complex of CD41/61 that is expressed by both megakaryocytes 
(Duperray et al., 1987) and platelets (Wagner et al., 1996b). The megakaryocytic-like 
cells were also shown to express the activated epitope of CD41/61, which acts as a 
fibrinogen receptor during platelet activation (Shattil et al., 1985).  
Additionally, an increase in CD62P expression, a protein normally contained within 
platelet alpha granules (Stenberg et al., 1985), was observed following PMA treatment 
on the cell surface of the differentiated megakaryocytic cells. Surprisingly, it was also 
found that CHRF-288-11 cells did not express CD42b (GPIbα) within either 
undifferentiated or differentiated cells. Although GPIbα is highly expressed on the 
surface of platelets (Li and Emsley, 2013), it is also expressed by megakaryocytes, with 
an increase in GPIbα expression being reported as a marker for both maturation and 
differentiation (Lepage et al., 2000). 
Following the initial characterisation of the CHRF-288-11 cells and their associated 
platelet-like phenotype, further investigations explored whether this cell type could 
interact with oral pathogens. Despite the role of platelets within the immune system 
being widely published (Klinger and Jelkmann, 2002; Yeaman, 2010b; Gardiner and 
Andrews, 2013; Ali, Wuescher and Worth, 2015; Koupenova and Freedman, 2015), 
research surrounding bacterial interactions with megakaryocytes is highly limited. 
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Megakaryocytes are derived through haematopoietic stem cell differentiation and as a 
cell type are extremely rare, accounting for approximately 0.1% of nucleated cells 
within the bone marrow, which would suggest that interactions with bacterial cells are 
highly improbable. However, as well as residing within the bone marrow, 
megakaryocytes are also routinely found within circulating blood (Kallinikos-Maniatis, 
1969) and have been shown to migrate to, terminally differentiate and produce 
platelets within the lung tissue (Howell and Donahue, 1937; Lefrançais et al., 2017) 
suggesting that although improbable, interactions with bacterial cells are not 
altogether impossible. It has also been previously reported that megakaryocytes 
express toll-like receptors, suggesting that they could hypothetically interact with 
bacterial cells (Beaulieu and Freedman, 2010), with a further study showing that 
isolated megakaryocytes can interact with heat-inactivated Escherichia coli, stimulating 
the translocation of complement protein C (Arbesu et al., 2016).  
In contrast, it is well-established that the periodontal pathogens P. gingivalis and T. 
forsythia ATCC 43037 interact and invade a range of cell types including epithelial cells 
(Nakajima et al., 2006; Stathopoulou et al., 2010; Suwannakul et al., 2010; Mishima 
and Sharma, 2011; Stafford et al., 2013),osteoblasts (Zhang et al., 2010), trophoblasts 
(Inaba et al., 2009) as well as cells of the hematopoietic stem cell lineage such as 
monocytes (Pollreisz et al., 2010; Bloch et al., 2018). Periodontal pathogens have also 
been associated with increasing risk of cardiovascular disease (Kebschull, Demmer and 
Papapanou, 2010) while P. gingivalis has been shown to induce platelet aggregation 
(Curtis et al., 1993a). However, the mechanisms of these interactions are not fully 
understood.  
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Using the CHRF-288-11 cells as a platelet-like cell line, the interaction of both P. 
gingivalis and T. forsythia were investigated. Increased association of pathogens with 
differentiated CHRF cells were observed by immunofluorescence microscopy and 
further confirmed by ELISA. P. gingivalis and T. forsythia invaded the differentiated 
cells in an antibiotic-protection assay and were shown to localise within peri-nuclei 
regions. This observed cellular interaction with CHRF-288-11 cells agrees with previous 
findings that demonstrate that both P. gingivalis (Belton et al., 1999) and T. forsythia 
(Inagaki et al., 2006) are able to localise intracellularly with cellular invasion occurring 
in similar levels to that observed within host epithelium.  
As well as characterising interactions with wild-type P. gingivalis, the role of the major 
outer membrane protein subunits OMPA1 and OMPA2 within CHRF-288-11 
interactions were also explored. No significant differences were observed between 
either the ΔompA1 or the ΔompA2 deficient mutants when compared to the parent 
strain within CHRF-288-11 association as determined by antibiotic protection assays 
and flow cytometry. It has previously been shown that OMPA, specifically the OMPA2 
subunit is fundamental for interactions between P. gingivalis and epithelial cells in 
vitro (Naylor et al., 2016). However the data produced within this chapter of work 
suggests that P. gingivalis interactions with CHRF-288-11 cells occur independently of 
either OMPA subunit, suggesting that both of the OMPA subunits can facilitate 
bacterial association with CHRF-288-11 cells independently. Further investigations 
therefore targeted understanding how P. gingivalis interacts with megakaryocytic-like 
cells.  
As pathogens such as Escherichia coli (Arbesu et al., 2016) are known to activate 
platelets and alter the expression levels of surface platelet markers, the effect of P. 
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gingivalis NCTC 11834 and ATCC W50 on the expression of specific cellular markers 
expressed by both CHRF-288-11 cells and mammalian platelets was investigated.  
The mammalian target of rapamycin (mToR), a serine kinase that integrates with 
several key process including cell proliferation, protein synthesis and autophagy (Hay 
and Sonenberg, 2004) has been identified within previous research by Stafford and 
colleagues (2013) as a target for P. gingivalis host cell manipulation. Within this 
chapter of work, immunofluorescent analysis revealed that incubation with P. 
gingivalis resulted in a decreased expression of mToR within differentiated CHRF-288-
11 cells in an MOI dependant relationship, whereas incubation with T. forsythia did 
not. In agreement with these findings, within epithelial cells, gingipains derived from P. 
gingivalis have been shown to degrade mToR and manipulate cell signalling pathways 
(Stafford et al., 2013) and could suggest a similar mechanism in which P. gingivalis 
interacts with megakaryocytic-like cells. 
Further to this, P. gingivalis is known to interact with host cells through multiple 
pathways including targeting and manipulating integrin expression, such as integrin β1 
(Yilmaz, Watanabe and Lamont, 2002; Li et al., 2013) and β3 (Li et al., 2013; Boisvert, 
Lorand and Duncan, 2014). Within this chapter of work, it was investigated as to 
whether P. gingivalis could affect integrin β1 and β3 expression within the CHRF-288-
11 cell line. Immunofluorescent images highlighted an overall increase in CHRF-288-11 
expression of integrin β3 following bacterial challenge with both P. gingivalis and T. 
forsythia. It was also found that CHRF-288-11 integrin β3 expressions was uniformly 
diffused throughout the cell membranes and no distinct localisation between integrin 
expression and the presence of either P. gingivalis or T. forsythia. This initial data was 
also further confirmed through the application of a cell based ELISA, which 
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demonstrated an increase in expression in both integrin β1 and β3 following exposure 
to both P. gingivalis NCTC 11834 and ATCC W50 that was not dependent on MOI. 
Surprisingly however, further application of this developed ELISA revealed that T. 
forsythia did not bind to either recombinant β1 or β3, suggesting that other external 
factors may be needed for T. forsythia to associate with CHRF-288-11 cells for example 
through binding of lectin-like receptors or interactions with host toll-like receptors 
through expressed leucine-rich repeat motifs (Sharma, 2010). 
Although the development of this protocol is novel within the study of 
megakaryocytic-like cells, it has previously reported that several bacterial species 
including Staphylococcus spp., Streptococcus spp. and Escherichia coli can induce and 
amplify platelet activation through interactions with the integrin complex αIIbβ3 
(Arman et al., 2014; Watson et al., 2016), with P. gingivalis also being shown to bind to 
both integrin αvβ3 and α5β1 when overexpressed with a Chinese hamster ovary cell 
lines. However research surrounding the interactions between either P. gingivalis or T. 
forsythia and cells of megakaryocytic lineage is to date extremely limited. Within this 
study, a more in-depth analysis of integrin expression by flow cytometry following 
exposure to periodontal pathogens was attempted but was deemed unsuccessful and 
did not generate any observable differences within any of the makers tested. It was 
originally hypothesised that sub-populations of invaded CHRF-288-11 cells could be 
identified through the application of pathogen specific antibodies but due to 
experimental and equipment limitations this could not be achieved.  
The application of the CHRF-288-11 cell line within this study has provided an 
unlimited and rapid screening methodology of bacterial interactions with several 
markers specific to mature mammalian platelets. However it must be noted that as 
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with many megakaryocytic cell lines, the CHRF-288-11 cells are of leukemic origin 
(Fugman et al., 1990) and despite the CHRF-288-11 cells actively expressing multiple 
phenotypes associated with both megakaryocytes and platelets, it is important to 
confirm any finding within a highly purified platelet population. Further to this, recent 
developments within megakaryocyte culture techniques are detailing the routine 
culture of primary megakaryocytes and the production of large volumes of platelets in 
vitro (Moreau et al., 2016; Strassel, Gachet and Lanza, 2018), meaning that the use of 
megakaryoblast cell lines as well as the need for regular blood acquisition could soon 
be abolished entirely within the field of platelet research. 
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3.5 Summary 
In conclusion, this study has highlighted that the CHRF-288-11 megakaryocytic-like 
cells can be utilised through a series of methodologies to study the pathogenic effects 
of periodontal pathogens on platelets and the megakaryocytic cells in vitro. This 
developed methodology could be applied to understand how these anaerobic bacteria 
can stimulate host cell responses and how platelets behave following infection.  
Although multiple previous have studies have shown that periodontal pathogens can 
infiltrate and interact various cell types (Lamont et al., 1995; Deshpande, Khan and 
Genco, 1998; Simin F Nakhjiri et al., 2001; Yilmaz, Watanabe and Lamont, 2002; Yilmaz 
et al., 2008; Kirschbaum et al., 2010a; Suwannakul et al., 2010; Honma, Mishima and 
Sharma, 2011; Stafford et al., 2013; Naylor et al., 2016) , as well as alter host cellular 
functions (Darveau et al., 1998; Tervahartiala et al., 2000; Kiili et al., 2002; Yilmaz et al., 
2003, 2008; Nakajima et al., 2006; Posch et al., 2011; Settem et al., 2013; Stafford et 
al., 2013; Ksiazek, Mizgalska, Enghild, et al., 2015; Lee et al., 2015; Naylor et al., 2016) 
very little work has focussed on how these bacterial species may impact platelets or 
result in atherosclerotic phenotypes (Yun et al., 2005; Nicu et al., 2009; 
Papapanagiotou et al., 2009; Arman et al., 2014). More specifically, no current work 
has explored; how T. forsythia may affect any haematopoietic cell lineages, how 
periodontal pathogens could affect platelet function or how platelet/periopathogen 
interactions and the resulting consequences occur at the cellular level.  Further work is 
needed to expand these initial studies to fully characterise the effects of P. gingivalis 
and T. forsythia on CHRF-288-11 cells as well as moving on to validating these finding 
in platelets, in order to answer these questions.  
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Chapter 4: Can periodontal pathogens interact with 
and induce platelet aggregation?  
 109 
4.1 Introduction 
The interactions between prokaryotes and mammalian platelets have been well 
documented with detailed studies showing that a broad spectrum of bacterial species 
can not only bind to platelets, but also induce platelet aggregation and activation 
(Clawson and White, 1971a, 1971b; Clawson, 1973; Clawson, Rao and White, 1975; 
Kerrigan, 2015). Examples of such interactions include the induction of aggregation 
and degranulation of platelets by Staphylococcus aureus (Hawiger et al., 1979) and the 
indirect interaction between Streptococcus pyogenes and platelets that is mediated by 
the availability of fibrinogen and von Willebrand factor (vWf) (Kurpiewski et al., 1983; 
Johnson and Bowie, 1992). Further to this several orally derived bacterial species, 
including Streptococcus spp., Staphylococcus spp., Pseudomonas aeruginosa and 
Porphyromonas gingivalis, have been implicated in cardiovascular disease (CVD) 
(McNicol and Israels, 2010; McNicol, 2015). It is thought that bacteria are able to gain 
access to the circulation, penetrate vascular walls causing secondary infections that 
ultimately lead to the formation of atherosclerotic plaques which then rupture and 
lead to platelet clotting and atherothrombosis (Kaplan and Jackson, 2011). Several 
studies have also suggested that bacterial-platelet interactions are crucial to the 
pathogenesis of some cardiovascular pathologies, as reviewed by McNicol and Israels 
(2010).  
Blood platelets undoubtedly play a predominant role within haemostasis, but their 
emerging role within antimicrobial host defence and in modulation of inflammatory 
responses could hold a crucial link that underpins the mechanism behind thrombotic 
and inflammatory events (Von Hundelshausen and Weber, 2007). In the context of 
periodontal pathogens, oral pathogenic bacteria have been reported to interact with 
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platelets through toll-like receptors (TLR's), causing platelet activation and the release 
of activation markers such as P-selectin and ADP (Shiraki et al., 2004; Blair et al., 2009; 
Zhang et al., 2009) as well as inducing the pro-thrombotic pathway (Roth et al., 2009). 
However the exact mechanisms by which these interactions occur are not fully 
elucidated. 
The sequence of events that follows platelet-bacterial association can be defined as; 
contact, shape change, early aggregation and irreversible aggregation (Clawson and 
White, 1971a). The use of light transmission aggregometry was initially developed in 
the 1960's (Born and Cross, 1963; Vigdahl, Marquis and Tavormina, 1969) and is still 
recognised as the gold-standard approach in platelet function testing in relation to 
cardiovascular diseases (Michelson, 2004). This chapter expands on the initial findings 
that P. gingivalis can induce platelet aggregation (Naito et al., 2006; Naito, 2007; Li et 
al., 2008) and investigates how viability and virulence factors of both P. gingivalis and 
T. forsythia could act as contributing factors to platelet/periopathogen interactions. 
4.2 Aims 
The studies described in this chapter aim to determine whether the periodontal 
pathogens P. gingivalis and T. forsythia induce platelet aggregation. This was 
investigated by determining: 
• The possible induction of platelet aggregation by a range of P. gingivalis and T. 
forsythia strains at varying multiplicities of infection. 
• The contribution of virulence associated bacterial proteins on the induction of 
platelet aggregation. 
• Whether heat-killed bacteria can induce platelet aggregation. 
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4.3 Results 
4.3.1 Platelet aggregation with wildtype P. gingivalis and T. forsythia 
Light transmission aggregometry was initially used to screen wildtype (WT) P. gingivalis 
strains NCTC 11834, ATCC W50, ATCC 381 and T. forsythia ATCC 43037 to determine 
whether they induced platelet activation at varying multiplicity of infection (MOI). 
Isolated platelet rich plasma (PRP) was exposed to wildtype P. gingivalis at an MOI of 
1:1 and 1:10. The rate of platelet aggregation was recorded over a period of 10 
minutes at 37 °C and compared to untreated PRP or PRP treated with ADP (20 μM), as 
a negative and positive control respectively. A representative aggregation plot is 
shown in Figure 4.1a. As expected ADP induced platelet aggregation (red), while no 
aggregation was observed with untreated PRP (blue). P. gingivalis NCTC 11834 was 
also observed to induce platelet aggregation which reached a peak at 8 minutes when 
compared to ADP with maximum aggregation reached within 4 minutes. 
Interestingly, aggregation was observed to be strain dependent with significant 
aggregation induced by P. gingivalis NCTC 11834 at an MOI of both 1:1 (p<0.05) and 
1:10 (p<0.001), and by P. gingivalis ATCC 381 at an MOI of 1:10 (p <0.001; Figure 4.1b). 
With P. gingivalis ATCC W50, no aggregation was observed at either MOI within the 10 
minute period (Figure 4.1b). In contrast to P. gingivalis, aggregation was not induced 
by wildtype T. forsythia at either MOI under the same experimental conditions (Figure 
4.1c). 
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Figure 4.1 Induction of platelet aggregation by wildtype (WT) periodontal pathogens. (A) Example 
aggregation plot. An example trace of light transmission aggregometry recorded over 10 minutes at 
37°C with P. gingivalis (green). Aggregation induced by ADP (20 μM, red) represents 100% aggregation 
and was included as a positive control. Untreated PRP (blue) was included as a negative control and 
demonstrates 0% aggregation. (B) Platelet aggregation by WT P. gingivalis. WT P. gingivalis NCTC 11834 
and ATCC 381 triggered platelet aggregation at MOI of 1:1 and 1:10. Aggregation was not observed with 
ATCC W50 at either MOI investigated over the 10 minute period. (C) Platelet aggregation by WT T. 
forsythia. Platelet aggregation was not observed in the presence of WT T. forsythia at an MOI of either 
1:1 or 1:10 ADP (20 μM) and untreated PRP are included as positive and negative control respectively. 
Data is expressed as ±SEM, p= *0.05, ***0.001. n=4.  
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4.3.2 Investigation of the effect of bacterial virulence on platelet 
aggregation in induced by P. gingivalis  
After the initial findings that wildtype P. gingivalis induces platelet aggregation in a 
strain dependant manner, further investigations were conducted to explore whether 
factors associated with bacterial virulence and/or interaction with cells could affect 
either the total percentage or the rate of aggregation. The ability of the P. gingivalis 
mutants P. gingivalis NCTC 11834 ΔompA1, P. gingivalis NCTC 11834 ΔompA2 and P. 
gingivalis ATCC 381 ΔSia0352 (described in Section 3.4) on platelet aggregation was 
determined. All mutants investigated, induced aggregation (p<0.001) at MOI 1:10, 
which was comparable to the parental strain (Fig 4.2). 
The rate of aggregation was determined by calculating the time taken to reach 50% 
aggregation (AG50). Interestingly, AG50 values were found to vary when wildtype and 
mutants were compared (Figure 4.2). Both PG mutants deficient in the outer-
membrane proteins OMPA1 (P. gingivalis NCTC 11834 ΔompA1) and OMPA2, (P. 
gingivalis NCTC 11834 ΔompA2) significantly induce platelet aggregation when 
compared to the parent wildtype strain (p<0.05, 0.01). The ΔompA2 mutant also 
exhibited a faster rate of aggregation when compared to the ΔompA1 mutant. This 
finding was also observed with P. gingivalis ATCC 381 ΔSia0352, which induced a 
significantly faster rate of platelet aggregation when compared to the wildtype strain 
(p<0.01; Fig. 4.2). 
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Figure 4.2 The effect of virulence associated proteins on platelet aggregation. (A) Induction of 
aggregation by mutants of P. gingivalis. Following exposure to mutants or WT strains of P. gingivalis, 
significant levels of aggregation was observed when compared to untreated PRP samples. (B) Time 
taken for platelet aggregation to reach 50% (AG50) of platelet aggregation when stimulated by WT P. 
gingivalis and mutants. Both mutants deficient in the outer membrane proteins (OMPA1 and OMPA2) 
and the Sialidase deficient strain (Sia0352) significantly induced a faster rate of aggregation when 
compared to the relevant WT strains. The ΔompA2 mutant was also observed to induce aggregation a 
faster rate when compared to the ΔompA1 mutant. ADP (20 μM) was included as a positive control for 
platelet aggregation. Data is expressed as ±SEM, p= *0.05, **0.01, ***0.001. n=4. 
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4.3.3 Investigation of aggregation induced by T. forsythia mutants 
After previous experiments (Section 4.3.2) revealed that bacterial virulence associated 
factors could affect the rate of platelet aggregation it was hypothesised that the 
virulence factors associated with T. forsythia could be preventing an aggregatory 
response. In order to investigate this both the T. forsythia ATCC 43037 ΔnanH deficient 
mutant and the T. forsythia ATCC 43037 ΔwecC isogenic mutant (described in Section 
3.4) were investigated in parallel with the wildtype strain. Contrary to the hypothesis, 
none of the bacterial stimulants caused platelet aggregation when compared to 
untreated PRP and PRP treated with ADP (20 μM) as a negative and positive control 
respectively (Figure 4.3). 
 
Figure 4.3 Platelet aggregation by T. forsythia WT strain and mutants. Platelets treated with T. 
forsythia ATCC 43037 or one of the two mutants (T. forsythia ATCC 43037 ΔnanH or T. forsythia ATCC 
43037 ΔwecC) did not induce platelet aggregation at an MOI of 1:10. ADP (20 μM) was included as a 
positive control and all samples were directly compared to untreated PRP. Data is expressed as ±SEM, 
p=***<0.001. n=4.  
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4.3.4 Investigations into the effect of bacterial viability on platelet 
aggregation 
After it had been demonstrated that platelet aggregation can be induced by viable 
periodontal pathogens, investigations were conducted to elucidate whether the 
pathogens need to be viable to elicit this effect. P. gingivalis NCTC 11834, ATCC W50 
and T. forsythia ATCC 43037 were heat treated and the effect of the resulting heat-
killed bacteria on platelet aggregation was determined. It was observed that both 
viable and heat killed P. gingivalis induced significant aggregation (p <0.01, 0.001), 
however when compared to the wildtype, the heat killed bacteria showed a significant 
decrease in percentage aggregation (p<0.001; Figure 4.4a). In contrast to this, although 
some aggregatory response was observed with wild type P. gingivalis ATCC W50, no 
significant aggregation was recorded with T. forsythia ATCC 43037 or P. gingivalis ATCC 
W50 in either treatment (Figure 4.4a)  
Earlier findings demonstrated that P. gingivalis lacking the outer membrane proteins 
OMPA1 and OMPA2 showed a significant increase in the rate of platelet aggregation. 
To further understand these findings, investigations were designed to explore whether 
bacterial viability could impact the aggregatory response as seen with wildtype P. 
gingivalis (Figure 4.4a). All bacterial treatments successfully resulted in stimulating 
platelet aggregation, however only the viable treatments resulted in significant 
readings (Figure 4.4b). Total percentage aggregation does not account for the time 
taken for aggregation to initiate or the rate of the recorded aggregatory response. To 
overcome this factor the data was further processed to analyse the time take for each 
sample to reach AG50. The analysis highlights that all bacterial treatments induce 
platelet aggregation (Figure 4.4b) but also that with heat killed, non-viable bacteria 
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there was a significant decrease in the rate of aggregation (Figure 4.4c) suggesting that 
interactions with viable bacteria are needed to induce a platelet aggregatory response. 
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Figure 4.4 The effect of bacterial viability on platelet aggregation. (A) Aggregation by periodontal 
pathogens. Both wild type (WT) and heat killed (HK) P. gingivalis NCTC 11834 induced a significant level 
of platelet aggregation. In contrast, both WT and HK P. gingivalis ATCC W50 and T. forsythia ATCC 43037 
did not induce significant aggregation. Interestingly, the HK treated P. gingivalis NCTC 11834 bacterium 
produced a significant reduction in aggregatory response when compared to the WT. (B) Induction of 
aggregation by viable and heat killed P. gingivalis deficient in the outer membrane proteins. Significant 
levels of aggregation was observed by P. gingivalis NCTC 11834 and mutants (P. gingivalis NCTC 11834 
ΔompA1 and P. gingivalis NCTC 11834 ΔompA2) when compared to untreated PRP. All HK treatments 
also induced some level of aggregation but none of these findings were statistically significant. (C) AG50 
of aggregation triggered by both viable and HK P. gingivalis. Platelets were exposed to both viable and 
HK bacteria before aggregation times were recorded against A significant decrease in the time taken to 
reach 50% aggregation was observed in the WT P. gingivalis NCTC 11834 and both mutant strains (PG 
NCTC 11834 ΔompA1 and PG NCTC 11834 ΔompA2). Aggregation was measured following exposure to 
pathogens (WT and HK) at an MOI of 1:10 for 10 minutes at 37 °C. Data is expressed as ±SEM, p= 
**0.01, ***0.001. n=4. 
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4.4 Discussion 
Understanding the relationship by which periodontal pathogens and platelets interact 
is crucial to explicate the postulated impact of oral pathogens on cardiovascular 
disease. This chapter investigated the effect of periodontal pathogens on the induction 
of platelet aggregation. The data presented here corroborate previous findings 
suggesting that P. gingivalis NCTC 11834 interacts with platelets and induces 
aggregation at increasing MOI (Naito et al., 2006; Naito, 2007; Li et al., 2008). 
This study demonstrates that P. gingivalis induced aggregation is strain specific as 
aggregation was observed with both P. gingivalis NCTC 11834 and P. gingivalis ATCC 
381 strains but not with ATCC W50. This is in contrast to the findings of Klarström 
Engström and co-workers (2015) who reported that ATCC W50 caused approximately 
50% aggregation when compared to NCTC 11834. The two studies however are not 
strictly comparable due to substantial differences in the methodology used. Klarström 
Engström et al (2015) conducted aggregation experiments in a modified Krebs Ringer 
glucose buffer, which replaces chelated cations that are lost within the platelet 
isolation process, over a longer time frame (15 minutes) and in the absence of relevant 
positive controls. In this work, all assays were conducted using isolated platelet rich 
plasma in citrate buffer and aggregation was monitored over 10 minutes. Throughout 
the optimisation of initial aggregation experiments with wildtype P. gingivalis strains 
within this body of work, it was noted that after three passages of bacterial culture all 
experimental conditions began to induce platelet aggregation. It is well documented 
that bacterial species are able adapt their behaviour and phenotype according to 
environmental conditions (Friedman et al., 2015) and for this reason all experiments 
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reported within this thesis were done with bacteria that had undergone no more than 
three passages. 
Strain-specific induction of platelet aggregation has been previously reported with 
other bacterial species including Helicobacter pylori which is associated with peptic 
stomach ulcers  and Streptococcus pneumoniae, one of the underlying causes of 
bacterial pneumonia (Corcoran et al., 2007; Keane et al., 2010), thereby suggesting 
that strain-specific factors may affect the pathogenicity of different bacterial isolates. 
This is further illustrated by the fact that strain variances are known to impact on the 
invasive and virulent characteristics of P. gingivalis (Jandik et al., 2008; Suwannakul et 
al., 2010; Baek et al., 2015). It was previously reported that both P. gingivalis NCTC 
11834 and P. gingivalis ATCC 381 are highly invasive when compared to P. gingivalis 
ATCC W50 in human umbilical vein endothelial cells (HUVEC) and KB epithelial cell lines 
when characterised via antibiotic protection assays (Dorn et al., 2000). 
Other work has also begun to elucidate the underlying genetics which may explain the 
observed variances across bacterial isolates. Igboin and colleagues (2009) 
demonstrated that, when compared by heteroduplex and ribosomal intergenic spacer 
region (ISR) sequencing, P. gingivalis strains NCTC 11834 and 381 were genetically 
highly related but are both highly divergent when similarly compared with P. gingivalis 
ATCC W50. These findings by Igboin et al., (2009) not only explain the observations of 
this study that NCTC 11834 and 381 but not ATCC W50 caused platelet aggregation, 
but may also provide an insight into the underlying genetic variances that contribute to 
P. gingivalis phenotypes and virulence. 
As well as strain specific variations, it was also hypothesised that periodontal-pathogen 
mediated platelet aggregation could be dependent on specific bacterial membrane 
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proteins and their involvement in mammalian cellular interactions. Therefore the role 
of the outer-membrane proteins OMPA1 and OMPA2 was investigated.  
Previous studies by Suwannakul and colleagues (2010) identified the OMPA protein as 
being important in host interactions. Further studies demonstrated that two major 
subunits of the outer membrane proteins namely OMPA1 and OMPA2 were important 
in biofilm formation as well as epithelial cell interactions (Naylor et al., 2016). In this 
study, the deletion of either subunit OMPA1 and OMPA2 did not impact on the overall 
percentage of aggregation although the data suggest a possible role in triggering the 
onset of an aggregatory response. When compared to the parent strain, both OMPA1 
and OMPA2 mutants were shown to significantly decrease the time taken to initiate 
platelet aggregation (p<0.05 and <0.001 for the OMPA1 and OMPA2 mutants, 
respectively). OMPA2 was also observed to induce aggregation at a faster rate than the 
OMPA1 mutant, but this difference was not statistically significant at the 0.05 level.  
In addition to the OMPA proteins, the P. gingivalis sialidase enzyme 0352 has also been 
implicated in cellular interactions and bacterial pathogenesis. Work by Aruni et al 
(2011) identified that 0352 sialidase facilitates bacterial-host interactions within the 
periodontal pocket by allowing the exposure of potential binding receptors on 
glycoproteins and glycolipids. Further to this, sialidase activity has also been directly 
associated with the expression of virulence factors in P. gingivalis including LPS, 
capsule, gingipain activity, fimbriae as well as circumventing host response (Aruni et 
al., 2011; Li et al., 2017; Yang et al., 2018). When the P. gingivalis ATCC 381Sia0352 
was screened in platelet aggregation, no differences were observed, with both the 
mutant and parent strain inducing a significant level of percentage aggregation 
(p<0.001). However, similarly to the findings with the OMP deficient mutants, P. 
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gingivalis ATCC 381 ΔSia0352 caused a significantly faster onset of platelet aggregation 
when compared to the wildtype P. gingivalis ATCC 381 (p<0.001). 
The P. gingivalis mutants screened throughout these aggregation studies were 
selected on the basis of their involvement in cellular interactions. Despite the stark 
biological differences between the OMPA and the ΔSia0352 mutants, the data suggests 
that disrupting bacterial/cellular interactions, results in a faster rate of aggregation 
more akin to that of a naturally occurring stimulant such as ADP. The process of 
delaying the aggregatory response that was observed with wildtype strains of P. 
gingivalis (NCTC 11834 and ATCC 381) could reflect a bacterial counterstrategy against 
the antimicrobial properties of platelets. Similar findings by Svensson and colleagues 
(2014) suggested that Streptococcus pyogenes not only initiates platelet aggregation, 
but exploits the fact that the formed aggregate is not significantly bactericidal allowing 
the bacterium to evade further host response, before disaggregating the platelets and 
escaping. P. gingivalis is well documented to supress and evade host response through 
a number of virulence factors including supressing complement activation though the 
secretion of LPS and gingipains, which promote bacterial survival (Hajishengallis, 2011). 
Taken together these observations suggest a possible mechanism in which P. gingivalis 
is able to hijack platelet aggregation and might be able to contribute to systemic 
pathogenesis. 
In contrast to P. gingivalis, the systemic impact of T. forsythia is less characterised. To 
date limited studies have investigated interactions between T forsythia and platelets. 
Under the same experimental conditions as P. gingivalis, wild type T. forsythia did not 
induce platelet aggregation. In an attempt to determine whether T. forsythia does not 
induce platelet aggregation or whether it actively evades platelet response, two 
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virulence factors of interest were selected. Firstly, the NanH sialidase is a virulence 
associated enzyme present in the outer membrane of T. forsythia that cleaves sialic 
acids on host glycoproteins, destroying their integrity and promoting cellular adhesion 
and invasion (Honma, Mishima and Sharma, 2011). Secondly, further work by Honma 
et al (2007) identified that the wecC gene present in T. forsythia is responsible for 
regulating biofilm formation. Disruption of the wecC gene promotes exopolysaccharide 
synthesis, promotes biofilm formation and an overall increase in bacterial virulence 
(Honma et al., 2007). These two virulence associated characteristics of wecC and nanH 
were then screened in further aggregation experiments using the T. forsythia ATCC 
43037nanH deficient mutant and T. forsythia ATCC 43037 ΔwecC isogenic mutant. 
Neither the parental strain nor the mutants resulted in an aggregatory response, 
suggesting that under these conditions, T. forsythia ATCC 43037 does not induce 
platelet aggregation. However, the lack of an aggregatory response does not indicate 
that T. forsythia cannot interact with platelets. Previous work has also identified that 
other bacterial species such as Staphylococcus aureus (Loughman et al., 2005) and 
Streptococcus gordonii (Kerrigan et al., 2007) do not interact directly with platelets but 
interact with them indirectly via bridging molecules. This indirect interaction process 
results in an increased lag time of up to 18 minutes to induce platelet aggregation 
(Loughman et al., 2005; Kerrigan et al., 2007) and could explain why no aggregation 
was recorded following stimulation by wild-type T. forsythia within this thesis during 
the 10 minute time period. It is also well established that bacterial species induce an 
'all or nothing' response in relation to platelet aggregation (Kerrigan, 2015) and thus 
further experiments are needed to fully characterise the potential interactions 
between platelets and T. forsythia. 
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In order to expand on initial aggregatory finding, the effects of bacterial viability were 
also explored within this chapter. The initial experiments screened both P. gingivalis 
(NCTC 11834 and ATCC W50) and T. forsythia (ATCC 43037) and found that both P. 
gingivalis ATCC W50 and T. forsythia ATCC 43037 did not induce significant levels of 
platelet aggregation with either the viable or heat-killed treatments. In contrast, P. 
gingivalis NCTC 11834 significantly induced platelet aggregation with both the viable 
and HK treatments (p<0.001), however comparatively the overall level of aggregation 
induced by the heat-killed P. gingivalis NCTC 11834 was significantly less in relation to 
the viable wildtype strain (p<0.05).  
To probe this further, wild type P. gingivalis NCTC 11834 was comparatively screened 
by aggregation against the two OMPA deficient mutants OMPA1 and OMPA2.  As 
previously mentioned, viable wild type NCTC11834 and both OMPA mutants were able 
to induce significant levels of aggregation (p<0.001). However in some cases, heat 
killed bacteria were observed to induce late-onset aggregation which is thought to 
reflect the variability in platelet response but this was not statistically significant. 
These finding were also compared to the rate at which aggregation occurred, with all 
the heat killed treatments (P. gingivalis NCTC 11834, OMPA1 and OMPA2) resulting in 
significantly longer times to reach AG50 when compared to the relevant viable 
treatments (p<0.01, 0.001). Taken together these findings suggest that while viability 
seems essential for a faster onset of platelet aggregation, it may be possible for non-
viable bacterium to interact with platelets but at a slower rate. Similar findings were 
reported by Klarström Engström and colleagues (2015) who demonstrated that P. 
gingivalis NCTC 11834 induces platelet aggregation at an MOI of 1:1, whereas heat 
killing the bacterium completely eradicated any aggregatory response. The authors 
concluded that the heat killed treatment lacked gingipain proteolytic activity and the 
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ability to induce cytosolic calcium changes thereby preventing platelet activation and 
aggregation (Klarström Engström et al., 2015). However, the observed reduction in 
platelet aggregation could also be explained by the experimental approach used, as 
although heat-killing bacterium is a standard laboratory procedure, the process does 
denature key proteins involved in bacterial virulence, such as gingipains (Belton et al., 
1999; Nakhjiri et al., 2001; Ankersmit, et al., 2007) and therefore it can be argued that 
these findings highlight the combined effect of denaturation and of bacteria cell 
viability.  
4.5 Summary 
In conclusion, this study demonstrates that viable P. gingivalis induces platelet 
aggregation in a strain dependant manner. Additionally, the data presented show that 
bacterial virulence associated with periopathogen/platelet interactions may reduce or 
dampen the aggregatory response. Within this study, neither wild-type T. forsythia nor 
any of the screened T. forsythia mutants were able to induce platelet aggregation. This 
suggests that T. forsythia cannot interact with platelets in the context that was 
observed with P. gingivalis.  
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Chapter 5: Development and characterisation of a 
multicolour flow cytometry panel 
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5.1 Introduction 
Platelets are small, anucleate discoid shaped blood cells, which play a fundamental 
role in both haemostasis and immune response (Sonmez and Sonmez, 2017). 
Normally, platelets circulate around the body in an unstimulated and resting form but, 
upon activation, they express a range of activation-specific markers (Jennings, 2009). 
This method was designed to identify and develop a panel for the simultaneous 
analysis of both platelet-surface and platelet-activation markers after treatment by an 
agonist or other stimulus following previously published guidelines on platelet analysis 
(Schmitz et al., 1998). Despite flow cytometry being routinely applied to the clinical 
analysis of whole blood to monitor platelet function in diseased states and being a 
well-established tool within platelet research (Michelson et al., 2000), very few 
comprehensive methodologies exist for quantitative analysis of platelet function that is 
relevant to their in vivo activity. 
As platelets can be easily activated during sample processing (Wallén et al., 1997) and 
storage (Rinder et al., 1991; Vučetić et al., 2018) in the absence of inhibitors, a 
standardised single-step analysis panel was developed and optimised using freshly 
acquired platelets from healthy donors. This would enable the capture of key platelet 
surface markers, as well as those altered during activation, thereby reducing 
experimental variability and the need for large sample volume. 
This five-colour flow cytometry panel was optimised to allow the differential 
expression of platelet surface receptors to be quantified in both unstimulated and 
stimulated platelet populations, following treatment with adenosine diphosphate 
(ADP) or bacterial stimulation.  
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The panel was specifically designed to include commercially available antibodies in a 
single-step staining process to minimise the risk of spontaneous platelet activation 
during sample handling and preparation. 
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5.2 Aims 
The aim of this chapter was to enable the quantification of a range of platelet surface 
markers following the addition of an agonist or bacterial stimulus. To minimise 
spontaneous activation of platelets and maximise the use of individual samples, a 
single-step protocol was developed to allow simultaneous measurement of key 
platelet markers. This chapter focusses on; 
• The development of a multicolour flow cytometry panel to study marker 
expression in stimulated and unstimulated platelet populations following 
treatment with ADP 
• The adaptation of an optimised multicolour flow cytometry panel to study the 
effect of periodontal pathogen interactions on platelet marker expression 
 
The methodology developed within this chapter has been written up as an original 
paper and submitted to the journal Cytometry Part A. 
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5.3 Method development and gating strategy 
This workflow has been optimised and validated for the analysis of freshly acquired 
platelets isolated from whole blood and from a range of healthy donors to ensure 
reproducibility. 
5.3.1 Panel selection 
To identify the platelet population, CD41 (αIIb, GPIIb) and CD61 (β3, GPIIIa) were 
selected as markers. CD41 is expressed exclusively on select early haematopoietic 
progenitors, megakaryocytes and platelets (Wiles and Keller, 1991; Mitjavila-Garcia et 
al., 2002), whilst CD61 is expressed on platelets, osteoclasts, fibroblasts, macrophages, 
and some tumour cells (Hynes, 1987; Savill et al., 1990; Engleman et al., 1997; Sloan et 
al., 2006). To determine levels of platelet activation following treatment, three 
markers and corresponding antibodies were selected. The antibody, against an 
activated epitope of the heterodimer CD41/CD61 (αIIbβ3, GPIIbIIIa) was included in 
the panel (Gardiner et al., 2007) as well as CD62P (P-selectin, GMP-140), a Type I 
transmembrane glycoprotein expressed on activated platelets (Ault et al., 1989). 
Finally, CD42b (GPIb) was included within the panel because its shedding can be 
related to both platelet activation in treated samples and platelet viability in untreated 
samples (Bergmeier et al., 2003, 2004; Gardiner et al., 2007). The panel also includes 
IgG isotype controls although the specific focus of this work is on the comparison of 
unstimulated and stimulated platelets.  
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5.3.2 Flow cytometer instrument configuration 
The panel was optimised for use on the Gallios flow cytometer (Beckman Coulter; 
Table 5.1). The Gallios flow cytometer was selected due to its three laser, 10 colour 
configuration and its routine application in both research and diagnostics. The Gallios 
flow cytometer has previously been applied to the phenotypic study of various 
haematopoietic cells including dendritic cells (Ferreira et al., 2013), monocytes 
(Morandi, Airoldi and Pistoia, 2014), B cells (Griffin and Rothstein, 2012), and platelets 
(Lacroix et al., 2010; Maugeri et al., 2012; Tynngård et al., 2015). 
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Laser 
(nm) 
Laser Power 
(mW) 
Laser Type Detector Spectral Range 
for Detector 
(nm) 
Dichroic Filter 
(nm) 
Band Pass 
(nm) 
Fluorochrome 
488 22 Solid State 
Diode 
FL-1 505-545 550 525/40 Alexa Fluor 488 
FL-2 560-590 595 575/30 PE 
Fl-5 >755 N/A 755LP PE/Cy7 
638 25 Solid State 
Diode 
FL-6 650-670 710 660/20 APC 
405 40 Solid State 
Diode 
FL-9 425-475 480 450/50 Pacific Blue 
 
Table 5.1 Flow cytometer instrument configuration. This panel was optimised for a Gallios flow cytometer (Beckman Coulter), with a 10 colour, three laser configuration 
(Blue/Red/Violet). APC-allophycocyain, Cy-cyanin, PE- R-phycoerythrin.
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To assess suitability of conjugates in a multi-colour panel (Table 5.2) compensation 
matrix was generated using FlowJo to determine spill-over of signals (Table 5.3). 
FlowJo FACS data analysis software is a leading analysis platform that computes and 
applies compensation corrections and enables visualization of all flow cytometry data 
(Herzenberg et al., 2006).  
Fluorescent intensities from single stain treatments were compared to those obtained 
through full panel analysis to account for potential steric hindrance and overlapping 
epitopes of antibodies. This single-stain approach allows both sample processing and 
analysis within four hours of blood sampling, which is critical for limiting spontaneous 
platelet activation and retaining in vivo platelet characteristics. 
Specificity Fluorochrome Clone Antigen Reference Stock Conc. 
(μg/ml) 
CD61 PE/Cy7 VI-PL2 Zola et al., (2007) 25 
CD41 Pacific Blue HIP8 Riberdy et al., (1994); 
Denzin and Cresswell, 
(1995); Denzin, (1996) 
80 
CD41/61 APC A2A9/6 Bennett et al., (1983); 
Clemetson and Clemetson, 
(1994); Matsumura-Takeda 
et al., (2007) 
150 
CD62P Alexa Fluor 
488 
AK4 Varki, (1994); McEver, 
Moore and Cummings, 
(1995) 
200 
CD42b PE HIP1 Clemetson et al., (1982); 
Fox, Aggerbeck and Berndt, 
(1988); Kuijpers et al., 
(1992) 
50 
Table 5.2 Commercial reagents used. Samples were fixed with 0.5% paraformaldehyde and then 
incubated with listed antibodies for 20 minutes at room temperature in the dark prior to analysis.  
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 Alexa Fluor 488 PE PE/Cy7 APC Pacific Blue 
Alexa Fluor 488 N/A 9.180% 2.430% 0.000% 5.880% 
PE 2.460 % N/A 1.360% 0.000% 0.021% 
PE/Cy7 2.160% 0.463% N/A 0.000% 0.027% 
APC 0.000% 0.000% 0.000% N/A 0.000% 
Pacific Blue 5.400% 0.195% 0.047% 0.000% N/A 
Table 5.3 Representative compensation matrix. Data from one sample with compensation analysis 
completed in FlowJo (Ver 7.6) to assess spill-over. 
 
The use of five fluorochromes allows additional application-specific markers to be 
introduced as needed. The selection of the antibody/fluorochrome combinations, 
based on expression levels of the antigen of interest and brightness of fluorophore; 
with the brighter fluorophores conjugated to lower density antigens, was guided by 
their commercial availability and possible application using a single-step staining 
approach. This also ensures that selected antibodies have a level of quality assurance 
and validation, whilst reducing the number of steps within the protocol. 
Following initial isolation of platelet rich plasma (PRP) from whole blood, platelets 
were treated as described in Chapter 2. Following fixation, a platelet population was 
first defined on the basis of forward size scatter (FSC) and side scatter (SSC) followed 
by gating on two platelet surface proteins CD41 and CD61, which allow for platelet 
subsets to be identified, irrespective of stimulation (Saboor, Moinuddin and Ilyas, 
2012).  
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To determine the activation status of platelets, three platelet activation 
markers/epitopes were selected; CD62P (Ault et al., 1989), CD42b (glycoprotein Ib) 
(Bergmeier et al., 2003, 2004; Gardiner et al., 2007) and an antibody against an 
epitope expressed on activated but not resting platelets CD41/CD61 (Gardiner et al., 
2007). 
The panel was designed with particular attention to antibody-fluorophore 
combinations to ensure that optimal staining was obtained whilst minimising spill-over 
of background fluorescence. The selection of antibodies was validated using non-
permeabilised platelets as benefits of this approach include a simpler and shorter 
procedure with minimal sample handling and processing. The finalised constructed 
panel therefore consists of Pacific Blue-CD41, PE/Cy7-CD61, APC-CD41/61, Alexa Fluor 
488-CD62P, PE-CD42b. 
  
 136 
5.4 Results 
5.4.1 Antibody optimisation 
In order to optimise antibody concentrations, antibodies were serially titrated on 
platelets isolated from healthy volunteers (n=6) before the scatter profiles were 
analysed to detect antibody saturation (Figure 5.1). Optimum antibody concentrations 
were determined at the plateau of signal intensity and are depicted with red boxes. 
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Figure 5.1 Reagent titrations. Antibodies were serially titrated (1:4) on platelets isolated from healthy volunteers. Individual files were concatenated to allow visualisation of all 
titrations in a single figure. Unstained controls samples are labelled as zero. Selected antibody titers used are highlighted with red boxes. IgG controls were used at the same 
concentration as the corresponding antibody. Antibody concentrations are arranged along the X-axis. 
.
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5.4.2 Gating strategy 
Following antibody optimisation, platelets were treated with ADP (20 μM) before 
analysis was undertaken with the designed gating strategy and comparative 
histograms. A representative plot is shown in Figure 5.2. Platelet populations were 
successfully isolated on CD41, CD61 positivity, with subsequent comparative 
histograms demonstrating an increased expression of both CD41/61 and CD62P, as 
well as a decreased expression of CD42b following stimulation with ADP (20 μM). 
  
 139 
 
Figure 5.2 Top Panel: Gating strategy. Following platelet isolation and full blood count to confirm 
platelet purity and sample treatment, initial platelet population was first identified on basis of forward 
size scatter (FSC) and side scatter (SSC) (A). Corresponding isotype controls (B) and platelet markers 
CD41 and CD61 (C) were used to isolate CD41+CD61+ platelet sub-population (>95% as shown).  
Bottom Panel: Comparative histograms. Unstimulated (blue lines) and adenosine diphosphate treated 
platelets (ADP, 20 μM; stimulated, red lines) illustrate changes in activation markers in relation to levels 
of CD41+/61+ (D), CD62P+ (E) and CD42b- (F) populations. Sample processing and analysis were 
completed within four hours of blood collection. 
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5.5 Adaptation of stimulated population 
The optimised multicolour flow cytometry panel was then adapted to allow the 
simultaneous analysis of bacterial association and stimulation of platelets. Platelets 
were stimulated with periodontal pathogens (P. gingivalis or T. forsythia, MOI 1:10) 
before populations of interest were identified using forward scatter (FSC) and side 
scatter (SSC) profiles (Figure 5.3a). Platelet purity was selected on CD41 positivity 
(Figure 5.3b-c). 
 
Figure 5.3 Representative revised gating strategy of platelet isolation. Platelet populations identified 
through forward-side scatter profiling (A) were selectively gated on CD41 positivity using IgG isotype 
controls (B) and antibody treated platelets (C). 
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Association of isolated platelets to bacterial cells was then determined by the relative 
fluorescent intensity of the bacterial specific antibodies, PGWC1 and TFWC. PGWC1 
staining produced a 'smeared' scatter profile, which resulted in a lack of distinct 
populations (Figure 5.4). To overcome this issue, several methodologies were 
considered before quadrant gates were allocated on the third contour of both the 
negative (Figure 5.4a) and positive (Figure 5.4b) controls. This gating strategy allows 
the separation of bacterial associated platelets (Figure 5.4c, Q2), from platelets that 
remain unassociated (Figure 5.4c, Q3), with simultaneous analysis of platelet activation 
markers within both subpopulations (Figure 5.5). No distinct population separation 
could be achieved with platelets treated with Tannerella forsythia and subsequent 
staining with TFWC antibody.  
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Figure 5.4 Isolation of pathogen associated platelets. Example plots of CD41+ platelets (left-hand 
panel), showing the applied gating strategy (right-hand panel) to untreated PRP (A), PRP treated with 20 
μM ADP (B) and P. gingivalis NCTC 11834 treated PRP (C). Due to the 'smeared' profile of bacterial 
antibody staining (PGWC1), upper gated quadrants were placed above the third contour of untreated 
PRP and PRP treated with ADP (20 μM). Using these defined gates, platelets treated with P. gingivalis (C) 
could be separated to define un-associated platelets (C,Q3) and P. gingivalis associated platelets (C,Q2). 
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Figure 5.5 Comparative histograms of platelet activation following exposure to P. gingivalis. 
Comparative histograms of un-associated platelets (blue lines) and P. gingivalis associated platelets (red 
lines) illustrate platelet activation relative to the expression of CD62P (A), CD41/61 (B) and CD42b (C).
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5.6 Discussion 
This chapter of work focuses on the development and adaptation of a single-step 
multicolour flow cytometry panel for the evaluation of platelet activation following 
exposure to periodontal pathogens. The application of flow cytometry combines the 
advantages of both microscopy and biochemical analysis techniques allowing for rapid, 
simultaneous phenotypic analysis of a large volume of cellular events (Muirheadi, 
Horan and Poste, 1985). 
The initial panel development and optimisation demonstrated that platelet sub-
population could be identified following PRP isolation and selective gating on both 
CD41 and CD61 positivity. It was also shown that ADP (20 μM) effectively stimulates 
platelet activation, which could be quantified through an increased expression of both 
CD62P and CD41/61 as well as a decreased expression of CD42b. As previously stated, 
one of the major difficulties surrounding platelet studies is spontaneous activation and 
a reduction in viability during sample processing (Wallén et al., 1997) and storage 
(Rinder et al., 1991). Within this study, utilising multiparameter flow cytometric 
analysis has allowed the detection of surface antigens in a sensitive and specific 
manner whilst in agreement with previously published guidelines limiting sample 
processing to a maximum of four hours(Schmitz et al., 1998). 
However, adaptation of the newly optimised panel to incorporate the application of 
bacterial specific antibodies produced a 'smeared' staining scatter profile, resulting in a 
lack of definition between expected populations. Although spontaneous platelet 
activation was kept to a minimum, some level of activation was expected in all 
experimental conditions and appears to result in positive staining throughout all 
samples incubated with bacterial specific antibodies. 
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In order to separate bacterial associated platelets treated with these antibodies, 
several gating methodologies were investigated in detail following previously 
published guidelines on flow cytometry data presentation (Alvarez et al., 2010). 
Initially it was hypothesised that the bacterial associated populations could be 
separated by comparative histograms but this was challenging due to the 
heterogeneous populations. Analysis by comparative histograms was also discarded 
due to reliance on the user to define which two samples were significantly different 
(Baggerly, 2001) with the resulting subjective selection of gating introducing over 
manipulation of data and inaccurate analysis (Overton, 1988). Similarly, although dot 
plots are widely used to view acquired data, this type of analysis also draws 
considerable limitations. The inherent characteristics of these plots can often mask the 
density and distribution of the data through overlapping dot placements and a lack of 
definition between highly populated and sparsely populated regions (Herzenberg et 
al., 2006). 
In agreement with Herzenburg and colleagues (2006), it was subsequently concluded 
that coloured density plots, (zebra plots, quantile contour plots) offer the most 
accurate representation of the acquired data, with the increased dynamic range and 
frequency definition allowing for accurate gating placement. Gates placed above the 
third contour of control samples resulted in P. gingivalis associated populations being 
successfully isolated and provides a reproducible analysis methodology for the 
quantitation of platelet activation markers. P. gingivalis association was determined to 
induce increased CD62P, CD41/61 and CD42b staining when compared to the 
unassociated populations. The developed methodology however was not effective in 
separating populations of platelets associated with T. forsythia. It was surmised that 
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this was due to a lack of association of the bacterium to platelets that resulted in a lack 
of population definition and was not attributed to limitations within the methodology. 
Polychromatic flow cytometry, as with any analytical technique does carry a number of 
caveats that must be considered. The design and optimisation of multiparameter flow 
cytometry panels is an extremely labour intensive and costly process. It cannot be 
overlooked that without carefully constructed panels, extensive antibody titrations, 
antibody ranking and expression characterisation, as well as dismissal of incorrect 
antibody combinations and the correct compensation measures, this methodology 
would lack both accuracy and reproducibility (Mahnke and Roederer, 2007). As well as 
limitations surrounding instrument and panel set-up, another underlying issue 
surrounding multicolour flow cytometry is the magnitude of data produced during 
sample acquisition and the subsequent data analysis that follows.  
One of the fundamental advantages to polychromatic flow cytometry is the ability to 
define and analyse subsets of cells within a population, however by introducing several 
antibody combinations as well as the possibility of exploring hundreds of different 
phenotypic characteristic, a pragmatic and sensible approach must be undertaken 
towards data analysis (Chattopadhyay and Roederer, 2012), which complies with the 
availability of suitable software (Roederer and Moody, 2008). Within this study, 
although five phenotypic parameters were applied within the panel, analysis was 
confined to the comparison of data within two-dimensional plots, meaning that only 
two phenotypes of interest can be compared at any one time. 
Despite these limitations, the polychromatic, multiparameter flow cytometry panel 
designed within this study provides a robust analysis methodology that provides 
reliable data acquisition and analysis within this system. 
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5.7 Summary 
This study provides a practical tool to evaluate the status of freshly isolated platelets 
following treatment with a stimulus in a single-step staining process. The simple and 
relatively quick protocol described can be used in settings where spontaneous platelet 
activation needs to be minimised, minimal sample volumes are available and where 
platelets cannot be stored on-site for an extended period. 
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Chapter 6:The effect of periodontal pathogens on 
platelet function and protein expression 
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6.1 Introduction 
It has been postulated that oral pathogens can either penetrate the surrounding 
tissues and vascular network of the periodontal pocket or release a barrage of 
biologically active molecules including gingipains and hemagglutinins  (Reyes et al., 
2013) that can then contribute to or exacerbate several systemic conditions including 
rheumatoid arthritis (Wegner et al., 2010), diabetes (Borgnakke et al., 2013) and 
cardiovascular disease (Kerr, 1951, 1962; Kebschull, Demmer and Papapanou, 2010).  
Within the vascular system, the role of platelets within homeostasis is well established 
(Zucker and Nachmias, 1985). Recent studies have highlighted the antimicrobial role of 
platelets within both the adaptive and innate immunity and how these mechanisms 
may contribute to atherosclerosis (Ali, Wuescher and Worth, 2015; Hamzeh-Cognasse 
et al., 2015; Koupenova and Freedman, 2015). Bacterial species are known to interact 
with platelets, including various streptococcal, staphylococcal and helicobacter strains 
(Kerrigan and Cox, 2010) with platelets being capable of Platelets  immobilising and 
internalising pathogens (Yeaman, 1997, 2010a, 2010b) and exhibiting antimicrobial 
activity (Zielinski et al., 2001; Lopes-Pires et al., 2012). Several mechanisms have been 
reported to facilitate bacterial-platelet association including direct interactions via Toll-
like receptors (Assinger et al., 2012), glycoprotein (GP) IIbIIIa, GPIb, the fcγRIIa 
receptor (Cox, Kerrigan and Watson, 2011), or indirect interactions such as  
lipopolysaccharides (LPS) (Shiraki et al., 2004; Scott and Owens, 2008) or various 
plasma protein bridges such as fibrinogen or von Willebrand factor (vWF) (Cox, 
Kerrigan and Watson, 2011). 
Periodontal pathogens in the form of bioflims have been reported to induce platelet 
aggregation (Tu et al., 2016). More specifically, P. gingivalis been shown to induce both 
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platelet aggregation and activation (Curtis et al., 1993b; Afrodite Lourbakos et al., 
2001; Li et al., 2008; Assinger et al., 2012; Klarström Engström et al., 2015) which may 
suggest a possible role of periodontitis in CVD. Although the interaction of P. gingivalis 
and platelets has previously been reported within the literature the underlying 
mechanisms as well as the full extent and consequences of these interactions are yet 
to be elucidated. 
6.2 Aims 
Previous findings (Chapter 4) demonstrated that the periodontal pathogen P. gingivalis 
interacts with platelets in a strain-dependant manner and induces platelet 
aggregation. This chapter focuses on elucidating the mechanisms underlying these 
platelet/pathogen interactions by addressing the following questions: 
• Do periodontal pathogens directly interact with platelets, resulting in the 
formation of aggregates? 
• Does P. gingivalis or T. forsythia interaction result in platelet activation, 
changes in integrin expression and degranulation of mammalian platelets? 
• What are the possible sites of interaction and association between platelets 
and periodontal pathogens? 
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6.3 Results 
6.3.1  Analysis of platelet-P. gingivalis interactions by 
immunofluorescence microscopy.  
Immunofluorescence (IF) microscopy was initially used to determine whether platelets 
are able to directly interact with the periodontal pathogens, P. gingivalis and T. 
forsythia. Platelets were exposed to P. gingivalis (MOI 1:10) and stained for F-actin to 
determine platelet morphology and with the pathogen specific antibody PGWC1 to 
identify P. gingivalis NCTC 11834 (Figure 6.1). The immunostaining demonstrates that 
P. gingivalis associates with, and appears to cause 'clumping' of the platelets when 
compared to control platelets not exposed to the pathogen. Platelets were also probed 
with integrin β1 (Figure 6.2) and β3 (Figure 6.3) specific antibodies, to investigate 
whether treatment with P. gingivalis NCTC 11834 could affect the overall expression of 
these integrins or whether any co-localisation of bacteria and integrins could be 
observed. DAPI staining was utilised for identification of P. gingivalis. Both integrin β1 
and β3 are expressed across all samples but do not seem to be affected by P. gingivalis 
treatment. Integrin staining was diffused throughout the cytoplasmic space, detailing 
that with this methodology no specific localisation or changes in expression could be 
determined.  
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Figure 6.1 P. gingivalis localises and associates with platelets. Isolated platelets were challenged with P. gingivalis NCTC 11834 (MOI: 10) for 20 minutes at RT before fixing. 
Platelets were permeabilised before incubation with pathogen specific antibody, PGWC1 (green) and an F-actin probe (red). Co-localisation and small aggregates of platelets 
with P. gingivalis were observed. Untreated and ADP treated platelets were included as negative and positive control respectively. Data is representative of at least three 
independent observations.  
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Figure 6.2 The effect of P. gingivalis on platelet integrin β1 expression. Isolated PRP was exposed to P. gingivalis NCTC 11834 for 20 minutes at room temperature before 
fixation. Cells were permeabilised, incubated with an integrin β1 specific antibody before analysis by immunofluorescence microscopy. DAPI staining was also included as a 
bacterial stain. Uniform diffused staining was observed throughout all treatments, with co-localisation between P. gingivalis and platelets (indicated by white arrows). 
Untreated and ADP treated platelets are included as negative and positive controls respectively. Data is representative of at least three independent observations.  
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Figure 6.3 The effect of P. gingivalis on platelet integrin β3 expression. Isolated PRP was incubated with P. gingivalis NCTC 11834 for 20 minutes at RT before fixation. Cells 
were then permeabilised, incubated with an integrin β3 specific antibody before analysis by immunofluorescence microscopy. DAPI staining was also included as a bacterial 
stain. Platelets stained positive for integrin β3, with diffused staining throughout all treatments. Co-localisation between P. gingivalis and platelets was also observed with 
platelets treated with NCTC 11834. Untreated and ADP treated platelets are included as negative and positive controls respectively. Data is representative of at least three 
independent observations. 
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Platelets were stained with an F-actin probe in combination with an anti-mToR 
antibody to determine the cytoskeletal rearrangements undertaken during platelet 
aggregate formation (Figure 6.4). DAPI staining was included to identify bacterial cells. 
While both the untreated platelet control and the platelet stimulated control (ADP) 
display a similar phenotype to the other staining figures (Figure 6.1) in relation to F-
actin staining, P. gingivalis NCTC 11834 treated platelets appear to have formed a 
large, fibrous matrix that is positively stained for mToR (Figure 6.4). Additionally, 
distributed throughout this fibrous matrix are platelets that stained positive for F-actin 
and bacteria suggesting that P. gingivalis NCTC 11834 might become trapped within 
these large fibrous aggregates. 
  
156
 
 
Figure 6.4 Platelet aggregate phenotyping by immunofluorescence microscopy. PRP was incubated with PG 11834(MOI: 10) for 20 minutes at RT before being fixed onto glass 
slides. The effect of P. gingivalis was determined by staining two cytoskeletal markers F-actin (red) and mToR (green), with DAPI also being included for bacterial visualisation. 
Platelets treated with PG 11834 form large fibrous aggregates that are highly positive for mToR staining that show F-actin positivity and bacterial cells distributed throughout. 
Untreated platelets and platelets treated with ADP (20 μM) were included as negative and positive controls. Data representative of at least three independent observations. 
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6.3.2 Investigation of platelet aggregates by electron microscopy 
The underlying characteristics of the platelet aggregates formed following P. gingivalis 
challenge were investigated by electron microscopy using PRP treated with P. 
gingivalis NCTC 11834 or ATCC W50. Untreated and ADP (20 μM) treated PRP were 
included as negative and positive controls respectively. Scanning electron microscopy 
(SEM) revealed that untreated platelets remained in an inactivated spherical shape, 
whereas when stimulated with ADP as positive control, a combination of small platelet 
aggregates together with individual platelets were observed (Figure 6.5). In contrast, 
platelets exposed to either wildtype strains of P. gingivalis (NCTC 11834 or ATCC W50), 
showed drastic phenotypic changes in comparison to both the positive and negative 
controls (Figure 6.5), with the formation of large, fibrous aggregates in which 
individual platelets can no longer be defined. Bacteria were also identified within the 
samples treated with P. gingivalis ATCC W50 and found embedded within the centre of 
a platelet aggregate and are isolated to a small area of the overall aggregate. It is 
suspected that similar findings could be identified within P. gingivalis NCTC 11834 
treated samples but due to the constraints of SEM and the expanse of the formed 
aggregates, bacteria could not be identified. 
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Figure 6.5 Phenotypic analysis of platelet aggregates by scanning electron microscopy (SEM). Platelets were treated with P. gingivalis (NCTC 11834 or ATCC W50) for 20 
minutes at room temperature before fixation and mounting and analysis by SEM. Platelets treated with P. gingivalis form large fibrous aggregates that encase the bacteria. 
When compared to the negative (untreated PRP) and positive controls (ADP, 20 μM), individual platelets are no longer visible, with the aggregates forming large masses. White 
arrows indicate small aggregates formed with ADP treatment.  
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To further probe these findings, bacterially treated platelets were also analysed by 
transmission electron microscopy (TEM), to identify possible ultrastructural changes 
and determine whether platelets can internalise P. gingivalis. As with SEM, within 
untreated PRP samples, individual platelets are easily identifiable and are 
phenotypically comparable to that of a resting platelet state (Figure 6.6).Samples 
treated with ADP (20 μM) were also easily identifiable and shown to have formed 
small aggregates with an increase in pseudopodial structures (white arrows; Figure 
6.6). Platelets treated with P. gingivalis NCTC 11834 and ATCC W50, showed large 
amounts of cellular debris amongst distinctive bacterial cells (black arrows), with no 
definitive platelets visible (Figure 6.6). Within the cellular debris are small structures, 
that could be the remnants of activated platelets but without distinctive phenotype 
and visible organelles this cannot be confirmed.
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Figure 6.6 Visualisation of platelet aggregates by transmission electron microscopy (TEM). Isolated 
PRP was incubated with P. gingivalis (NCTC 11834 or ATCC W50; MOI 1:10) for 20 minutes at room 
temperature before fixation and processing for imaging by TEM. Within the samples treated with P. 
gingivalis, bacteria surrounded by cellular debris (indicated with black arrows) are clearly visible. 
Platelets treated with ADP as a positive control show small aggregate formations indicated with white 
arrows. Untreated PRP was included as a negative control. Each image is shown at two magnifications 
(left panel 2 µm and right panel 0.5 µm) for increased definition. 
  
 161 
6.3.3 Analysis of platelet activation and bacterial association by flow 
cytometry 
Following the visualisation of platelet aggregates, flow cytometry was used to 
determine whether bacteria associated with platelets and induce platelet activation 
using the optimised multiparameter, polychromatic flow cytometry panel developed in 
Chapter 5. 
Initial analysis was undertaken to determine wildtype bacterial association to platelets, 
in relation to bacterial specific antibody staining (PGWC1/TFWC; Figure 6.7). Significant 
association of both wildtype P. gingivalis NCTC 11834 and ATCC W50 was detected 
within populations of CD41+ platelet (p<0.001), whereas no association of T. forsythia 
ATCC 43037 could be determined (Figure 6.7). A slight increase in staining was also 
observed within samples treated with ADP (20 μM) but this was not statistically 
significant.  
 162 
 
Figure 6.7 Detection of wild-type periodontal pathogen-platelet association by flow cytometry. 
Isolated platelets were exposed to periodontal pathogens (MOI 1:10) before fixation, staining and 
analysis by flow cytometry. Isolated CD41+platelet populations significantly associated with both P. 
gingivalis NCTC 11834 and ATCC W50. No bacterial association was observed with platelets treated with 
T. forsythia ATCC 43037. Untreated PRP and PRP treated with ADP (20 μM) were included as a negative 
and positive control respectively. Data is presented as ±SEM, p0.001. n=3.  
 
P. gingivalis-associated platelets were further analysed to determine the relative 
expression of platelet activation markers. Platelets associated with P. gingivalis NCTC 
11834 showed significantly higher expression levels of CD41/61 (p0.05), CD62P 
(p0.05) and CD42b (p0.01) when compared with unassociated platelets within the 
same population (Figure 6.8). Similarly, platelets associated with P. gingivalis ATCC 
W50 were also shown to exhibit significantly higher expression of both CD41/61 
(p0.05) and CD42b (p0.05), whilst also inducing an increase in CD62P expression 
although the latter was not statistically significant (Figure 6.8). 
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Figure 6.8 Expression of platelet activation markers following association with P. gingivalis. Platelet rich plasma was exposed to P. gingivalis NCTC 11834 and ATCC W50 (MOI 
1:10) before fixation and staining for activation specific antigens. Samples were analysed via flow cytometry. Platelets associated with bacteria showed an increased expression 
of CD41/61 (A), CD62P (B) and CD42b (C) when compared to associated platelets within the sample population. Data is expressed at ±SEM, n=3. p= *0.05, **0.01. 
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After identifying a possible role for the P. gingivalis outer-membrane proteins OMPA1 
and OMPA2 within platelet aggregation (Chapter 4), further investigations probed the 
role of these outer membrane proteins within P. gingivalis-platelet association and the 
induction of platelet activation.  
OMPA1 and OMPA2 deficient mutants were shown to significantly associate with 
platelets (p0.001) with no observable differences between the mutants and the 
parent strain NCTC 11834 (Figure 6.9). When compared to the unassociated platelet 
populations, bacterial association was also shown to induce significant increase in 
expression of CD41/61 (p0.05), CD62P (p<0.05) and CD42b (p<0.01) within samples 
treated with the OMP A1 deficient mutant (Figure 6.10). Bacterial association with the 
OMP A2 deficient mutants also induced an increased expression of CD41/61 as well as 
significantly increasing the expression of CD62P (p<0.05) and CD42b (p<0.01) (Figure 
6.10). 
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Figure 6.9 The role of P. gingivalis outer membrane protein A (OMPA) in platelet association. Isolated 
PRP was exposed to P. gingivalis (NCTC 11834, NCTC 11834 ΔompA1 or NCTC 11834 ΔompA2; MOI 1:10) 
and fixed. Bacterial association was determined through staining with a P. gingivalis specific antibody 
(PGWC1) and flow cytometry analysis. Significant levels of bacterial association were observed with wild 
type P. gingivalis and both OMPA subunit deficient mutants, OMPA1 and OMPA2. Untreated PRP and 
PRP treated with ADP (20 μM) was included as a negative and positive control. Data is expressed as 
±SEM, p= ***<0.001. n=3 
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Figure 6.10 P. gingivalis outer membrane protein (OMP) deficient mutants induce platelet activation. Isolated PRP was resuspended in modified Tyrode's buffer before being 
exposed to P. gingivalis (NCTC 11834, NCTC 11834 ΔompA1 or NCTC 11834 ΔompA2; MOI 1:10) and fixed. Platelets were stained with antibodies specific for platelet activation 
associated antigens and analysed on a Gallios flow cytometer. Platelets associated with P. gingivalis 11834 and the OMP A1 mutant induced significant expression of CD41/61 
(A), CD62P (B) and CD42b (C) when compared with unassociated populations. Similarly, platelet populations associated with the OMP A2 deficient mutant showed an increased 
expression of CD41/61 (A), as well as significant increases in the expression of both CD62P (B) and CD42b (C). PRP treated with ADP (20 μM) and untreated PRP were included 
as a positive and negative control respectively. Data is expressed as ±SEM, p= *<0.05 **<0.01. n=3. 
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6.3.4 Induction of calcium mobilisation by periodontal pathogens 
Having demonstrated that periodontal pathogens can associate with, and induce 
platelet activation, the effect on intracellular calcium mobilisation was investigated. 
Isolated platelets were pre-loaded with the intracellular calcium indicator FURA-2/AM 
and real-time calcium mobilisation was monitored following exposure to pathogens at 
an MOI of 1:10 (P. gingivalis NCTC 11834, ATCC W50; T. forsythia ATCC 43037). 
Untreated PRP and platelets treated with ADP (20 μM) were included as a negative 
and positive control respectively. A representative plot of intracellular calcium flux is 
shown in Figure 6.11a. Both P. gingivalis NCTC 11834 and ATCC W50 induced 
significant platelet calcium mobilisation (p<0.001), whereas no response was recorded 
with T. forsythia ATCC 43037 (Figure 6.11b). P. gingivalis ATCC W50 induced a 
significantly higher level of calcium mobilisation when compared to P. gingivalis NCTC 
11834 (p<0.001). 
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Figure 6.11. Platelet calcium mobilisation is induced by wild type periodontal pathogens. Platelets pre-
loaded with FURA-2/AM were exposed to either wild type P. gingivalis (PG NCTC 11834 or PG ATCC 
W50) or wild type T. forsythia (T. forsythia ATCC 43037). Real time intracellular calcium mobilisation was 
monitored after injection of bacteria as a ratio of fluorescent emission excited at both 340 and 380 nm. 
(A) Representative calcium mobilisation plot. (B) Both wild type P. gingivalis strains significantly induce 
calcium mobilisation, with no response being recorded with T. forsythia. P. gingivalis ATCC W50 also 
induced a significantly higher level of calcium flux when compared to NCTC 11834. Untreated platelets 
and platelets treated with ADP (20 μM) were included as a negative and positive control. Data is 
expressed as ±SEM, p <0.001. n=3. 
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Similarly to wild type P. gingivalis strains, the effect of the two outer-membrane 
proteins OMPA1 and OMPA2 on platelet calcium mobilisation was determined. As with 
the parental strain P. gingivalis NCTC 11834, both OMPA1 and OMPA2 deficient 
mutants significantly induced platelet intracellular calcium flux (p<0.001) (Figure 6.12) 
with the OMPA2 deficient mutant inducing a significantly higher levels of calcium 
mobilisation when compared to both the wildtype P. gingivalis NCTC 11834 and the 
OMPA1 mutant (p<0.001), whereas no difference was observed between the wildtype 
and OMPA1. 
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Figure 6.12 Platelet calcium mobilisation is induced by OMPA deficient P. gingivalis mutants. Platelets 
pre-loaded with FURA-2/AM were exposed to wild type P. gingivalis NCTC 11834 or either OMPA 
deficient mutants (PG NCTC 11834 ΔompA1 or PG NCTC 11834 ΔompA2) and intracellular calcium 
mobilisation was monitored as a ratio of fluorescent emission excited at both 340 and 380 nm. (A) An 
example calcium mobilisation plot. (B) Wildtype P. gingivalis and both OMPA mutants significantly 
induce calcium mobilisation. The OMPA2 mutant also induced significantly higher levels of calcium flux 
when compared to both the wildtype and OMPA1 mutant. Untreated platelets and platelets treated 
with ADP (20 μM) were included as a negative and positive control. Data is expressed as ±SEM, p<0.001. 
n=3. 
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6.3.5  Investigations into platelet degranulation by P. gingivalis  
Having demonstrated that P. gingivalis can trigger intracellular calcium mobilisation, 
the effects on alpha and dense granule release were investigated. 
Isolated PRP was exposed to either P. gingivalis NCTC 11834 or ATCC W50 before 
granular secretion of platelet factor 4 (PF4), serotonin and interleukin 1β (IL-1β) was 
determined by enzyme-linked immunosorbent assays (ELISA). Untreated and ADP (20 
μM) treated PRP were included as a negative and positive control respectively. ELISA 
assays revealed that both P. gingivalis NCTC 11834 and ATCC W50 induced significant 
secretion of PF4 (p<0.001) and serotonin (p<0.05), whereas no significant levels of IL-
1β were detected (Figure 6.13a-c). 
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Figure 6.13 Induction of platelet degranulation by wild type P. gingivalis. PRP, resuspended in modified Tyrode's buffer were exposed to P. gingivalis NCTC 11834 or P. 
gingivalis ATCC W50 after which the supernatants were removed and analysed by ELISAs specific for platelet factor 4 (PF4), serotonin and interleukin 1β (IL-1β). Both P. 
gingivalis NCTC 11834 and ATCC W50 significantly induced PF4 (A) and serotonin (B) release from platelets whilst no changes in IL-1β release were observed (C). Untreated 
platelets and platelets treated with ADP (20 μM) were included as a negative and positive control respectively. Data is presented as ±SEM. p= *<0.05, **<0.01, ***<0.001. n=3. 
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6.3.6 Does the secretome of P. gingivalis induce platelet aggregation? 
To determine whether proteins secreted by P. gingivalis were sufficient to induce 
platelet aggregation, the bacterial culture supernatants of P. gingivalis NCTC 11834 
and ATCC W50 was utilised as stimulants in aggregatory assays. An example 
aggregation plot is shown in Figure 6.14a. Both bacterial supernatants from P. 
gingivalis NCTC 11834 and ATCC W50 failed to induce an aggregatory response (Figure 
6.14b). As expected, wildtype whole cell P. gingivalis NCTC 11834 is able to stimulate 
platelet aggregation whereas P. gingivalis NCTC 11834 does not. Untreated PRP, PRP 
treated ADP (20 μM) and PRP treated with bacterial growth media were also included 
as both positive and negative experimental controls. 
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Figure 6.14 Platelet aggregatory response following exposure to P. gingivalis culture supernatant. 
Wildtype P. gingivalis NCTC 11834 and ATCC W50 were grown as liquid cultures in BHI media until an 
optical density of 0.8 at 600 nm before centrifugation at 13000 g. The supernatants were removed and 
used as stimulants in platelet aggregation assays. Sterile BHI media and the relevant WT strains were 
also included as experimental controls. (A) An example aggregation plot. (B) No aggregatory response 
was observed with supernatants from either P. gingivalis NCTC 11834 or ATCC W50. Untreated PRP and 
PRP treated with ADP (20 μM) was included as a negative and positive control. Data is expressed as 
±SEM, n=3. 
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It was also hypothesised that lipopolysaccharide (LPS) from P. gingivalis could interact 
with and induce platelet aggregation at higher concentrations. This was determined 
using commercially available LPS derived from P. gingivalis NCTC 11834 at varying 
concentrations. An example aggregation figure is shown in Figure 6.15a. However as 
with bacterial supernatants, no aggregatory response was observed with LPS at 
concentrations of 10, 20 or 40 μg/ml (Figure 6.15b).  
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Figure 6.15 P. gingivalis LPS as a platelet agonist. Isolated PRP was utilised in aggregation experiments 
where commercial LPS derived from P. gingivalis NCTC 11834 was used as a platelet stimulant. (A) An 
example aggregation plot. (B) No Platelet aggregation was recorded following stimulation with P. 
gingivalis NCTC 11834 LPS at all tested concentrations (10-40 μg). Untreated PRP and PRP treated with 
ADP (20 μg) was included a negative and positive control respectively. Data is expressed as ±SEM, n=3. 
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6.3.7  Investigation of platelet receptor inhibitors on P. gingivalis 
induced platelet aggregation 
6.3.7.1 The effect of Toll-like receptor inhibitors on P. gingivalis induced 
platelet aggregation 
Having demonstrated that P. gingivalis directly associates with platelets, possible 
mammalian site of interactions were investigated. 
The role and contribution of Toll-like receptor 2 (TLR2), Toll-like receptor 4 (TLR4) in 
platelet aggregation were determined. Isolated platelets were pre-incubated with 
either a TLR2 or TLR4 inhibitor or a combination of both before being bacterially 
challenged with P. gingivalis NCTC 11834 and aggregation was measured (Figure 6.16a-
c). A representative plot including the untreated and ADP treated platelets is shown in 
Figure 6.16a-b. No significant changes were observed in total percentage aggregation 
following pre-incubation with either TLR inhibitors or in combination when compared 
to PRP exposed to wildtype P. gingivalis NCTC 11834 (Figure 6.17a). In contrast 
however, all three of the TLR inhibitory treatments did cause a significantly quicker 
onset of aggregation (AG0) when compared to the wildtype control (p<0.05 or <0.001; 
Figure 6.17b)  
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Figure 6.16 The effect of Toll-like receptor inhibitors on P. gingivalis induced platelet aggregation. 
Isolated PRP was pre-incubated with either TLR2, TLR4 or both inhibitors for 15 minutes at room 
temperature before aggregation assays in the presence or absence of P. gingivalis NCTC 11834 were 
undertaken. (A) An example aggregation plot of the effects of TLR2 and TLR4 inhibitors on untreated 
PRP aggregation. (B) An example aggregation plot of the effects of TLR2 and TLR4 inhibitors on platelets 
stimulated with ADP (20 μM). (C) TLR2 and TLR4 inhibitors cause a faster onset of aggregation when 
compared to untreated PRP stimulated with P. gingivalis NCTC 11834. Unstimulated PRP and PRP 
stimulated with ADP (20 μM) was included as a negative and positive control. n=3. 
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Figure 6.17 The effects of Toll-like receptor inhibitors on P. gingivalis-platelet interactions. Isolated 
PRP was pre-incubated with TLR2 inhibitor, TLR4 inhibitor or both for 15 minutes at room temperature 
before aggregation experiments were undertaken. (A) No changes in total percentage aggregation were 
observed with TLR2, TLR4 or the combination of both TLR2+4 inhibitors. (B) Incubation with TLR2 and 4 
inhibitors resulted in a significantly quicker onset of platelet aggregation (AG0) when compared with 
PRP stimulated with wild type P. gingivalis NCTC 11834 only. PRP treated with ADP (20 μM) and 
untreated PRP were included as a positive and negative control respectively. Data is expressed as ±SEM, 
p= *<0.05, ***<0.001. n=4. 
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6.3.7.2 The effects of integrin α2β1 and β3 inhibitors on P. gingivalis-induced 
platelet aggregation 
The role of the integrins β3 and α2β1 in P. gingivalis-induced platelet aggregation was 
determined using integrin-specific inhibitors. Following pre-incubation of isolated 
platelets with β3 and α2β1 inhibitors, aggregation assays were conducted. To ascertain 
whether these integrin inhibitors affected normal platelet function, effect on 
untreated PRP and PRP treated with ADP (20 μM) were measured. Incubation with 
either inhibitor did not result in any changes in aggregatory response within 
unstimulated PRP or PRP stimulated with ADP (20 μM). Representative aggregation 
plots for both integrin β3 inhibitor (Figure 6.18) and α2β1 (Figure 6.19) are shown 
below. 
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Figure 6.18 Representative aggregation plots following incubation with integrin β3 inhibitor. Isolated 
PRP was incubated with the β3 inhibitor for 15 minutes at room temperature before routine aggregation 
experiments were undertaken. The effects of the inhibitor were determined on untreated PRP as 
negative control (A) and PRP treated with ADP (20 μM) as a positive control (B). No changes in 
aggregatory response were recorded in any of the experimental conditions. Representative aggregation 
plots from three independent observations. 
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Figure 6.19 Representative aggregation plots following incubation with integrin α2β1 inhibitor. Isolated 
PRP was incubated with the α2β1 inhibitor for 15 minutes at room temperature before routine 
aggregation experiments were undertaken. The effects of the inhibitor were determined against 
untreated PRP as negative control (A) and PRP treated with ADP (20 μM) as a positive control (B). No 
changes in aggregatory response were recorded in any of the experimental conditions. Representative 
aggregation plots from three independent observations. 
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Following incubation with the β3 integrin inhibitor, no changes were observed in either 
the total percentage aggregation or the onset of aggregation (AG0) when platelets 
were exposed to P. gingivalis NCTC 11834 at an MOI of 1:10 (Figure 6.20). In contrast, 
following incubation with the α2β1 inhibitor at a concentration of 20 μM resulted in a 
significant and complete inhibition of platelet aggregation following addition of P. 
gingivalis NCTC 11834 (p<0.001; Figure 6.21a-b). At a lower concentration of 10 μM, 
no significant changes in total percentage aggregation were observed. The α2β1 
inhibitor did not induce any alterations in the aggregatory response in either the 
negative (untreated PRP) or the positive (ADP treated) control at both 10 and 20 μM. 
The α2β1 inhibitor also resulted in a significant increase in the onset of aggregation 
(AG0) at both 10 and 20 μM (p<0.001), with a significant increase in lag time also being 
observed between platelets exposed 20 μM compared with the lower concentration of 
10 μM (p<0.001; Figure 6.21c) 
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Figure 6.20 Effects of integrin β3 inhibitor on P. gingivalis NCTC 11834 induced platelet aggregation. 
Isolated PRP was incubated with the β3 inhibitor for 15 minutes at room temperature before routine 
aggregation experiments were undertaken. Representative aggregation plot (A). No significant 
differences were observed with either total percentage aggregation (B) or the onset time of aggregation 
(C) following exposer to P. gingivalis NCTC 11834. Untreated PRP and PRP treated with ADP (20 μM) 
were included as a negative and positive control. Data is expressed as ±SEM, n=3. 
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Figure 6.21 Effects of integrin α2β1 inhibitor on P. gingivalis NCTC 11834 induced platelet aggregation. 
Isolated PRP was pre-incubated with the α2β1 inhibitor for 15 minutes at room temperature before 
routine aggregation experiments were undertaken. (A) Representative aggregation plot. (B) Incubation 
with the α2β1 inhibitor at 20 μM completely inhibited platelet aggregation following stimulation by P. 
gingivalis NCTC 11834, with no significant differences observed with the lower concentration (10 μM). 
(C) The integrin α2β1 inhibitor significantly increases the lag-time of platelet aggregation following 
stimulation with P. gingivalis NCTC 11834 at both 10 and 20 μM. When incubated with 20 μM of 
inhibitor P. gingivalis NCTC 11834 stimulated aggregation is abolished. Untreated PRP, PRP treated with 
ADP (20 μM) and PRP treated with P. gingivalis NCTC 11834 only were included as comparative 
experimental controls. Data is expressed as ±SEM, p= ***<0.001. n=3.  
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6.3.8  Development of a recombinant protein-based ELISA for the 
detection of P. gingivalis-platelet integrin interactions 
Having demonstrated that integrin α2β1 inhibition prevented P. gingivalis from 
stimulating platelet aggregation, a recombinant protein-based ELISA was developed to 
investigate whether P. gingivalis NCTC 11834 or ATCC W50 could directly bind to either 
integrin α2β1 or αIIbβ3 using immobilised recombinant integrins. 
Successful immobilisation of recombinant integrins was confirmed with β1 and β3 
specific monoclonal antibodies which showed integrin specific binding (Figure 6.22a-b). 
P. gingivalis NCTC 11834 showed significant levels of binding to the recombinant 
integrin α2β1 (p<0.0001), whereas no significant binding was observed with either P. 
gingivalis NCTC 11834 treated or untreated controls (Figure 6.22c). In contrast no 
significant binding was observed with integrin αIIbβ3 (Figure 6.22d). 
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Figure 6.22 Detection of P-gingivalis-integrin binding by recombinant protein-based ELISA. 96-well 
plates were coated with either recombinant αIIbβ3 or α2β1 overnight at 4 °C. Plates were then either 
incubated with integrin specific antibodies (A-B) to determine successful protein coating or were 
challenged with P. gingivalis (NCTC 11834 or ATCC W50) and then incubated with PG specific antibodies 
to determine bacterial binding (C-D). Plates were successfully coated with α2β1 (A) and αIIbβ3 (B). P. 
gingivalis NCTC 11834 significantly binds to integrin α2β1, with no significant changes observed with 
either PG ATCC W50 treatment or untreated controls (C). No binding was observed in any of the 
experimental treatments with integrin αIIbβ3 (D).Data is presented as ±SEM, p=***<0.001. n=3. 
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6.4 Discussion 
Periodontitis and its associated bacterial pathogens have been historically linked to 
several systemic diseases (Kerr, 1951, 1962). In this study, the interactions of 
periodontal pathogens and platelets were further characterised. A growing body of 
research has also documented the importance of platelets within the innate and 
adaptive immunity in the defence against bacterial infections (Kerrigan, 2015).  
P. gingivalis induced platelet aggregates were analysed using both SEM and TEM. P. 
gingivalis (NCTC 1834 or ATCC W50) treated platelets resulted in aggregate formation 
as observed by SEM, whereby bacteria were found encapsulated within the aggregates 
and the platelets were phenotypically dissimilar to untreated or ADP stimulated 
controls. TEM analysis also revealed that incubation with P. gingivalis resulted in the 
complete loss of any defined platelet phenotypic structures. These observations are in 
agreement with those of Li and colleagues (2008) who demonstrated that NCTC 11834 
induced the formation of small bacteria-associated aggregates (Li et al., 2008). 
However as the later study used a lower MOI of .3 and was conducted under stirring 
conditions, it could explain why smaller aggregates were observed. Further 
confirmation of the pathogen encapsulated within the aggregates was obtained in TEM 
imaging. These findings are in agreement with those observed with both Escherichia 
coli and Staphylococcus aureus that show the formation of bacterial-platelet clusters 
(Kraemer et al., 2011; Vieira-de-Abreu et al., 2012).  
Studies involving patients suffering from chronic periodontitis have shown the 
presence of an associated condition of heightened circulatory platelet activation and 
suggested that this is a direct consequence of the pathogenic bacteria present within 
the disease (Papapanagiotou et al., 2009). Additionally, an increase in expression level 
of the platelet activation marker CD62P by P. gingivalis has been demonstrated in both 
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a murine model, (Yu et al., 2011) and in vitro with isolated mammalian platelets 
exposed to the pathogen (Klarström Engström et al., 2015). In this study, levels of a 
panel of platelet specific proteins were quantified. Using an optimised in-house flow 
cytometry, a significant increase in expression of both CD62P (p<0.001) and PAC-1 
(CD41/61, GPIIbIIIa, αIIbβ3; p<0.05) was observed in platelet population which was 
positive for P. gingivalis (NCTC 11834 or W50; p<0.001). CD62P is a type1 
transmembrane glycoprotein, normally contained within the -granule but which 
becomes expressed on activated platelets (Ault et al., 1989). CD41/61, also known as 
the glycoprotein heterodimer complex GPIIbIIIa and as integrin IIbβ3 is normally 
expressed on platelets as a heterodimer in a resting form (Bennett, 2005). However, 
during platelet activation, CD41/61 undergoes a change in conformation and expresses 
activation-induced epitopes to which the CD41/61 antibody also known as PCA-1 can 
bind to (Shattil et al., 1985). The increase in PAC-1 suggest that the integrin CD41/61 
has move from its resting state to an activated state (Shattil et al., 1985) and confirms 
the activation status of platelets. 
 
Surprisingly, an increase in CD42b expression (p<0.01) was observed following 
bacterial exposure. This is in contrast with previous studies which have documented a 
decrease in CD42b expression following platelet activation due to ectodomain 
shedding (Tao et al., 2016) but supports the increase in CD42b expression induced on 
platelets by the Dengue virus (Núñez-Avellaneda et al., 2018). CD42b also known as 
glycoprotein Ibα (GPIbα) exists within a non-covalent complex of GPIb-IX-V on the 
platelet surface membrane (Modderman et al., 1992) and plays a role on platelet 
adhesion to subendothelial matrix, endothelial cells and leukocytes (Berndt et al., 
2001). It has also been suggested that in addition to its role in haemostasis, GP1bα 
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plays a fundamental role within platelet immune response and vascular inflammation 
(Pitchford, Pan and Welch, 2017) with the common structural motifs of leucine rich 
repeat regions within each subunit of the GPIb-IX-V complex mirroring those present in 
all 13 members of the TLR family and suggesting a common ancestry between platelet 
and leukocytes as well as an involvement with bacterial interaction (Corken et al., 
2014). Bacterial species including Streptococcus gordonii (Bensing, López and Sullam, 
2004) and Streptococcus sanguis (Plummer et al., 2005) have been shown to exploit 
the GP1bα ligand in order to bind to platelets and subsequently induce an aggregatory 
response. The consistent increase in GPIbα expression was observed following P. 
gingivalis exposure can also be partly attributed to the presentation of the receptor 
through alpha granule release however this would account for only ~10% of GPIbα 
expression (Berger, Massé and Cramer, 1996; Maynard et al., 2007).  
The increase in expression of both CD62P and CD41/61 and the observed platelet 
aggregation suggests platelet granule secretion, cytoskeletal rearrangements and 
further signal transduction (van Velzen et al., 2012). To probe alterations occurring 
within platelets granular secretion and alteration in calcium mobilisation were 
investigated. A significant increase in intracellular calcium mobilisation (p<0.001), 
serotonin release (p<0.05) as well as PF4 secretion (p<0.001) was observed following P. 
gingivalis stimulation. Intracellular calcium mobilisation is an essential cofactor that 
drives platelet signalling at a molecular level, resulting in platelet activation, secretion 
and aggregation (Gerrard, White and Peterson, 1978; Heemskerk et al., 1992, 2001). 
Our findings agree with earlier studies which demonstrated that P. gingivalis are able 
to induce calcium flux in vitro within both epithelial cells and washed platelet 
preparations (Lourbakos et al., 2001; Klarström Engström et al., 2015). The detection 
of both serotonin and platelet factor 4 release further confirms that P. gingivalis 
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stimulates the full signalling cascade of platelet aggregation, with granule release also 
being directly implicated within the role of platelets within the innate and adaptive 
immunity (Ali, Wuescher and Worth, 2015). Induction of platelet granular release have 
reported with several bacterial species with Streptococcus sanguinis, Staphylococcus 
aureus, Streptococcus oralis and Streptococcus pneumoniae stimulating both alpha and 
dense granule release as an adaptive immune response to bacterial 
stimulation(Erickson and Herzberg, 1993; Arman et al., 2014). Interestingly, despite 
previous reports stating that platelets release IL-1β following stimulation with ADP 
(Sedlmayr et al., 1995; Cha et al., 2000; Brown et al., 2013), both viable P. gingivalis 
and purified LPS failed to show secretion of IL-1β. The release of IL-1β by platelets is 
currently disputed as other studies (Pillitteri et al., 2007) have suggested that the 
detectable levels of IL-1β, is a direct consequence of leukocyte contaminants within 
the platelet isolation process (Pillitteri et al., 2007). Interestingly, P. gingivalis has also 
been shown to degrade several inflammatory chemokines and cytokines in vitro, for 
example; TNF, IL-6, CCL2, CCL5 (RANTES), CXCL1, CXCL8 (IL-8), CXCL10 and IL-2 
excreted by fibroblasts (Palm, Khalaf and Bengtsson, 2013), IL-2 produced by jukrat T-
cells (Khalaf and Bengtsson, 2012) and isolated mammalian IL-1β, IL-6 and IL-1 
receptor antagonist (Fletcher et al., 1998). Thus, further work is required to determine 
whether IL-1β is being degraded by the well documented protease activity of P. 
gingivalis (Tokuda et al., 1998; Holt, 1999; Lourbakos et al., 2001). 
Studies investigating the interactions of P. gingivalis with oral epithelial cells identified 
the subunits of two major outer membrane proteins OMPA1 and OMPA2 of P. 
gingivalis NCTC 11834 as being essential for biofilm formation and a contributory 
factor to bacterial virulence (Suwannakul et al., 2010; Aruni et al., 2011; Naylor et al., 
2016) whilst the sialidase enzyme 0352 as being crucial within P. gingivalis virulence 
 192 
through bacterial adherence and biofilm formation (Li et al., 2017; Yang et al., 2018). 
The role and importance of these proteins in platelet aggregation was determined and 
aggregation studies revealed that that not only do both OMPA deficient mutants 
induce a faster aggregatory response but they also induce significantly higher levels of 
platelet activation and intracellular calcium mobilisation when compared to the 
parental strain. A similar response was observed with the ΔSia0352 mutants 
suggesting that disrupting bacterial/cellular interactions, results in a heightened 
platelet response. As previously discussed (Chapter 4) it is hypothesised that these 
disruptions within key outer-membrane proteins such as OMPA and the sialidase 
enzyme possibly reduce the evasive characteristics of P. gingivalis resulting in a faster 
and more heightened combative platelet activation. 
Bacteria are known to bind to oral epithelial cells and platelets via glycoprotein 
receptors such as integrins. Interactions between bacterial species such as Escherichia 
coli (Vieira-de-Abreu et al., 2012) and Staphylococcus aureus (Kraemer et al., 2011) 
with platelets have been previously visualised by both fluorescence and electron 
microscopy. Using fluorescence microscopy, uniform expression of integrins β1 and β3, 
as well an F-actin probe was observed in the untreated samples showing a phenotypic 
discoid platelet shape. Additionally, an increase in clumping of platelets were seen 
when platelets were treated with P. gingivalis. Disruption in the expression of integrin 
β1 (Yilmaz, Watanabe and Lamont, 2002; Li et al., 2013), integrin β3 (Li et al., 2013; 
Boisvert, Lorand and Duncan, 2014) and in actin (Kinane et al., 2012) following P. 
gingivalis treatment have been documented within epithelial cells. However, reduction 
in expression of the integrins was not observed with platelets and this could reflect the 
fact that platelets aggregate within minutes and protein degradation is not possible in 
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such a small time frame, protein degradation in epithelial cells, usually occurring after 
two to four hours following bacterial challenge. 
The observed formation of platelet aggregates suggests that platelets must undergo 
cytoskeletal re-arrangements (Bearer, Prakash and Li, 2002). This was investigated by 
staining for the mammalian target of rapamycin (mTOR), a serine kinase that 
integrates with several key process including cell proliferation, protein synthesis and 
autophagy (Hay and Sonenberg, 2004) has been identified within previous research by 
Stafford and colleagues (2013) as a target for P. gingivalis host cell manipulation. 
Within platelets, mTOR has many reported functions including the regulation of mRNA 
translation and protein synthesis (Weyrich et al., 1998). In this study, following 
exposure to P. gingivalis NCTC 11834, platelets were observed to form large 
aggregates consisting of interconnected, fibrous-like structures which stained 
positively for mTOR, within which were embedded a combination of pathogen and 
discoid platelet structures that are positively stained for F-actin. This is in contrast with 
reports of P. gingivalis degrading mTOR following cellular invasion of oral epithelial 
cells (Stafford et al., 2013) and is likely to reflect the time taken for P. gingivalis to 
invade oral epithelial cells and degrade mTOR via its secreted gingipains (Stafford et 
al., 2013) whilst the response of platelets to P. gingivalis happens at much faster rate 
within minutes such that protein degradation might not be feasible. The presence of 
mTOR within the aggregates might also contribute to aggregate formation as studies 
by Aslan and colleagues (2012) have implicated mTOR in lamellipodia formation and 
thrombus stability (Aslan and McCarty, 2012). Further to this mToR is also known to be 
downstream of integrin/glycoprotein signalling (Watson et al., 2005; Z. Li et al., 2010), 
which as previously mentioned is a target for P. gingivalis cellular interactions  
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Proteases secreted by P. gingivalis known as gingipains (Curtis et al., 1993b; A 
Lourbakos et al., 2001; Naito et al., 2006) and lipopolysaccharide (Zhang et al., 2009) 
have been shown to induce platelet aggregation within washed platelet preparations. 
In this study, the effects of both gingipains and LPS on isolated but not washed 
platelets were investigated and it was observed that neither P. gingivalis culture 
supernatants containing gingipains nor isolated LPS initiated a platelet aggregatory 
response under the conditions used. This could reflect the different experimental 
conditions used i.e. isolated platelets contained within plasma as opposed to washed 
platelets. Despite both PRP and washed platelets being readily utilised within platelet 
research there are stark differences attached to each platelet preparation. Washed 
platelets are more resilient against spontaneous activation and allow analysis to be 
undertaken completely removed from any anticoagulant used within sample 
acquisition (Cazenave et al., 2004). However one of the major caveats to washed 
platelet suspensions is the removal of key plasma proteins and the formation of highly 
selective platelet subpopulations through the centrifugation stages and the use of a 
physiological buffer (Cazenave et al., 2004). The presence of plasma proteins has also 
been shown to have a direct impact on platelet function within immunity, with 
research by Damien and colleagues (2015) demonstrating that soluble CD14 present in 
plasma facilitates platelet TLR4 stimulation by bacterial LPS. 
Previous work has also demonstrated that bacterial species including group B 
Streptococcus (Ma et al., 2009) and Streptococcus pneumoniae (Keane et al., 2010) can 
induce platelet activation through interactions with toll-like receptor 2 (TLR2), whereas 
bacterial LPS derived from Escherichia coli stimulates platelet activation through 
interaction with toll-like receptor 4 (TLR4) (Andonegui et al., 2005; Ma et al., 2009). P. 
gingivalis has also been shown to activate endothelial and dendritic cells through TLR4, 
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while epithelial cells were activated through TLR2 (Darveau et al., 2004; Kocgozlu et 
al., 2009). It was therefore hypothesised as platelets express TLR receptors, inhibiting 
platelet TLR2 and TLR4 independently as well as in a combined treatment should 
impede platelet-P. gingivalis interaction and consequently reduced or fully inhibit the 
observed aggregatory responses if P. gingivalis interacted with platelets through TLRs. 
Surprisingly, addition of TLR antagonists resulted in no alteration in the total 
percentage aggregation induced by the pathogen but caused a significantly quicker 
onset of aggregation when compared to the untreated P. gingivalis control (p= NCTC 
11834 <0.05, ATCC W50 <0.001). Although strain variation has previously been 
reported to impact platelet aggregation lag time (Moriarty et al., 2016), the observed 
findings cannot be fully explained. One possible explanation could be that antagonising 
the TLR 2 and 4 receptors results in an upregulation or increased trafficking of further 
TLR receptors which has been previously reported in dendritic cells following LPS 
stimulation (Chamorro et al., 2009), however further work would be needed to further 
explore this premise  
Having demonstrated that P. gingivalis associated with and activated platelets inducing 
aggregation, which was not abrogated by TLR inhibitors, the interactions of P. 
gingivalis with platelet surface integrins were investigated. Studies using selective 
platelet inhibitors have led to the identification of potential binding sites for platelet-
bacterial interaction: the selective inhibition of GPIIbIIIa (integrin αIIbβ3) with 
Abciximab completely abolished Streptococcus gordonii binding to platelets (Petersen 
et al., 2010) and both Streptococcus sanguis (Kerrigan et al., 2002) and Helicobacter 
pylori (Byrne et al., 2003) interact with platelets through GPIbα. Using aggregation 
assays, the effect of selected integrin inhibitors on P. gingivalis induced aggregation 
was therefore determined. The addition of the selective β3 inhibitor did not affect the 
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total percentage aggregation or the initiation of aggregatory response, suggesting that 
P. gingivalis induced aggregation is not dependent on integrin β3 interaction.  
In contrast, the selective integrin α2β1 inhibitor, resulted in complete abolishment of 
any aggregatory response at 20 μM (p<0.001) and a significant increase in lag time 
when compared to the untreated P. gingivalis control at 10 μM (p<0.001). Previous 
research has shown that P. gingivalis can physically associate with α5β1 integrin 
expressed by endothelial cells via major fimbriae (FimA) proteins (Nakagawa et al., 
2002; Yilmaz et al., 2003; Kato et al., 2007; Al-Taweel, Douglas and Whawell, 2016) and 
could propose a common pathway by which P. gingivalis invades nucleated host cells 
(Olsen and Progulske-Fox, 2015) and interacts with platelets inducing platelet 
aggregation. This hypothesis is further supported by the ELISA based assays which 
revealed that findings that P. gingivalis NCTC 11834 but not ATCC W50 bound to 
recombinant integrin β1 (p<0.001) whilst both P. gingivalis strains did not bind to 
recombinant integrin β3. Within epithelial cells it is suggested that integrin β1 provides 
a functional receptor for fimbriae mediated adherence and invasion for P. gingivalis 
NCTC 11834 (Amano, 2003). 
Interestingly, P. gingivalis strains are known to express different types of the major 
fimbriae gene fimA, with NCTC 11834 expressing type I and ATCC W50 expressing type 
IV (Amano et al., 1999). When compared phenotypically, this varying fimA expression 
results in P. gingivalis ATCC W50 displaying much shorter, sparsely populated fimbriae 
as opposed to the much longer and widely presented fimbriae of P. gingivalis NCTC 
11834 (Sojar, Hamada and Genco, 1997). These inter-strain variances could therefore 
offer a possible explanation to the differential integrin β1 binding observed and 
account for the abrogation of the strain specific aggregation induced by P. gingivalis 
NCTC 11834 by integrin β1 inhibitors. Taken together, the data suggest that in the case 
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of by P. gingivalis ATCC W50 both platelet activation and calcium mobilisation occurs 
independently of integrin β1 and additional adhesins or receptors are likely to 
contribute to P. gingivalis ATCC W50-platelet interactions. 
Similar studies were conducted with T. forsythia, a well-documented periodonto-
pathogen shown to be epidemiologically relevant to the progression of periodontitis 
(Darveau, 2010) and capable of  invade epithelial cells (Sabet et al., 2003; Inagaki et al., 
2006; Kirschbaum et al., 2010a). Periodontitis patients who are positive for both P. 
gingivalis and T. forsythia also have a heightened level of platelet activity (Nicu et al., 
2009). However, T. forsythia does not associate with isolated platelets or initiate 
platelet activation via intracellular calcium mobilisation. Collectively, these findings 
suggest that T. forsythia does not interact with isolated mammalian platelets under 
the given conditions.  
Other bacterial species including Streptococcus sanguinis and Staphylococcus aureus 
have shown that bacterial interactions with platelets can occur directly as well as 
indirectly through the dependent synthesis of plasma bridging proteins (Fitzgerald, 
Foster and Cox, 2006). This could highlight further mechanisms in which T. forsythia 
could interact with platelets but further work would be needed to fully test this 
hypothesis. 
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6.5 Summary 
To conclude this chapter of work, this data demonstrate that P. gingivalis is able to 
directly associate with mammalian platelets, forming large fibrous aggregates, that 
stain highly for mToR and encapsulate bacterial cells. The expression of mToR may also 
be implemented in platelet cytoskeletal rearrangement and thrombus construction 
following P. gingivalis stimulation.  
P. gingivalis is able to initiate platelet activation though intracellular calcium 
mobilisation that leads to the release of both alpha and dense granules, independent 
of bacterial outer membrane protein OMPA. P. gingivalis NCTC 11834 but not ATCC 
W50 actively associates and interacts with integrin α2β1 inducing strain dependant 
platelet aggregation and could suggest a role for bacterial fimbriae within platelet 
interactions. 
Further work is required to determine the extent to which platelet-P. gingivalis 
interactions are dependent on inter-strain variations and could also provide novel 
pathways to fully characterise how these interactions take place and to identify 
pathways that could be developed as therapeutic targets. 
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Chapter 7: General discussion and future directions   
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7.1 Introduction 
The overall aim of this study was to increase current understanding of the mechanism 
by which periodontal pathogens interact with platelets. The main objectives were to 
(a) develop an in vitro platelet-like cell model and (b) to optimise and multicolour flow 
cytometry panel (c) to enable the interactions of two of the red complex oral 
pathogens P. gingivalis and T. forsythia with platelets to be further characterised. It is 
anticipated that these findings will contribute to current knowledge of how 
periopathogens-platelet interactions might contribute to cardio vascular disease, 
specifically atherosclerotic vascular disease. The findings of this study have been 
discussed in detail within each relevant chapter. Here a summary of the major findings 
are presented alongside implications and possible future directions for this work 
7.2 The use of CHRF-288-11 cells as an in vitro platelet model 
The CHRF-288-11 cell line originally characterised by Fugman and colleagues (1990) 
has been proposed as a lucrative model to study megakaryocyte/platelet behaviour 
(Lev-Lehman et al., 1997). In this study, it was observed that through differentiation, 
CHRF-288-11 cells adopt a platelet like phenotype that be utilised to study periodonto-
platelet pathogen interactions in vitro. PMA (50 ng/ml) over five days resulted in 
successful CHRF-288-11 differentiation as characterised by the formation of large 
multi-lobed nuclei and pseudopodia pro-platelet protrusions. Differentiated CHRF-288-
11 cells were shown to express the platelet specific glycoprotein CD41, the complex 
CD41/61, the platelet activation market CD62P (P-selectin) but not CD42b as 
quantified by flow cytometry.  
CHRF-288-11 cells were shown to associate with and were invaded by P. gingivalis 
strains NCTC 11834, ATCC W50 and T. forsythia ATCC 43037. Association of P. 
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gingivalis resulted in an increase in binding of integrin β1 and β3 specific antibodies 
which suggest either a change in integrin conformation or potential upregulation of 
the receptor as well as a reduction in binding of mToR antibodies, whereas association 
with T. forsythia did not.  
These characteristics detail the novel application of the CHRF-288-11 cell line as a 
platelet-like in vitro cell model through the expression and utilisation of phenotypic 
platelet markers. 
7.3 Development of a multiparameter flow cytometry panel 
Following previously published guidelines on flow cytometry panel development 
(Schmitz et al., 1998), a single step staining and analysis protocol for platelets was 
designed to simultaneously record platelet-pathogen association and the resulting 
changes in the expression of platelet activation markers. Using an advanced multi-
parameter gating strategy, a subset population of platelets associated with P. 
gingivalis were isolated from CD41+ platelet populations and the relative expression of 
CD41/61, CD62P and CD42b were determined. P. gingivalis association led to 
significant increases in CD41/61, CD62P and CD42b when compared to unassociated 
platelets. This optimised flow cytometry offers a new, practical analysis tool that can 
be used in settings where spontaneous platelets activation needs to be minimised, 
minimum sample volumes are available and where platelets cannot be stored on-site 
for extended period. 
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7.4 Periodontal pathogens and platelet interactions 
Periodontal pathogen-platelet interaction studies revealed that viable P. gingivalis 
directly interacts with mammalian platelets whereas T. forsythia does not. Exposure to 
P. gingivalis induced platelet activation via calcium mobilisation and granule release, 
suggesting an immunological role against P. gingivalis infection. 
Platelet activation, following platelet association with P. gingivalis, resulted in an 
increased expression of CD41/61, CD62P and CD42b as quantified by flow cytometry as 
well as the release of serotonin and platelet factor 4, quantified by ELISA. These 
investigations also revealed that platelet activation induced by P. gingivalis occurs 
independently of interactions with the major bacterial outer membrane subunits 
OMPA1 and OMPA2. 
Surprisingly, although all strains of P. gingivalis induced platelet activation, platelet 
aggregation was only observed in a strain dependant manner by P. gingivalis NCTC 
11834 and ATCC 381 but not by ATCC W50.  
Investigations into the underlying mechanisms of P. gingivalis induced platelet 
aggregation demonstrated that within the applied methodology, both P. gingivalis 
secreted proteome and isolated P. gingivalis lipopolysaccharide (LPS) were unable to 
stimulate platelet aggregation, under the experimental conditions used in this study, 
possibly further emphasising a dependency on direct platelet to pathogen interactions.  
Screening of P. gingivalis mutants deficient in either the major outer membrane 
protein subunits OMPA1/OMPA2 or the virulence associated sialidase 0352 resulted in 
no impact on the total percentage aggregation induced by P. gingivalis but did result in 
a faster onset of the aggregatory response. Similarly, screening of specific platelet 
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receptor inhibitors found that platelet aggregation occurred independently of 
interactions with toll-like receptor 2 and 4 as well as integrin β3 but all inhibitory 
experiments resulted in a faster onset of the aggregatory response. 
Interestingly, platelet aggregation induced by P. gingivalis NCTC 11834 was completely 
abolished following incubation with a specific integrin α2β1 inhibitor, with P. gingivalis 
also being shown to directly associate with recombinant integrin β1 within an ELISA. 
Collectively, these findings suggest that platelet aggregation induced by P. gingivalis 
NCTC 11834 is dependent on interactions with integrin α2β1, specifically the β1 
subunit and could reveal independent virulence mechanisms such as fimbriae 
exhibited by P. gingivalis. 
These findings provide novel data which demonstrate that P. gingivalis induces platelet 
aggregation and activation via granule release within platelet rich plasma, with the 
observed aggregatory response occurring in a strain dependant manner. 
7.5 Future Directions 
Within this body of work, it was postulated that through the associated localised 
bleeding and increased bacterial load found within chronic periodontitis, pathogenic 
bacterial species, specifically Porphyromonas gingivalis and Tannerella forsythia, 
opportunistically penetrate the vascular system. During this invasive process, these 
pathogenic bacteria would interact with platelets, giving rise to an altered platelet 
state, the formation of bacterial-platelet aggregates and ultimately contribute to the 
progression of atherosclerotic vascular disease.  
As detailed above, this study does not only demonstrate that periodontal pathogenic 
bacteria are able to interact with platelets and megakaryocytic-like cells but may also 
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provide novel pathways in which periodontitis is able to contribute to the progression 
of CVD's. 
The CHRF-288-11 cell line provides a unique niche in which to study bacterial-platelet 
interactions and with further expansion could reduce the need for regular blood 
acquisition for platelet studies. Although within this study, CHRF-288-11 cells have 
been shown to express a number of platelet markers, further analysis of protein 
expression could reveal a plethora of platelet markers expressed by the CHRF cells 
adding further benefit to the reported applications of these megakaryocytic like cells. 
It is also possible that through varied differentiation protocols such as those detailed 
by Lepage and colleagues (2000) that utilise cytokines as opposed to PMA could reveal 
varying phenotypes within the cell line further adding to its applications within a 
platelet-like cell model. Novel developments within the field of in vitro megakaryocyte 
culture and in vitro platelet production could abrogate the need for blood donations 
entirely (Moreau et al., 2016; Strassel, Gachet and Lanza, 2018),possibly replacing the 
CHRF-288-11 cells and allowing for platelet methodologies to become routine and high 
throughput. 
 Interestingly, it was found that although T. forsythia is able to interact with and invade 
the megakaryocytic cell line, it was not observed to interact with platelets within any 
investigations. However from the investigations undertaken within this body of work it 
cannot be concluded that T. forsythia is unable to interact with platelets and could 
suggest an alternative pathway in which periodontal-pathogens and platelets interact.  
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Further work could be used to highlight whether T. forsythia is able to interact with 
mammalian platelets, whether it actively evades platelet response or whether T. 
forsythia-platelet interactions are reliant on the synthesis of cofactors such as those 
observed with Staphylococcus aureus aggregation (Yeaman, 2010b). 
Similarly, it is well established that pathogenic bacterial species within the oral biofilm 
are able to coaggregate (Kolenbrander, Andersen, Blehert, et al., 2002), with 
suggestions that this may facilitate synergistic behaviour between the pathogens, 
increasing virulence activity (Kolenbrander, 2000; Kesavalu et al., 2007; Kirschbaum et 
al., 2010b). Exposing platelets to co-cultures of P. gingivalis and T. forsythia could 
expose mechanisms by which T. forsythia is able to interact with platelets and reveal 
further aspects of P. gingivalis-platelet interactions thereby providing a closer 
representation of the biofilm present with the periodontal pocket. 
In addition, the inter-strain variances of P. gingivalis induced platelet aggregation and 
activation suggest that bacterial genetics as well as their associated virulence factors 
such as fimbriae contribute to the combative platelet response.  
Interestingly, phylogenetic comparisons of the P. gingivalis strains utilised within this 
study reveal that NCTC 11834 and ATCC 381 are highly similar, whereas ATCC W50 is 
comparatively highly divergent (Griffen et al., 1999). This is further emphasised 
through full genome comparisons as illustrated by a circular genome representation 
(Figure 7.1). In order to expand on the initial findings within this thesis, full screening 
of the ATCC 381 strain as well as the introduction of further P. gingivalis strains such as 
ATCC W83 which is closely related to ATCC W50 would further explore the strain 
specific nature of platelet aggregation in response to P. gingivalis. This study also 
found strain specific interactions with integrin α2β1, with the full extent of P. 
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gingivalis-platelet interactions as well as the underlying mechanisms remaining 
inconclusive. It is hypothesised that through the application of pull-down assays, the 
specific mammalian protein targets for P. gingivalis could be identified and allow the 
proposal of a comprehensive mechanistic pathway.  
These pull-down assays could then be coupled with an extensive proteomic study of 
both the mammalian platelets and the bacterial pathogens. With regards to platelets, 
it could be used to identify specific pathways in which platelets respond to varying 
pathogenic bacterial species and could implicate further roles for platelets within both 
the innate and adaptive immune system. Further work could also highlight the exact 
proteinous nature of the fibrin-like structures which form following platelet exposure 
to P. gingivalis. These investigations could utilise fluorescently labelled fibrinogen to 
determine whether the formed matrix is similar to that of a haemostatic fibrin mesh 
(Holinstat, 2017) as well as being coupled with further immunofluorescent microscopy 
and western blotting to confirm the presence of further proteins such as mToR and 
actin which are known to stabilise thrombus formation (Aslan and McCarty, 2012). 
As a separate approach, analysing the bacterial strains could also reveal specific 
bacterial genetic features and proteomic differences, which not only contribute to the 
observed variances in platelet activation and aggregation but could also highlight 
highly virulent pathogenic strains in relation specifically to CVD. 
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Figure 7.1 Circular representation of the P. gingivalis NCTC 11834, ATCC 381 and ATCC W50 genomes. P. gingivalis NCTC 11834 (431947.7) and ATCC 381 (1403335.5) are 
genetically highly similar whereas comparatively ATCC W50 (1125722.3) is highly divergent. This representation was generated using the PATRIC online genome comparison tool. 
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In order to expand on the findings surrounding platelet-pathogen interactions, there 
are many potential investigative avenues that could be explored. Initially it would very 
interesting to investigate as to whether periodonto-pathogens influence platelet 
adhesion, which is a known contributor to atherosclerosis and atherothrombosis (Finn 
et al., 2010; Badimon, Padró and Vilahur, 2012; Anlamlert, Lenbury and Bell, 2015). At 
the principle level, this could be undertaken using platelet adhesion assays which 
quantitate platelet adhesion to either glass coverslips or a collagen coated surface. 
This methodology could then be applied to a microfluidics system, which would 
investigate whether platelets can interact with periodonto-pathogens under shear 
flow and whether these interactions interfere with platelet adhesion properties under 
physiological conditions. 
Further to this, platelet interactions with the vessel wall, specifically dysfunctional or 
activated endothelium are thought to be crucial in the role of platelets within the 
development of the atherosclerotic legion as well as the terminal thrombotic events 
(Sachais, 2001). Recent developments within microfluidic chambers allow the study of 
the platelet endothelium interface and could be utilised to investigate whether 
periodontal pathogens promote the adherence to the endothelium, resulting in 
atherosclerotic disease-like phenotypes (Zilberman-Rudenko et al., 2017). 
These future studies could be coupled with patient blood samples and clinical isolates 
of periodonto-pathogens to ascertain whether the presence of specific strains of P. 
gingivalis is directly associated with the progression of CVD or whether patients with 
periodontitis behave differently to the healthy blood samples applied within this study, 
specifically addressing whether patients with an increasing severity of periodontitis 
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also present with an increase in platelet activation and aggregation, as well as an 
increased risk of CVD. 
Used in combination, the findings within this thesis as well as further work could 
identify novel contributory factors to the development of CVD, aid in the identification 
of risk factors associated with periodontitis and help develop a personalised medical 
approach to the treatment of patients through the use of platelets as complex 
biomarkers. Here it is postulated that through the identification of specific 'at risk' 
patients as well as the application of preventative periodontal monitoring and 
treatments could hold substantial prognostic promise for the future treatment of CVD. 
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